Skip to content
Calculator

Interaction Matrix

Every one of the 696 entries in the encyclopedia, with what is known about its drug interactions and where that knowledge comes from. Where a prescribing label exists it is the source; where no label exists, the record is a published study or a recorded search that found none. Entries not yet reviewed say so.

3PRGD2None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("3PRGD2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
5-Amino-1MQNone found

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("5-Amino-1MQ"[tiab] OR "5-Amino-1-methylquinolinium"[tiab] OR "5A1MQ"[tiab] OR "5-amino-1-methylquinoline"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AbaloparatideNone found

No interaction study was found in a PubMed search on 2026-10-06 (1 hit read).

The search("Abaloparatide"[tiab] OR "Tymlos"[tiab] OR "BA058"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is an animal study of myocardial ischaemia; no human interaction study.

AbarelixNone found

No interaction study was found in a PubMed search on 2026-10-05 (3 hits read).

The search("Abarelix"[tiab] OR "Plenaxis"[tiab] OR "R-3827"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are reviews of abarelix (Plenaxis) and GnRH antagonists; no interaction study. The Plenaxis label is no longer on DailyMed (withdrawn in the US).

ACE-031None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("ACE-031"[tiab] OR "ramatercept"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Decapeptide-3"[tiab] OR "Ac-YRSRKYTSWY-NH2"[tiab] OR "Rejuline"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Dipeptide-1 Cetyl Ester"[tiab] OR "Ac-Tyr-Arg-cetyl ester"[tiab] OR "Acetyl tyrosylarginine cetyl ester"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Dipeptide-3 Aminohexanoate"[tiab] OR "Ac-Arg-Ahx-Ala"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Heptapeptide-4"[tiab] OR "Ac-EEMQRRA"[tiab] OR "Fensebiome"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Hexapeptide-1"[tiab] OR "Melitane"[tiab] OR "Ac-Nle-Ala-His-D-Phe-Arg-Trp-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Acetyl Hexapeptide-30"[tiab] OR "Inyline"[tiab] OR "Acetyl Hexapeptide-25 (former INCI)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Acetyl hexapeptide-37"[tiab] OR "Diffuporine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Hexapeptide-38"[tiab] OR "Adifyline"[tiab] OR "Ac-SVVVRT"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Hexapeptide-49"[tiab] OR "Delisens"[tiab] OR "Ac-FFWFHV"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Hexapeptide-51 Amide"[tiab] OR "Ac-YEKLQV-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("acetyl octapeptide-3"[tiab] OR "SNAP-8"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Pentapeptide-1"[tiab] OR "Ac-RKDVY"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl SH-Heptapeptide-1"[tiab] OR "Acetyl Heptapeptide-20"[tiab] OR "Ac-DEETGEF"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Acetyl Tetrapeptide-11"[tiab] OR "Ac-PPYL"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2021 cell study of peptide combinations with niacinamide on skin cells; not a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Tetrapeptide-15"[tiab] OR "Skinasensyl"[tiab] OR "Ac-YPFF-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Acetyl tetrapeptide-2"[tiab] OR "Uplevity"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Tetrapeptide-22"[tiab] OR "Ac-HLLR"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Tetrapeptide-3"[tiab] OR "Ac-KGHK-NH2"[tiab] OR "Folixyl"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Acetyl Tetrapeptide-5"[tiab] OR "Eyeseryl"[tiab] OR "Ac-βAla-His-Ser-His"[tiab] OR "Ac-bAla-His-Ser-His"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Tetrapeptide-9"[tiab] OR "Ac-QDVH"[tiab] OR "Dermican"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Acetyl Tripeptide-1"[tiab] OR "Ac-GHK"[tiab] OR "Acetyl-Gly-His-Lys"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AclerastideNone found

No interaction study was found in a PubMed search on 2026-11-05 (0 hits read).

The search("aclerastide"[tiab] OR "DSC-127"[tiab] OR "DSC127"[tiab] OR "NorLeu3-angiotensin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AdamaxNone found

No interaction study was found in a PubMed search on 2026-10-06 (1 hit read).

The search("Adamax"[tiab] OR "Ac-MEHFPGP-AG-NH2"[tiab] OR "N-acetyl Semax with adamantyl P21 modification"[tiab] OR "Adamax peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a machine-learning paper on drug-combination prediction; no study of Adamax.

AdipotideNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Adipotide"[tiab] OR "Fat-Targeted Proapoptotic Peptide"[tiab] OR "Prohibitin-TP01"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AdrenomedullinNone found

No interaction study was found in a PubMed search on 2026-10-05 (67 hits read).

The search("Adrenomedullin"[tiab] OR "pro-Adrenomedullin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are animal and cell co-administration studies of the endogenous peptide; no human interaction study.

No interaction study was found in a PubMed search on 2026-10-28 (4 hits read).

The search("adrenomedullin 2"[tiab] OR "adrenomedullin-2"[tiab] OR "intermedin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All 4 hits are animal or cell studies of adrenomedullin 2 with other agents; no human drug-interaction study.

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("adrenorphin"[tiab] OR "metorphamide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (3668866): none studies a drug interaction with adrenorphin in people

AdropinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Adropin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AfamelanotideNone found

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Afamelanotide"[tiab] OR "Scenesse"[tiab] OR "Melanotan I"[tiab] OR "CUV1647"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit, a review of anti-acne agents that mentions afamelanotide in passing; not an interaction study.

No interaction study was found in a PubMed search on 2026-11-05 (29 hits read).

The search("agrp"[tiab] OR "agouti-related peptide"[tiab] OR "agouti-related protein"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

29 hit(s) read October 30, 2026 (42680126, 42411184, 40726519, 39457671, 33301842, 30035543, 29924583, 27111742, 24931195, 23872279, 22565812, 22390932, 21363936, 19933997, 17974626, 17023531, 16797500, 16226323, 16141394, 16084498): none studies a drug interaction with agouti-related peptide in people

AHK-CuNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("AHK-Cu"[tiab] OR "AHK copper peptide"[tiab] OR "Ala-His-Lys-copper"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AlamandineNone found

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("alamandine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (38008350): none studies a drug interaction with alamandine in people

PubMed

  • digoxin, warfarin, a low-dose oral contraceptive (norethindrone with ethinyl estradiol): no clinically significant pharmacokinetic or pharmacodynamic interaction in three phase 1 studies in healthy volunteers; warfarin's INR unaffectedBush, M. et al. (2012). Effects of multiple doses of albiglutide on the pharmacokinetics, pharmacodynamics, and safety of digoxin, warfarin, or a low-dose oral contraceptive. Postgraduate Medicine, 124(6), 55-72. PubMed
  • drugs studied in its clinical programme: no clinically relevant drug interactions observed (review by the manufacturer's clinical pharmacologists)Young, M. A. et al. (2014). Clinical pharmacology of albiglutide, a GLP-1 receptor agonist. Postgraduate Medicine, 126(7), 84-97. PubMed

Albiglutide was discontinued by its maker; the studies date from its development.

PubMed

  • lopinavir/ritonavir: albuvirtide exposure essentially unchanged (AUC ratio 1.09), but lopinavir (AUC ratio 0.63) and ritonavir (0.62) exposure fell; authors judged effectiveness may not be reducedYang, W. et al. (2017). Evaluation of pharmacokinetic interactions between long-acting HIV-1 fusion inhibitor albuvirtide and lopinavir/ritonavir, in HIV-infected subjects, combined with clinical study and simulation results. Xenobiotica, 47, 133-143. PubMed
AlexamorelinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Alexamorelin"[tiab] OR "Ala-His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("AlF-NOTA-octreotide"[tiab] OR "NOTA-octreotide"[tiab] OR "18F-AlF-NOTA-octreotide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Alfatide IINone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Alfatide II"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Alpha-MSHNone found

No interaction study was found in a PubMed search on 2026-10-05 (118 hits read).

The search("Alpha-MSH"[tiab] OR "α-MSH"[tiab] OR "Alpha-Melanocyte Stimulating Hormone"[tiab] OR "α-Melanotropin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are animal and cell studies of the endogenous hormone; no human interaction study.

PubMed (human clinical-trial screen)

  • L-propionyl-carnitine: enhanced PGE1's short-term effects on pain, walking distance and ulcer size in critical limb ischaemiaPharmacological treatment of patients with chronic critical limb ischemia: L-propionyl-carnitine enhances the short-term effects of PGE-1 (2009). PubMed
  • alteplase (rtPA): PGE1 did not change fibrinogen or tPA levels or clearance during thrombolysisProstaglandin E1 does not accelerate rTPA-induced thrombolysis in acute myocardial infarction (1994). PubMed

Most other human-trial hits are of PGE1 analogues (misoprostol, rioprostil), not alprostadil. The Caverject label says interactions have not been formally studied.

AmilomotideNone found

No interaction study was found in a PubMed search on 2026-10-30 (0 hits read).

The search("amilomotide"[tiab] OR "CAD106"[tiab] OR "CAD-106"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AmycretinNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Amycretin"[tiab] OR "NNC0487-0111"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AmylinNone found

No interaction study was found in a PubMed search on 2026-10-05 (83 hits read).

The search("Amylin"[tiab] OR "Islet Amyloid Polypeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are animal co-administration studies (for example with GLP-1 agonists); human combination trials are of analogues with their own entries, such as cagrilintide.

AnamorelinNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Anamorelin"[tiab] OR "ONO-7643"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Anamorelin is approved in Japan as Adlumiz; its Japanese label was not read for this record, so any interactions it lists are not reflected here.

Angiotensin IIFrom the label

FDA label, section 7

  • ACE inhibitors: may increase the response to angiotensin IIGiapreza (angiotensin II) injection, US prescribing information, section 7. DailyMed version 18, effective July 22, 2026, read September 30, 2026.
  • angiotensin II receptor blockers: may decrease the response to angiotensin IIGiapreza (angiotensin II) injection, US prescribing information, section 7. DailyMed version 18, effective July 22, 2026, read September 30, 2026.

PubMed

  • bradykinin: in healthy men it potentiated bradykinin's forearm vasodilation dose-dependently, through nitric oxideUeda S, et al. (2001). Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man. J Hypertens. PubMed
  • ACE inhibitors (with bradykinin): in heart failure patients on ACE inhibitors it had no effect alone and did not change bradykinin's vasodilationDavie AP, et al. (1999). Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor. Hypertension. PubMed
AnidulafunginFrom the label

FDA label, section 7

  • cyclosporine, voriconazole, tacrolimus: no significant change in either drug; no dose adjustmentPfizer. ERAXIS (anidulafungin) US prescribing information, section 7. DailyMed version of August 19, 2025, read October 3, 2026.
  • rifampin, liposomal amphotericin B: no significant change in anidulafungin; no dose adjustmentPfizer. ERAXIS (anidulafungin) US prescribing information, section 7. DailyMed version of August 19, 2025, read October 3, 2026.
ANPStudied

PubMed (human clinical-trial screen)

  • furosemide: in 14 heart-failure patients, ANF given with furosemide prevented the small rises in blood pressure, vascular resistance and wedge pressure seen with furosemide aloneInteraction of intravenous atrial natriuretic factor with furosemide in patients with heart failure (1994). PubMed
  • prazosin: in 8 healthy men, prazosin blunted ANF's natriuresis from a 130% to a 35% increase without changing its blood-pressure effectPrazosin attenuates the natriuretic response to atrial natriuretic factor in man (1992). PubMed

Carperitide, the approved ANP drug in Japan, has its own entry.

AnserineNone found

No interaction study was found in a PubMed search on 2026-11-07 (8 hits read).

The search("anserine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

8 hit(s) read October 30, 2026 (38135076, 32645617, 31311296, 26052340, 17240507, 15121241, 12132593, 6636174): none studies a drug interaction with anserine in people

AOD-9604None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("AOD-9604"[tiab] OR "AOD9604"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ApaminNone found

No interaction study was found in a PubMed search on 2026-10-28 (110 hits read).

The search("Apamin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

110 hits; the 40 most recent titles were screened. Apamin appears as a laboratory tool for blocking SK channels in vascular, neuronal and smooth-muscle experiments with other drugs; none is a drug interaction study in people.

ApelinNone found

No interaction study was found in a PubMed search on 2026-10-05 (20 hits read).

The search("Apelin"[tiab] OR "APLN"[tiab] OR "Apelin-13"[tiab] OR "Apelin-36"[tiab] OR "Pyr-Apelin-13"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are rodent, zebrafish and cell studies of apelin with other agents; no human interaction study.

ApidaecinNone found

No interaction study was found in a PubMed search on 2026-11-07 (3 hits read).

The search("apidaecin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (42419241, 27285299, 20206169): none studies a drug interaction with an apidaecin in people

ApitegromabNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Apitegromab"[tiab] OR "SRK-015"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ApraglutideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Apraglutide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AprotininStudied

PubMed

  • heparin: under standard heparinisation during bypass, the celite activated clotting time ran about twice as long with aprotinin, so that test overstates heparin's effect; high-dose thromboplastin and thrombin times were not affectedTabuchi N, et al. (1994). Monitoring of anticoagulation in aprotinin-treated patients during heart operation. Ann Thorac Surg. PubMed
ARA-290None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("ARA-290"[tiab] OR "Cibinetide"[tiab] OR "pHBSP"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ArenicinNone found

No interaction study was found in a PubMed search on 2026-11-07 (3 hits read).

The search("arenicin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (30360557, 28429214, 22705395): none studies a drug interaction with an arenicin in people

ArgirelineNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Argireline"[tiab] OR "Acetyl Hexapeptide-3"[tiab] OR "Acetyl Hexapeptide-8"[tiab] OR "AH-8"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AsprosinNone found

No interaction study was found in a PubMed search on 2026-11-05 (0 hits read).

The search("asprosin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AtosibanNone found

No interaction study was found in a PubMed search on 2026-09-30 (23 hits read).

The search("Atosiban"[tiab] OR "Tractocile"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

23 hits: intravenous Y-site compatibility studies, combined tocolysis experiments in isolated myometrium, and animal work. Compatibility in a line is not a pharmacological interaction, and no human interaction study was found.

Augurin (ECRG4)None found

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("augurin"[tiab] OR "ecrg4"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AureinNone found

No interaction study was found in a PubMed search on 2026-11-07 (3 hits read).

The search("aurein"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (29523862, 28478484, 17220421): none studies a drug interaction with an aurein in people

AvexitideNone found

No interaction study was found in a PubMed search on 2026-10-05 (24 hits read).

The search("Avexitide"[tiab] OR "exendin 9-39"[tiab] OR "exendin-(9-39)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits use exendin (9-39) as a GLP-1 receptor blocker in animal and cell experiments; no human drug interaction study.

AvorelinNone found

No interaction study was found in a PubMed search on 2026-11-05 (0 hits read).

The search("avorelin"[tiab] OR "meterelin"[tiab] OR "EP-23904"[tiab] OR "EP23904"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Azagly-nafarelin"[tiab] OR "Gonazon"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AZD6234None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("AZD6234"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
AzetirelinNone found

No interaction study was found in a PubMed search on 2026-11-05 (3 hits read).

The search("azetirelin"[tiab] OR "YM-14673"[tiab] OR "YM14673"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (10408236, 9487550, 2005571): none studies a drug interaction with azetirelin in people

B7-33None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("B7-33"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
BacitracinNone found

No interaction study was found in a PubMed search on 2026-09-30 (79 hits read).

The search("Bacitracin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

79 hits, essentially all laboratory synergy testing against bacteria (bacitracin combined with other antibiotics or compounds in culture) or bacitracin used as a protease inhibitor in absorption experiments; none is a drug interaction study in people.

BalenineNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Balenine"[tiab] OR "Ophidine"[tiab] OR "Isoanserine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
BalixafortideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Balixafortide"[tiab] OR "POL6326"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
BeinaglutideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search"beinaglutide"[tiab] AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

The alias 'Benefit' was excluded from the search because as a common word it matched 3,513 unrelated papers; the name-only query returned none.

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("beta-casomorphin-7"[tiab] OR "bcm-7"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (26404362): none studies a drug interaction with beta-casomorphin-7 in people

Beta-EndorphinNone found

No interaction study was found in a PubMed search on 2026-10-05 (9 hits read).

The search("Beta-Endorphin"[tiab] OR "b-Endorphin"[tiab] OR "Beta-EP"[tiab] OR "Endorphin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

The 9 human-trial hits measure endogenous beta-endorphin levels or use opioid antagonists; none gives beta-endorphin with another drug.

Beta-lipotropinNone found

No interaction study was found in a PubMed search on 2026-10-30 (15 hits read).

The search("Beta-lipotropin"[tiab] OR "Lipotropin beta"[tiab] OR "beta-LPH"[tiab] OR "Beta-lipotrophin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 15 hits are rat, guinea pig and cell studies of pro-opiomelanocortin peptides, fragments of sheep beta-lipotropin, or studies of beta-endorphin release; none gave beta-lipotropin to people, and it is measured rather than administered.

BimagrumabNone found

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("Bimagrumab"[tiab] OR "BYM338"[tiab] OR "ActRII antibody"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-05 (1 hit read).

The search("Bioactive Food Peptides"[tiab] OR "Food-Derived Peptides"[tiab] OR "Dietary Bioactive Peptides"[tiab] OR "Casein Peptides"[tiab] OR "Whey Peptides"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a rat study of opioid receptors in the antihypertensive effect of a casein hydrolysate; no human interaction study.

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Biotinoyl Tripeptide-1"[tiab] OR "Biotinyl-GHK"[tiab] OR "Procapil component"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
BivalirudinFrom the label

FDA label, section 7

  • heparin, warfarin, thrombolytics or glycoprotein IIb/IIIa inhibitors: increased risk of major bleeding when given together, seen in PCI trialsBivalirudin for injection (Avenacy), US prescribing information, section 7. DailyMed version 2, effective August 20, 2026, read September 30, 2026.
BleomycinFrom the label

FDA label, Drug Interactions

  • nephrotoxic drugs, including cisplatin: bleomycin is cleared mainly by the kidneys; cumulative cisplatin cut bleomycin clearance in a report of two children, and fatal lung toxicity occurred in a patient with unrecognised cisplatin-induced kidney failureBleomycin for injection, USP, US prescribing information, Drug Interactions. DailyMed set 640602f9, version 3, effective April 17, 2026, read October 28, 2026.
BNPStudied

PubMed

  • milrinone: studied together in decompensated heart failure; both lower filling pressures and the combination has been examined for additive hypotensionAronson D, Burger AJ. "Concomitant use of nesiritide and milrinone in decompensated congestive heart failure." Am J Health Syst Pharm. 2005;62(4):410-4. PMID: 15719588. PubMed
  • heparin-coated pulmonary artery catheters: a reported physical interaction during infusion, which is a device interaction rather than a pharmacological oneDunlap SH, et al. "Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure." Pharmacotherapy. 2004;24(12):1799-802. PMID: 15537565. PubMed
BofanglutideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("bofanglutide"[tiab] OR "GZR18"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
BombesinNone found

No interaction study was found in a PubMed search on 2026-11-05 (133 hits read).

The search("bombesin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

133 hit(s) read October 30, 2026 (29556947, 29191578, 27497631, 25563590, 24326363, 24287321, 24138638, 23826298, 23386378, 22751419, 19631337, 17669624, 16644908, 16466656, 15891892, 15860644, 15746304, 15629539, 15383372, 15147945): none studies a drug interaction with bombesin in people

Botulinum ToxinFrom the label

FDA label, section 7

  • aminoglycosides and other agents interfering with neuromuscular transmission (e.g., curare-like agents): the toxin's effect may be potentiated; use together only with cautionBOTOX (onabotulinumtoxinA), US prescribing information, section 7. DailyMed version 62, effective November 18, 2023, read October 5, 2026.
  • anticholinergic drugs: use after BOTOX may potentiate systemic anticholinergic effectsBOTOX (onabotulinumtoxinA), US prescribing information, section 7. DailyMed version 62, effective November 18, 2023, read October 5, 2026.
  • other botulinum toxin products: giving another before the previous effect has resolved may worsen excessive weaknessBOTOX (onabotulinumtoxinA), US prescribing information, section 7. DailyMed version 62, effective November 18, 2023, read October 5, 2026.
  • muscle relaxants: excessive weakness may be exaggerated when given before or after BOTOXBOTOX (onabotulinumtoxinA), US prescribing information, section 7. DailyMed version 62, effective November 18, 2023, read October 5, 2026.
BPC-157In the checker

No interaction study was found in a PubMed search on 2026-10-27 (13 hits read).

The search("BPC 157"[tiab] OR "BPC-157"[tiab] OR "Body Protective Compound 157"[tiab] OR "PL 14736"[tiab] OR "PL14736"[tiab] OR "Pentadecapeptide BPC 157"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Not studied in people. Restricted to human-only records (humans[MeSH Terms] NOT animals[MeSH Terms]) the same query returns none: the 13 hits are animal and laboratory studies. Pairs with other peptides are rated in the Interaction Checker.

BradykininStudied

PubMed (human clinical-trial screen)

  • ACE inhibitors (quinapril): bradykinin-induced release of active t-PA in the forearm more than doubled on quinapril compared with placebo or losartanPotentiation of bradykinin-induced tissue plasminogen activator release by angiotensin-converting enzyme inhibition (2001). PubMed
  • neprilysin inhibition (thiorphan) on top of an ACE inhibitor: in 10 heart-failure patients, thiorphan increased bradykinin-induced vasodilation 1.4-fold and t-PA release 1.5-foldNeutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition (2004). PubMed

Bradykinin here is an infused research probe, not a medicine; these are human vascular studies. The screen was limited to human clinical trials because the template query alone returns hundreds of records.

BrevininNone found

No interaction study was found in a PubMed search on 2026-11-07 (2 hits read).

The search("brevinin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hit(s) read October 30, 2026 (38683168, 24474334): none studies a drug interaction with a brevinin in people

BrimapitideNone found

No interaction study was found in a PubMed search on 2026-10-30 (3 hits read).

The search("brimapitide"[tiab] OR "AM-111"[tiab] OR "XG-102"[tiab] OR "D-JNKI-1"[tiab] OR "D-JNKI1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (21756552, 15773921, 14645003): animal and cell studies that used the peptide as a JNK-blocking tool; none studies a drug interaction in people

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("BRN2 (POU3F2) Research Peptide"[tiab] OR "POU3F2-derived peptide"[tiab] OR "N-Oct3 fragment"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
BronchogenNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Bronchogen"[tiab] OR "Ala-Glu-Asp-Leu"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
BuforinNone found

No interaction study was found in a PubMed search on 2026-11-07 (4 hits read).

The search("buforin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hit(s) read October 30, 2026 (33297583, 11152438, 11035200, 10817738): none studies a drug interaction with buforin in people

PubMed

  • pravastatin (OATP1B1 substrate): at high-dose bulevirtide steady state, pravastatin AUC rose 1.32-foldZhu, V. et al. (2023). Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Front Pharmacol, 14, 1128547. PubMed
  • tenofovir disoproxil: no relevant change in tenofovir pharmacokinetics; CYP3A activity fell 29% during combination; plasma bile acids rose 19-foldBlank, A. et al. (2018). The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics. Clin Pharmacol Ther, 103, 341-348. PubMed
BuserelinNone found

No interaction study was found in a PubMed search on 2026-09-30 (20 hits read).

The search("Buserelin"[tiab] OR "Suprefact"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

20 hits: absorption-enhancer and drug-delivery experiments using buserelin as a model peptide, animal work, and trials of other drugs given in GnRH agonist protocols. No human interaction study of buserelin itself.

C-peptideNone found

No interaction study was found in a PubMed search on 2026-10-28 (97 hits read).

The search("C-peptide"[tiab] OR "connecting peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Of the 97 hits, the 25 most relevant by PubMed's ranking were read by title: each measures C-peptide as a marker of insulin secretion in studies of other drugs, or is a review or case report; none gives C-peptide itself as a drug with another drug.

PubMed

  • semaglutide 2.4 mg: concomitant administration studied in a randomised phase 1b trial (96 participants) of safety, pharmacokinetics and pharmacodynamics; the combination is investigational as CagriSemaEnebo, L. B. et al. (2021). Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet, 397, 1736-1748. PubMed

Found by a follow-up search for concomitant administration (the template query does not include 'concomitant'). The template's six hits are rat studies, the REDEFINE 2 efficacy trial of the combination, and two unrelated pharmacokinetics papers.

CagriSemaNone found

No interaction study was found in a PubMed search on 2026-10-06 (2 hits read).

The search("CagriSema"[tiab] OR "cagrilintide/semaglutide 2.4/2.4"[tiab] OR "NN9838"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are the efficacy trial of the cagrilintide-semaglutide combination itself and an animal study; no study of CagriSema with another drug.

CalcitoninFrom the label

FDA label, section 7 (no formal interaction studies were performed)

  • lithium: may lower plasma lithium by increasing its urinary clearance; the lithium dose may need adjustingMiacalcin (calcitonin salmon) injection, US prescribing information, section 7. DailyMed version 5, effective September 15, 2024, read September 30, 2026.
CanvuparatideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("canvuparatide"[tiab] OR "MBX 2109"[tiab] OR "MBX2109"[tiab] OR "PPL 2717"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
CapreomycinNone found

No interaction study was found in a PubMed search on 2026-10-05 (28 hits read).

The search("Capreomycin"[tiab] OR "Capastat"[tiab] OR "Capreomycin sulfate"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory synergy studies against mycobacteria and tuberculosis reviews; no human pharmacokinetic interaction study.

CapromorelinNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Capromorelin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Capromorelin is approved only as a veterinary drug (Entyce, Elura); no human interaction study is published.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Caprooyl Tetrapeptide-3"[tiab] OR "Hexanoyl-Gly-Gln-Pro-Arg"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
CarbetocinNone found

No interaction study was found in a PubMed search on 2026-09-30 (4 hits read).

The search("Carbetocin"[tiab] OR "Pabal"[tiab] OR "Duratocin"[tiab] OR "Lonactene"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The four hits are animal behaviour studies and an in vitro enzyme study; no interaction study in people. Approved outside the US.

CardiogenNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Cardiogen"[tiab] OR "Ala-Glu-Asp-Arg"[tiab] OR "AEDR"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • midazolam (a CYP3A substrate): carfilzomib inhibited CYP3A in human liver microsomes, but did not change midazolam pharmacokinetics in patients with solid tumours; because it is cleared mainly by peptidases and epoxide hydrolysis, CYP450 inhibitors or inducers are unlikely to change its exposureWang, Z. et al. (2013). Clinical pharmacokinetics, metabolism, and drug-drug interaction of carfilzomib. Drug Metab Dispos, 41, 230-7. PubMed

85 hits, most of them laboratory combination studies; the targeted search for a clinical interaction study found the 2013 clinical pharmacokinetics and interaction study, read in full abstract.

CarnosineStudied

PubMed

  • acetaminophen (paracetamol): co-administration relieved neuropathic pain more than acetaminophen alone in rats with nerve injury; animal workOwoyele BV, et al. "Synergistic interaction between acetaminophen and L-carnosine improved neuropathic pain via NF-κB pathway and antioxidant properties in chronic constriction injury model." Korean J Pain, 2022;35(3):271-279. PMID: 35768982. PubMed
  • 5-fluorouracil: in colon cancer cells it overcame acquired resistance to 5-fluorouracil; laboratory workIovine B, et al. "l-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis." Biochimie, 2016;127:196-204. PMID: 27234614. PubMed

Most of the 37 hits are animal or cell combinations; no interaction study in people was found.

CarperitideNone found

No interaction study was found in a PubMed search on 2026-09-30 (5 hits read).

The search("Carperitide"[tiab] OR "α-hANP"[tiab] OR "human atrial natriuretic peptide"[tiab] OR "recombinant hANP"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The five hits are in vitro and animal studies (for example, human bronchial rings in vitro, 1994); no interaction study in people. Approved in Japan.

CART peptideNone found

No interaction study was found in a PubMed search on 2026-10-30 (15 hits read).

The search("CART peptide"[tiab] OR "Cocaine- and amphetamine-regulated transcript peptide"[tiab] OR "CARTp"[tiab] OR "CART(42-89)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 15 hits are rat and mouse studies combining CART peptide given into the brain with other agents, plus one retracted paper; none is a human interaction study, and CART has not been given to people.

CartalaxNone found

No interaction study was found in a PubMed search on 2026-09-30 (2 hits read).

The search("Cartalax"[tiab] OR "Ala-Glu-Asp"[tiab] OR "AED tripeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The two hits are unrelated (a breast-cancer genomics paper and a heparin cofactor peptide).

CaspofunginFrom the label

FDA label, section 7

  • cyclosporine: raises caspofungin exposure (AUC) with transient ALT/AST increases; monitor liver enzymesMerck. CANCIDAS (caspofungin acetate) US prescribing information, section 7. DailyMed version of October 11, 2024, read October 3, 2026.
  • tacrolimus: monitor tacrolimus trough concentrations and adjust its doseMerck. CANCIDAS (caspofungin acetate) US prescribing information, section 7. DailyMed version of October 11, 2024, read October 3, 2026.
  • rifampin: expected to lower caspofungin concentrations; label gives a higher daily caspofungin doseMerck. CANCIDAS (caspofungin acetate) US prescribing information, section 7. DailyMed version of October 11, 2024, read October 3, 2026.
  • efavirenz, nevirapine, phenytoin, dexamethasone, carbamazepine: hepatic enzyme inducers: label says to consider a higher daily caspofungin doseMerck. CANCIDAS (caspofungin acetate) US prescribing information, section 7. DailyMed version of October 11, 2024, read October 3, 2026.
CatestatinNone found

No interaction study was found in a PubMed search on 2026-11-05 (4 hits read).

The search("catestatin"[tiab] OR "cateslytin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hit(s) read October 30, 2026 (29123174, 19785998, 16612252, 15326220): none studies a drug interaction with catestatin in people

CathelicidinNone found

No interaction study was found in a PubMed search on 2026-10-05 (1 hit read).

The search("Cathelicidin"[tiab] OR "hCAP-18"[tiab] OR "Cathelicidin Antimicrobial Peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

The one human-trial hit measures blood cathelicidin levels after vitamin D therapy; nothing gives cathelicidin with another drug. LL-37, the active fragment, has its own entry.

CecropinNone found

No interaction study was found in a PubMed search on 2026-10-05 (28 hits read).

The search("Cecropin"[tiab] OR "Cecropin A"[tiab] OR "Cecropin B"[tiab] OR "Cecropin P1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory and rodent synergy studies of insect cecropins with antibiotics; no human interaction study.

CenderitideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("cenderitide"[tiab] OR "CD-NP"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
CerebrolysinNone found

No interaction study was found in a PubMed search on 2026-09-30 (16 hits read).

The search("Cerebrolysin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study in people. The co-administration hits are rodent neuroprotection experiments combining it with stem cells, antibodies or nanowired delivery, one of which has been retracted; a 2020 Russian clinical paper discusses combining neuroprotective regimens without measuring an interaction.

CerlutenNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Cerluten"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • gemcitabine and nab-paclitaxel: co-administration is the point of the drug, not a hazard to avoid: in 31 patients the peptide was given on each chemotherapy day with no dose-limiting toxicity and a side-effect pattern the authors judged consistent with the chemotherapy pair aloneDean, A. et al. (2022). Dual alphaV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study. Lancet Gastroenterology & Hepatology, 7(10), 943-951. PubMed
  • impaired kidney function (not a drug interaction, recorded here because it changes exposure): clearance falls and exposure rises as creatinine clearance falls, which is why trials required adequate renal function; body weight affects the volumes of distributionWinning, B. et al. (2025). Population pharmacokinetic modeling of certepetide in human subjects with metastatic pancreatic ductal adenocarcinoma. Journal of Clinical Pharmacology. PubMed

Of the 45 hits, none is a conventional drug interaction study of this peptide: they are nanoparticle, liposome and conjugate papers that use the word co-administration for carrying a payload. The record is 'studied' because the human work above was done precisely to measure what happens when the peptide is given with chemotherapy, which is how it is always used. The pharmacokinetic interaction itself has only been measured in animals: in mice the peptide raised the tumour uptake and therapeutic index of doxorubicin, nab-paclitaxel, liposomal doxorubicin and trastuzumab without being attached to any of them (the 2010 co-administration paper, carded on the entry page). Its size in people is unmeasured.

CeruletideNone found

No interaction study was found in a PubMed search on 2026-10-05 (111 hits read).

The search("Ceruletide"[tiab] OR "Caerulein"[tiab] OR "Cerulein"[tiab] OR "Tymtran"[tiab] OR "Ceruletide diethylamine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Ceruletide is used to induce pancreatitis in animal models; the hits are animal studies of other agents given with it, not interaction studies in people.

CetrorelixNone found

No interaction study was found in a PubMed search on 2026-10-06 (6 hits read).

The search("Cetrorelix"[tiab] OR "Cetrotide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are cell and animal studies (one of clomiphene pretreatment in cultured pituitary cells); no human interaction study. The Cetrotide label says no formal interaction studies were performed.

CGRPStudied

PubMed (human clinical-trial screen)

  • sumatriptan: CGRP dilated the middle meningeal artery and sumatriptan contracted it (15% to 25%)Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers (2010). PubMed

Most human-trial hits are drug-drug studies of the CGRP-blocking migraine drugs (gepants, erenumab), not of CGRP itself.

CholecystokininFrom the label

FDA label (Kinevac, sincalide), section 7

  • drugs that stimulate or inhibit gallbladder motility or contraction: may interfere with the response to sincalide; consider stopping them before the testBracco. KINEVAC (sincalide) for injection, US prescribing information, section 7. DailyMed version effective October 18, 2023, read October 5, 2026.

The approved product is sincalide, the C-terminal octapeptide of cholecystokinin.

ChonlutenNone found

No interaction study was found in a PubMed search on 2026-10-05 (1 hit read).

The search("Chonluten"[tiab] OR "Glu-Asp-Gly"[tiab] OR "EDG tripeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit studies genomic variability in breast-cancer patients' samples with a peptide bioregulator and metal ions; it is not a drug interaction study.

ChromofunginNone found

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("chromofungin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
CilengitideNone found

No interaction study was found in a PubMed search on 2026-10-03 (6 hits read).

The search("Cilengitide"[tiab] OR "EMD 121974"[tiab] OR "EMD121974"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All 6 hits are animal or cell studies of cilengitide combined with other cancer drugs or exposures (doxorubicin cardiotoxicity in rats, melphalan limb perfusion in a sarcoma model, temozolomide in melanoma, a FAK inhibitor with cabozantinib, SO2/arsenic exposure, a dual-action combination); none is a human drug interaction study.

CJC-1293None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("CJC-1293"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
CJC-1295In the checker

No interaction study was found in a PubMed search on 2026-10-27 (0 hits read).

The search("CJC-1295"[tiab] OR "CJC 1295"[tiab] OR "DAC:GRF"[tiab] OR "Drug Affinity Complex:GRF"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Not studied: no published interaction study. Pairs with other peptides are rated in the Interaction Checker.

ClavaninNone found

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("clavanin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (28226206): none studies a drug interaction with a clavanin in people

CNPStudied

PubMed

  • corticorelin (CRH) stimulation test: a 300 microgram CNP infusion enhanced the cortisol and prolactin responses to CRH in 8 healthy men; 150 micrograms had no clear effectC-type natriuretic peptide exerts stimulatory effects on the corticotropin-releasing hormone-induced secretion of hormones in normal man (1997). PubMed

Most other hits are animal or cell studies, and several are unrelated uses of the abbreviation CNP.

ColistinFrom the label

FDA label, Drug Interactions

  • aminoglycosides and polymyxins: also interfere with neuromuscular transmission; give together only with the greatest cautionColy-Mycin M Parenteral (colistimethate sodium) for injection, US prescribing information, Drug Interactions. DailyMed version 27, effective June 8, 2026, read September 30, 2026.
  • curariform muscle relaxants such as tubocurarine, and ether, succinylcholine, gallamine, decamethonium and sodium citrate: potentiate neuromuscular blockade; use with extreme cautionColy-Mycin M Parenteral (colistimethate sodium) for injection, US prescribing information, Drug Interactions. DailyMed version 27, effective June 8, 2026, read September 30, 2026.
  • sodium cephalothin: may increase kidney toxicity; the label says to avoid using them togetherColy-Mycin M Parenteral (colistimethate sodium) for injection, US prescribing information, Drug Interactions. DailyMed version 27, effective June 8, 2026, read September 30, 2026.
Colivelin (CLN)None found

No interaction study was found in a PubMed search on 2026-11-07 (3 hits read).

The search("colivelin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (42660454, 41868946, 34956461): none studies a drug interaction with colivelin in people

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("collagen peptides"[ti] OR "collagen hydrolysate"[ti]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit tests a milk-ceramide and collagen-peptide mixture against UV damage in cells and mice, a supplement combination rather than a drug interaction.

ColostrininNone found

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Colostrinin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit is a rat hippocampal culture study of amyloid-beta toxicity, not an interaction.

ColulintideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("colulintide"[tiab] OR "LY3541105"[tiab] OR "LY-3541105"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
CopeptinNone found

No interaction study was found in a PubMed search on 2026-10-28 (3 hits read).

The search("copeptin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 3 hits measure copeptin as a marker in studies of other drugs or are conference abstracts; copeptin is not given as a drug.

Copper Cu 64 dotatateFrom the label

FDA label, section 7

  • long-acting somatostatin analogues: compete for receptors; a 28-day washout is recommended before imagingCurium. DETECTNET (copper Cu 64 dotatate) US prescribing information, section 7. DailyMed version of January 31, 2025, read October 3, 2026.
  • short-acting somatostatin analogues: compete for receptors; a 2-day washout is recommended before imagingCurium. DETECTNET (copper Cu 64 dotatate) US prescribing information, section 7. DailyMed version of January 31, 2025, read October 3, 2026.

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Corifollitropin alfa"[tiab] OR "Elonva"[tiab] OR "FSH-CTP"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is an unrelated fusion-protein construct paper. Approved in the EU (Elonva); its EU product information is not yet part of this review.

CortagenNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Cortagen"[tiab] OR "Cortexin peptide"[tiab] OR "Ala-Glu-Asp-Pro"[tiab] OR "AEDP"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
CortexinNone found

No interaction study was found in a PubMed search on 2026-09-30 (2 hits read).

The search("Cortexin"[tiab] OR "Cortexinum"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are a Russian review of drug synergism in neuroprotection and a 1988 animal study of transplacental carcinogenesis; no human interaction study.

CorticorelinFrom the label

FDA label, precautions (drug interactions)

  • dexamethasone pretreatment: inhibits or blunts the plasma ACTH response to corticorelinFerring. ACTHREL (corticorelin ovine triflutate for injection), US prescribing information, Precautions: Drug Interactions. DailyMed version of November 12, 2021, read September 30, 2026.
  • heparin (to keep an intravenous cannula open): not recommended during the test; a possible interaction may explain a major hypotensive reaction after corticorelinFerring. ACTHREL (corticorelin ovine triflutate for injection), US prescribing information, Precautions: Drug Interactions. DailyMed version of November 12, 2021, read September 30, 2026.
CorticotropinFrom the label

FDA label, section 7

  • diuretics: may accentuate diuretic-associated electrolyte loss; no formal interaction studies were performedMallinckrodt. ACTHAR GEL (repository corticotropin injection) US prescribing information, section 7. DailyMed version 32, effective October 13, 2026, read October 27, 2026.

No interaction study was found in a PubMed search on 2026-11-03 (0 hits read).

The search("corticotropin-like intermediate lobe peptide"[tiab] OR "corticotropin-like intermediate peptide"[tiab] OR "ACTH(18-39)"[tiab] OR "ACTH 18-39"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No hits; CLIP has not been given to people, only measured in tissue and given to animals. The bare abbreviation CLIP is excluded from the query because it also names unrelated molecules (CLIP-170, the class II invariant-chain peptide).

PubMed

  • GHRH: an infusion of human cortistatin-17 blunted the growth hormone response to GHRH, as somatostatin-14 didCortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans (2004). PubMed
  • ghrelin: cortistatin-17 blunted ghrelin's growth hormone response and abolished ghrelin's inhibition of insulinCortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans (2004). PubMed

Of the 4 hits, one is an infusion of rat cortistatin-14 (a different molecule, listed under References on the entry), one is a cell study of amyloid effects on expression, one a receptor review and one a somatostatin study in chicks. The human interaction rows above come from the human cortistatin-17 infusion study on the entry.

CotadutideNone found

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Cotadutide"[tiab] OR "MEDI0382"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit is a receptor-pharmacology paper on biased agonism at the GLP-1 and glucagon receptors, not an interaction study.

CP04None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("CP04"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Cyclic Glycine-Proline"[tiab] OR "Cyclo(Gly-Pro)"[tiab] OR "Cyclo(glycylprolyl)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2026 study of dietary peptides from essence of chicken and their synergy in neuroprotection models; not a drug interaction study in people.

Cyclo(His-Pro)None found

No interaction study was found in a PubMed search on 2026-10-28 (7 hits read).

The search("Cyclo(His-Pro)"[tiab] OR "Histidyl-proline diketopiperazine"[tiab] OR "Cyclo(L-His-L-Pro)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

7 hits, all rat or mouse studies from 1984 to 2001 combining cyclo(His-Pro) with amphetamine, fenfluramine, serotonin, TRH, zinc and arachidonic acid, or an opioid dipeptide; none is a drug interaction study in people.

CyclosporineFrom the label

FDA label (Neoral), Clinical Pharmacology and Precautions (both Drug Interactions sections)

  • drugs that raise cyclosporine levels (for example diltiazem, verapamil, fluconazole, itraconazole, ketoconazole, azithromycin, clarithromycin, methylprednisolone, allopurinol, amiodarone): higher cyclosporine concentrations; monitor levels and adjust the doseNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • grapefruit and grapefruit juice: raise cyclosporine concentrations and should be avoidedNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • drugs and supplements that lower cyclosporine levels (for example rifampin, carbamazepine, phenytoin, phenobarbital, St. John's wort, octreotide, orlistat, terbinafine): lower cyclosporine concentrations and possible loss of effect; monitor levelsNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • drugs that may worsen kidney function (for example gentamicin, tobramycin, vancomycin, amphotericin B, ciprofloxacin, tacrolimus, NSAIDs such as diclofenac and naproxen): additive risk of kidney dysfunction; monitor closelyNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor blockers and potassium-containing drugs: risk of high potassium; caution, and avoid potassium-sparing diureticsNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • digoxin, colchicine, statins, aliskiren, bosentan, dabigatran, repaglinide, sirolimus and etoposide: cyclosporine can raise their exposure; see the other drug's labelNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • live vaccines: vaccination may be less effective; live vaccines should be avoidedNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • diclofenac and methotrexate: their exposure rose significantly when co-administered with cyclosporine in rheumatoid arthritis patientsNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
  • aspirin, ketoprofen, piroxicam and indomethacin: no clinically significant pharmacokinetic interaction was seenNovartis. NEORAL (cyclosporine capsules, modified) US prescribing information, Clinical Pharmacology and Precautions, Drug Interactions. DailyMed version effective August 10, 2026, read October 5, 2026.
D-4FNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("D-4F"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a mouse and monkey study of D-4F with statins; no human drug-interaction study.

DactinomycinNone found

No interaction study was found in a PubMed search on 2026-10-28 (476 hits read).

The search("Dactinomycin"[tiab] OR "Actinomycin D"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

476 hits; the 40 most recent titles were screened. Nearly all use actinomycin D as a laboratory reagent in cell experiments with other drugs; one 2025 paediatric cardiotoxicity analysis lists it among anticancer drugs. None is a pharmacokinetic drug interaction study, and the label read for this entry has no drug interaction section.

DalazatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Dalazatide"[tiab] OR "ShK-186"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DalbavancinFrom the label

FDA label, section 7

  • CYP450 substrates, inhibitors and inducers: no clinical drug-drug interaction studies conducted; the label states minimal potential for interactionAbbVie. DALVANCE (dalbavancin) for injection, US prescribing information, section 7. DailyMed version effective January 13, 2025, read October 3, 2026.
  • laboratory clotting tests (PT, aPTT): the label states dalbavancin at therapeutic concentrations does not artificially prolong themAbbVie. DALVANCE (dalbavancin) for injection, US prescribing information, section 7. DailyMed version effective January 13, 2025, read October 3, 2026.
DanegaptideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Danegaptide"[tiab] OR "ZP1609"[tiab] OR "ZP-1609"[tiab] OR "GAP-134"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DanuglipronNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Danuglipron"[tiab] OR "PF-06882961"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DapiglutideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("dapiglutide"[tiab] OR "ZP7570"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DAPTANone found

No interaction study was found in a PubMed search on 2026-11-03 (3 hits read).

The search("DAPTA"[tiab] OR "D-Ala-peptide T-amide"[tiab] OR "peptide T"[tiab] OR "Adaptavir"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (24316469, 11457652, 3287919): animal and cell studies that used it as a CCR5-blocking tool; none studies a drug interaction in people

DaptomycinFrom the label

FDA label, section 7

  • HMG-CoA reductase inhibitors (statins): experience together is limited and some patients on both had raised creatine phosphokinase; consider suspending the statin during treatmentCubicin RF (daptomycin) for injection, US prescribing information, section 7. DailyMed version 22, effective March 17, 2025, read September 30, 2026.
  • recombinant thromboplastin reagents used for prothrombin time and INR: a laboratory interaction that falsely prolongs PT and raises INR; draw the sample near the trough and consider another methodCubicin RF (daptomycin) for injection, US prescribing information, section 7. DailyMed version 22, effective March 17, 2025, read September 30, 2026.
DasiglucagonFrom the label

FDA label (Zegalogue), section 7

  • beta-blockers: transient increase in pulse and blood pressureNovo Nordisk. ZEGALOGUE (dasiglucagon) injection, US prescribing information, section 7. DailyMed version effective January 1, 2023, read October 5, 2026.
  • indomethacin: dasiglucagon may fail to raise blood glucose or may even produce hypoglycaemiaNovo Nordisk. ZEGALOGUE (dasiglucagon) injection, US prescribing information, section 7. DailyMed version effective January 1, 2023, read October 5, 2026.
  • warfarin: may increase warfarin's anticoagulant effectNovo Nordisk. ZEGALOGUE (dasiglucagon) injection, US prescribing information, section 7. DailyMed version effective January 1, 2023, read October 5, 2026.
DavalintideNone found

No interaction study was found in a PubMed search on 2026-11-05 (1 hit read).

The search("davalintide"[tiab] OR "AC-2307"[tiab] OR "AC2307"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (24167604): none studies a drug interaction with davalintide in people

DavunetideNone found

No interaction study was found in a PubMed search on 2026-09-30 (3 hits read).

The search("Davunetide"[tiab] OR "AL-108"[tiab] OR "NAPVSIPQ"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are a rat epilepsy study, a study of NAP analogues and a development review; the alias 'NAP' was excluded as a common word.

DazdotuftideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Dazdotuftide"[tiab] OR "TRS01"[tiab] OR "TRS-01"[tiab] OR "tuftsin-phosphorylcholine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Decapeptide-12None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Decapeptide-12"[tiab] OR "Lumixyl"[tiab] OR "YRSRKYSSWY"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DegarelixNone found

No interaction study was found in a PubMed search on 2026-10-06 (5 hits read).

The search("Degarelix"[tiab] OR "Firmagon"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are reviews and an in-vitro CYP450 study; the Firmagon label says degarelix is not a CYP450 substrate, inducer or inhibitor and that no interaction studies were done.

DeltorphinNone found

No interaction study was found in a PubMed search on 2026-11-05 (59 hits read).

The search("deltorphin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

59 hit(s) read October 30, 2026 (33374986, 25598508, 25446445, 24039246, 23965295, 23183627, 22995282, 20970925, 19846714, 19020012, 18815346, 18648240, 18537773, 18434033, 17855473, 17568695, 17494863, 17110034, 16847946, 16716526): none studies a drug interaction with deltorphin in people

DemoxytocinNone found

No interaction study was found in a PubMed search on 2026-11-05 (1 hit read).

The search("demoxytocin"[tiab] OR "desaminooxytocin"[tiab] OR "deaminooxytocin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (4293787): none studies a drug interaction with demoxytocin in people

DepreotideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Depreotide"[tiab] OR "Tc-99m depreotide"[tiab] OR "NeoTect"[tiab] OR "Neospect"[tiab] OR "P829"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DermcidinNone found

No interaction study was found in a PubMed search on 2026-10-05 (2 hits read).

The search("Dermcidin"[tiab] OR "DCD-1L"[tiab] OR "Sweat antimicrobial peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are laboratory studies (a bacterial ionophore acting with host peptides; a hair-follicle microbiome odorant); no human drug interaction study.

DermorphinNone found

No interaction study was found in a PubMed search on 2026-10-05 (21 hits read).

The search("Dermorphin"[tiab] OR "[D-Ala2]-dermorphin"[tiab] OR "Phyllomedusa opioid peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are rat, guinea-pig and cell pharmacology studies; the one human study, from 1983, measured dermorphin's own effect on growth hormone, not an interaction.

No interaction study was found in a PubMed search on 2026-11-06 (12 hits read).

The search("des-acyl ghrelin"[tiab] OR "desacyl ghrelin"[tiab] OR "unacylated ghrelin"[tiab] OR "des-octanoyl ghrelin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

12 hit(s) read October 30, 2026 (36958671, 36580314, 34132689, 30045005, 29860222, 25047815, 21435395, 19628651, 19153523, 18938204, 17578884, 17068144): des-acyl ghrelin is studied for its interaction with acylated ghrelin (which it opposes), not as a drug-drug interaction in people

DesirudinNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("desirudin"[tiab] OR "Iprivask"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are reviews and trials of desirudin, not human drug-interaction studies.

DeslorelinNone found

No interaction study was found in a PubMed search on 2026-10-05 (4 hits read).

The search("Deslorelin"[tiab] OR "D-Trp6-Pro9-NEt-LHRH"[tiab] OR "Suprelorin"[tiab] OR "Somagard"[tiab] OR "deslorelin acetate"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are formulation and cyclodextrin-binding studies and a 1986 sperm-density study of an LHRH analogue with testosterone; no interaction study of the veterinary implant.

DesmopressinFrom the label

FDA label, precautions (drug interactions)

  • other pressor agents: large doses should be used with other pressor agents only with careful monitoringFerring Pharmaceuticals. DDAVP (desmopressin acetate) tablets, US prescribing information, Precautions: Drug Interactions. DailyMed version of December 10, 2025, read September 30, 2026.
  • drugs that raise the risk of water intoxication with hyponatraemia (tricyclic antidepressants, SSRIs, chlorpromazine, opiate analgesics, NSAIDs, lamotrigine, carbamazepine): use together with cautionFerring Pharmaceuticals. DDAVP (desmopressin acetate) tablets, US prescribing information, Precautions: Drug Interactions. DailyMed version of December 10, 2025, read September 30, 2026.
DetirelixNone found

No interaction study was found in a PubMed search on 2026-11-05 (1 hit read).

The search("detirelix"[tiab] OR "RS-68439"[tiab] OR "RS68439"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (1787450): none studies a drug interaction with detirelix in people

DifelikefalinNone found

No interaction study was found in a PubMed search on 2026-10-03 (1 hit read).

The search("Difelikefalin"[tiab] OR "Korsuva"[tiab] OR "CR845"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit is a drug review of difelikefalin for kidney-disease itch, not an interaction study. The Korsuva label (DailyMed August 26, 2025) has no drug interactions section.

DihexaNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Dihexa"[tiab] OR "PNB-0408"[tiab] OR "N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Dipeptide-2None found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Dipeptide-2"[tiab] OR "Valyltryptophan"[tiab] OR "Val-Trp"[tiab] OR "L-valyl-L-tryptophan"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: a 1996 study of angiotensin-converting-enzyme inhibition by retro-inverso peptide analogues and a 1979 mouse study of amino acids in gelatin-induced inflammation; neither is a drug interaction study of Val-Trp in people.

DirucotideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Dirucotide"[tiab] OR "MBP8298"[tiab] OR "MBP 82-98"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DisomotideNone found

No interaction study was found in a PubMed search on 2026-11-03 (0 hits read).

The search("disomotide"[tiab] OR "gp100:209-217(210M)"[tiab] OR "g209-2M"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DolcanatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("dolcanatide"[tiab] OR "SP-333"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DOTA-EB-TATENone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("DOTA-EB-TATE"[tiab] OR "EB-TATE"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DOTA-LM3None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("DOTA-LM3"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DOTA-MGS5None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("DOTA-MGS5"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DOTAMTATENone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("DOTAMTATE"[tiab] OR "oxoreotide atexetan"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DOTANOCNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("DOTANOC"[tiab] OR "DOTA-NOC"[tiab] OR "DOTA-nal3-octreotide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DrosocinNone found

No interaction study was found in a PubMed search on 2026-11-07 (0 hits read).

The search("drosocin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DSIPStudied

PubMed

  • corticorelin (human CRH) stimulation test: intravenous DSIP (3-4 mg) did not change ACTH or cortisol responses to CRH, or the meal-related midday surge, in healthy young menDelta-sleep-inducing peptide does not affect CRH and meal-induced ACTH and cortisol secretion (1995). PubMed

The other hits are rat studies.

DulaglutideFrom the label

FDA label, section 7

  • oral medicines, especially those with a narrow therapeutic index such as warfarin: delays stomach emptying and can slow their absorption; monitor drug levelsTrulicity (dulaglutide) injection, US prescribing information, section 7. DailyMed version 62, effective June 16, 2026, read September 30, 2026.
  • insulin secretagogues such as sulfonylureas, or insulin: raises the risk of low blood sugar; consider reducing their dose when startingTrulicity (dulaglutide) injection, US prescribing information, section 7. DailyMed version 62, effective June 16, 2026, read September 30, 2026.
DusquetideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Dusquetide"[tiab] OR "SGX942"[tiab] OR "SGX94"[tiab] OR "SGX945"[tiab] OR "Arg-Ile-Val-Pro-Ala-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
DynorphinNone found

No interaction study was found in a PubMed search on 2026-10-05 (1 hit read).

The search("Dynorphin"[tiab] OR "Dynorphin A"[tiab] OR "Dynorphin B"[tiab] OR "Big Dynorphin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

The one human-trial hit is a study of a kappa-opioid antagonist drug; no study gives dynorphin with another drug.

EbiratideNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Ebiratide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: a 1994 study of protease inhibitors protecting ebiratide in rat intestine and a 1988 rat brain neurochemistry study; neither is a drug interaction study in people.

EcallantideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("ecallantide"[tiab] OR "DX-88"[tiab] OR "Kalbitor"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The Kalbitor label (DailyMed July 1, 2025) states that no formal drug interaction or in vitro metabolism studies were performed.

ECC5004None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("AZD5004"[tiab] OR "ECC5004"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • rosuvastatin and digoxin: no clinically significant pharmacokinetic interaction and no dose adjustment needed, though digoxin monitoring is advised in kidney impairmentEffect of a novel GLP-1 analogue ecnoglutide on the pharmacokinetics of rosuvastatin and digoxin in healthy participants (2026). PubMed
  • warfarin and metformin: no clinically significant interaction; INR profiles unchangedNo dose adjustment required for warfarin or metformin when coadministered with the novel GLP-1 receptor agonist ecnoglutide (2026). PubMed
EdotreotideFrom the label

FDA label, section 7

  • long-acting somatostatin analogues: compete for the same receptors; image just before the next long-acting doseUIHC PET Imaging Center. Ga 68 DOTATOC (gallium Ga 68 edotreotide) injection US prescribing information, section 7. DailyMed version of December 8, 2021, read October 3, 2026.
  • short-acting somatostatin analogues: can be used up to 24 hours before imagingUIHC PET Imaging Center. Ga 68 DOTATOC (gallium Ga 68 edotreotide) injection US prescribing information, section 7. DailyMed version of December 8, 2021, read October 3, 2026.
EdratideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Edratide"[tiab] OR "hCDR1"[tiab] OR "TV-4710"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EfinopegdutideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("efinopegdutide"[tiab] OR "MK-6024"[tiab] OR "JNJ-64565111"[tiab] OR "HM12525A"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("efmedaglutide"[tiab] OR "TG103"[tiab] OR "TJ103"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EfocipegtrutideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("efocipegtrutide"[tiab] OR "HM15211"[tiab] OR "HM-15211"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EfpeglenatideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Efpeglenatide"[tiab] OR "HM11260C"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EfruxiferminNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("efruxifermin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • digoxin, metformin: at steady state on 3 mg, digoxin's peak fell about 24% and its AUC rose about 15%, metformin was not noticeably affected; the authors judged neither clinically significant and saw no need to adjust dosesWu X, et al. (2025). Effect of Efsubaglutide Alfa on the Pharmacokinetics of Metformin and Digoxin in Healthy Participants. Clin Pharmacokinet. PubMed

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Eftansomatropin alfa"[tiab] OR "GX-H9"[tiab] OR "efpegsomatropin"[tiab] OR "Declage"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ElabelaNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("elabela"[tiab] OR "ELA-32"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ElagolixFrom the label

FDA label, section 7

  • digoxin: raises digoxin levels; monitor more closely when starting or stopping elagolixOrilissa (elagolix) tablets, US prescribing information, section 7. DailyMed version 112, effective December 19, 2025, read September 30, 2026.
  • oral midazolam: lowers midazolam levels; consider up to a two-fold dose increase, individualisedOrilissa (elagolix) tablets, US prescribing information, section 7. DailyMed version 112, effective December 19, 2025, read September 30, 2026.
  • rosuvastatin: lowers rosuvastatin levels; monitor lipids and adjust if neededOrilissa (elagolix) tablets, US prescribing information, section 7. DailyMed version 112, effective December 19, 2025, read September 30, 2026.
  • omeprazole: raises omeprazole levels; consider a lower omeprazole dose at higher dosesOrilissa (elagolix) tablets, US prescribing information, section 7. DailyMed version 112, effective December 19, 2025, read September 30, 2026.
  • combined hormonal contraceptives: raises ethinyl estradiol and lowers levonorgestrel; use effective non-hormonal contraception during treatment and for 28 days afterOrilissa (elagolix) tablets, US prescribing information, section 7. DailyMed version 112, effective December 19, 2025, read September 30, 2026.
  • strong CYP3A inhibitors: raise elagolix levels; concomitant use with 200 mg twice daily beyond 1 month is not recommended, and with 150 mg once daily is limited to 6 monthsOrilissa (elagolix) tablets, US prescribing information, section 7. DailyMed version 112, effective December 19, 2025, read September 30, 2026.
ElamipretideNone found

No interaction study was found in a PubMed search on 2026-11-05 (3 hits read).

The search("elamipretide"[tiab] OR "SS-31"[tiab] OR "SS31"[tiab] OR "MTP-131"[tiab] OR "Bendavia"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (42443448, 39732061, 20463406): none studies a drug interaction with elamipretide in people

ElcatoninNone found

No interaction study was found in a PubMed search on 2026-10-05 (7 hits read).

The search("Elcatonin"[tiab] OR "Eel calcitonin analogue"[tiab] OR "Elcatonina"[tiab] OR "Elcatonine"[tiab] OR "[Asu1,7]-eel calcitonin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Human hits are combination efficacy trials (elcatonin with conjugated oestrogens, a transdermal elcatonin study, and a comparison with incadronate in hypercalcaemia), not interaction studies; the rest are animal and formulation studies.

EloralintideNone found

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("Eloralintide"[tiab] OR "LY3841136"[tiab] OR "LY-3841136"[tiab] OR "AMY-1176"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ElpamotideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("elpamotide"[tiab] OR "VEGFR2-169"[tiab] OR "OTS102"[tiab] OR "OTS-102"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ElsiglutideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Elsiglutide"[tiab] OR "ZP1846"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EM66None found

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("em66"[tiab] OR "em-66"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EmodepsideNone found

No interaction study was found in a PubMed search on 2026-10-28 (6 hits read).

The search("Emodepside"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

6 hits: in vitro and worm studies of emodepside combined with other anthelmintics (diethylcarbamazine potentiated it in Ascaris muscle), a Trichuris egg-hatching assay, and a 2021 phase I safety and pharmacokinetics study in healthy men; none is a drug-drug interaction study in people.

EndolutenNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Endoluten"[tiab] OR "Pineal peptide bioregulator"[tiab] OR "A-8 (pineal peptide preparation)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Endomorphin-1None found

No interaction study was found in a PubMed search on 2026-10-28 (45 hits read).

The search("Endomorphin-1"[tiab] OR "EM-1"[tiab] OR "Tyr-Pro-Trp-Phe-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

45 hits; the 40 most recent titles were screened. They are animal and cell studies of endomorphin-1 given with other analgesics or receptor drugs, and one 2013 clinical study of clobazam that the search matched on an unrelated term; none is a drug interaction study of endomorphin-1 in people.

No interaction study was found in a PubMed search on 2026-11-07 (28 hits read).

The search("endomorphin-2"[tiab] OR "endomorphin 2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

28 hit(s) read October 30, 2026 (30626554, 29044528, 24512946, 24126280, 23142372, 22047797, 20083143, 18499626, 17555728, 16730704, 16519663, 16223698, 16034447, 15713278, 15698629, 15527737, 14999057, 14997173, 14755004, 12754318): none studies a drug interaction with endomorphin-2 in people

PubMed (human clinical-trial screen)

  • nifedipine, indomethacin or cyclosporine: none changed the pressor response to infused endothelin-1 in healthy men, but nifedipine markedly raised plasma endothelin-1 during the infusionEffect of endothelin-1 in man: pretreatment with nifedipine, with indomethacin and with cyclosporine A (1992). PubMed

Endothelin-1 was given as a research infusion; it is not a marketed medicine.

EneboparatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("eneboparatide"[tiab] OR "AZP-3601"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • ritonavir and ritonavir-boosted saquinavir: no pharmacokinetic interaction in HIV-1-infected patientsLack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patients (2004). PubMed
  • rifampicin: no enzyme-inducing effect on enfuvirtide pharmacokineticsLack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtide (2003). PubMed

Fuzeon is now listed as discontinued in the US; most of the 53 query hits are laboratory synergy studies.

EnicepatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("enicepatide"[tiab] OR "CT-388"[tiab] OR "RO7795068"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EnkephalinNone found

No interaction study was found in a PubMed search on 2026-10-05 (4 hits read).

The search("Enkephalin"[tiab] OR "Met-Enkephalin"[tiab] OR "Leu-Enkephalin"[tiab] OR "YGGFM"[tiab] OR "YGGFL"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

The 4 human-trial hits use synthetic enkephalin analogues (FK 33-824, DAMME) or measure circulating enkephalin; none gives native enkephalin with another drug.

EnlicitideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Enlicitide"[tiab] OR "MK-0616"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
EnterostatinNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("enterostatin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are animal studies or a review on how other peptides modify enterostatin's effect on fat intake; none is a human drug-interaction study.

Epinecidin-1None found

No interaction study was found in a PubMed search on 2026-11-07 (3 hits read).

The search("epinecidin"[tiab] OR "epinecidin-1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (39218372, 23598079, 20580756): none studies a drug interaction with epinecidin-1 in people

EpithalaminNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Epithalamin"[tiab] OR "Pineal peptide preparation Epithalamin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits, both rat studies (1975, 2000) combining epithalamin with L-DOPA, estrogen or adrenergic drugs; neither is a drug interaction study in people.

EpithalonNone found

No interaction study was found in a PubMed search on 2026-10-05 (2 hits read).

The search("Epithalon"[tiab] OR "Epitalon"[tiab] OR "Epithalamin"[tiab] OR "AEDG"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are Soviet-era rat studies of epithalamin (pineal extract); no human interaction study.

EptifibatideFrom the label

FDA label, section 7

  • antiplatelet agents, thrombolytics, heparin, aspirin and chronic NSAID use: coadministration increases the risk of bleedingAvenacy. Eptifibatide injection, US prescribing information, section 7.1. DailyMed set c0781dae, version 4, effective October 2, 2026, read October 27, 2026.
  • other glycoprotein IIb/IIIa inhibitors: avoid concomitant useAvenacy. Eptifibatide injection, US prescribing information, section 7.1. DailyMed set c0781dae, version 4, effective October 2, 2026, read October 27, 2026.

No interaction study was found in a PubMed search on 2026-10-28 (60 hits read).

The search("Equine Chorionic Gonadotropin"[tiab] OR "PMSG"[tiab] OR "pregnant mare serum gonadotropin"[tiab] OR "serum gonadotropin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

60 hits, read by title: almost all are rodent or livestock superovulation and ovary studies in which eCG (PMSG) is co-administered with another agent (inhibin antiserum, insulin, melatonin, clomiphene and others); none is a drug-drug interaction study in people.

PubMed (human clinical-trial screen)

  • androgens: in end-stage kidney disease, adding androgen to low-dose EPO raised haematocrit significantly more than EPO aloneAndrogens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease (1991). PubMed
  • intravenous iron: in chemotherapy-associated anaemia, adding IV ferric gluconate to darbepoetin gave no benefit over oral iron or placeboPhase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia (2011). PubMed
EsculentinNone found

No interaction study was found in a PubMed search on 2026-11-07 (5 hits read).

The search("esculentin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

5 hit(s) read October 30, 2026 (42725961, 32003660, 30381056, 19725877, 19520127): none studies a drug interaction with an esculentin in people

EtelcalcetideFrom the label

FDA label (Parsabiv), Warnings and Precautions 5.1 (the label has no separate interactions table)

  • cinacalcet or another oral calcium-sensing receptor agonist: risk of severe, life-threatening hypocalcaemia; stop cinacalcet at least 7 days before starting etelcalcetideAmgen. PARSABIV (etelcalcetide) injection, US prescribing information, section 5.1. DailyMed version effective March 8, 2026, read October 5, 2026.
  • other therapies that lower serum calcium: monitor corrected serum calcium closelyAmgen. PARSABIV (etelcalcetide) injection, US prescribing information, section 5.1. DailyMed version effective March 8, 2026, read October 5, 2026.
ExenatideFrom the label

FDA label, section 7

  • warfarin: postmarketing reports of a raised INR, sometimes with bleeding; monitor prothrombin time more often after starting or changing the doseByetta (exenatide) injection, US prescribing information, section 7. DailyMed version 26, effective September 2, 2025, read September 30, 2026.
  • oral medicines that depend on reaching a threshold concentration, such as contraceptives and antibiotics: slowed stomach emptying can reduce their absorption; take them at least 1 hour before the injectionByetta (exenatide) injection, US prescribing information, section 7. DailyMed version 26, effective September 2, 2025, read September 30, 2026.
  • insulin secretagogues such as sulfonylureas, or insulin: raises the risk of low blood sugar; consider reducing their dose when startingByetta (exenatide) injection, US prescribing information, section 7. DailyMed version 26, effective September 2, 2025, read September 30, 2026.
FAP-2286None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("FAP-2286"[tiab] OR "rofapitide tetraxetan"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Feline Interferon Omega"[tiab] OR "rFeIFN-omega"[tiab] OR "recombinant feline interferon-omega"[tiab] OR "Virbagen Omega"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • tricyclic antidepressants: a 1979 study examined the safety of prilocaine with felypressin in patients taking tricyclics, the group in whom adrenaline-containing anaesthetics are a concernPerovic J, et al. "Safety of local anaesthesia induced by prilocaine with felypressin in patients on tricyclic antidepressants." Bull Group Int Rech Sci Stomatol Odontol, 1979;22(2):57-62. PMID: 294301. PubMed
  • cocaine: a 1985 case report describes severe hypertension and ST depression after intranasal cocaine followed by felypressin injection, and suspected a drug interactionel-Din AS, et al. "Severe hypertension during anaesthesia for dacryocystorhinostomy." Anaesthesia, 1985;40(8):787-9. PMID: 4037272. PubMed
  • halothane anaesthesia: during nasal surgery under halothane, prilocaine with felypressin caused significantly fewer cardiac dysrhythmias than lignocaine with adrenaline, with somewhat less complete haemostasisElhakim M, et al. "Cardiac dysrhythmias during nasal surgery--a comparison with lignocaine-adrenaline and prilocaine-octapressin during halothane anaesthesia." Anaesthesiol Reanim, 1990;15(4):199-203. PMID: 2222714. PubMed
FexapotideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Fexapotide"[tiab] OR "Fexapotide triflutate"[tiab] OR "NX-1207"[tiab] OR "NX1207"[tiab] OR "NYM-4805"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
FGL PeptideNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("FGL Peptide"[tiab] OR "NCAM-derived FGL peptide"[tiab] OR "EVYVVAENQQGKSKA"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
FK-13None found

No interaction study was found in a PubMed search on 2026-10-05 (1 hit read).

The search("FK-13"[tiab] OR "LL-37(17-29)"[tiab] OR "FKRIVQRIKDFLR"[tiab] OR "LL-37 central fragment"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a laboratory study of FK-13 analogues with chloramphenicol against bacteria; no human interaction study.

Flotufolastat F 18From the label

FDA label, section 7

  • androgen deprivation therapy and other therapies targeting the androgen pathway: can change flotufolastat F 18 uptake in prostate cancer; the effect on PET performance has not been establishedPosluma (flotufolastat F 18) injection, US prescribing information, section 7. DailyMed set 907ac4a4, version 11, effective July 25, 2026, read October 28, 2026.
FluciclatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Fluciclatide"[tiab] OR "AH-111585"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Follistatin-315None found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Follistatin-315"[tiab] OR "FS-315"[tiab] OR "Follistatin 315"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Follistatin-344None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("FS344"[tiab] OR "follistatin 344"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-06 (3 hits read).

The search("Follitropin alfa"[tiab] OR "Gonal-f"[tiab] OR "Gonal-F RFF"[tiab] OR "Gonal-F RFF Redi-ject"[tiab] OR "rFSH alfa"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are trials of lutropin alfa and a review of follitropin delta; no interaction study of follitropin alfa.

No interaction study was found in a PubMed search on 2026-10-06 (2 hits read).

The search("Follitropin beta"[tiab] OR "Follistim"[tiab] OR "Follistim AQ"[tiab] OR "Puregon"[tiab] OR "rFSH beta"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are a review and a retrospective switching study; no interaction study. The Follistim label says none were performed.

No interaction study was found in a PubMed search on 2026-09-30 (2 hits read).

The search("Follitropin delta"[tiab] OR "Rekovelle"[tiab] OR "FE 999049"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits, neither an interaction study: a within-patient rescue-protocol comparison and a review of personalised dosing.

ForigerimodNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Forigerimod"[tiab] OR "Lupuzor"[tiab] OR "P140 peptide"[tiab] OR "rigerimod"[tiab] OR "IPP-201101"[tiab] OR "CEP-33457"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2014 commentary on excipients in lupus trials; not a drug interaction study.

FOXO4-DRINone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("FOXO4-DRI"[tiab] OR "FOXO4-p53 interfering peptide"[tiab] OR "FOXO4 DRI"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
FPPRGD2None found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("FPPRGD2"[tiab] OR "18F-FPPRGD2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2016 MRI study of abraxane with cisplatin in which the tracer is not the subject; not a drug interaction study of FPPRGD2.

Galacto-RGDNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Galacto-RGD"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GalaninStudied

PubMed (human clinical-trial screen)

  • GHRH (growth hormone-releasing hormone): a galanin infusion with a GHRH bolus potentiated GH release in young and older adults, restoring a response in older people who responded poorly to either alonePotentiating effect of galanin on GHRH-induced GH release. Comparison between old and young subjects (1996). PubMed

Galanin was given as a research infusion; the alias GAL was excluded as too ambiguous.

No interaction study was found in a PubMed search on 2026-11-06 (13 hits read).

The search("galanin-like peptide"[tiab] OR "galanin-like-peptide"[tiab] OR "galp"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

13 hit(s) read October 30, 2026 (42419536, 41617283, 41203176, 39551101, 39442850, 16819983, 16481456, 15757136, 15710240, 15706228, 14610237, 14576185, 7711837): none studies a drug interaction with galanin-like peptide in people

Galinpepimut-SNone found

No interaction study was found in a PubMed search on 2026-10-28 (5 hits read).

The search("Galinpepimut-S"[tiab] OR "WT1 peptide vaccine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

5 hits: phase 1 combination studies with nivolumab (mesothelioma, ovarian cancer) that report safety and immune response, not a drug interaction, and studies of other WT1 vaccines; none is a pharmacokinetic interaction study.

FDA label, section 7

  • somatostatin analogues (octreotide, lanreotide): compete for the same receptors and may affect imaging; image just before the next long-acting analogue doseAdvanced Accelerator Applications. NETSPOT (kit for gallium Ga 68 dotatate) US prescribing information, section 7. DailyMed version of July 6, 2026, read October 3, 2026.
  • high-dose glucocorticoids: repeated high doses before the scan may affect imagingAdvanced Accelerator Applications. NETSPOT (kit for gallium Ga 68 dotatate) US prescribing information, section 7. DailyMed version of July 6, 2026, read October 3, 2026.
GanirelixFrom the label

FDA label, Drug Interactions (which states that no formal studies were performed)

  • any drug: the label records that no formal drug interaction studies have been performedGanirelix acetate injection, US prescribing information, Drug Interactions. DailyMed version 2, effective May 11, 2026, read September 30, 2026.
GaretosmabNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Garetosmab"[tiab] OR "REGN2477"[tiab] OR "Pasatru"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GastrinNone found

No interaction study was found in a PubMed search on 2026-10-28 (206 hits read).

The search("gastrin"[tiab] OR "gastrin-17"[tiab] OR "gastrin 17"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits use gastrin as a measured marker (for example, raised gastrin under acid-suppressing drugs), concern gastrin-receptor or gastrin-releasing-peptide receptor drugs and radiotracers, or are animal studies; none studies a drug interaction with gastrin given as a drug.

No interaction study was found in a PubMed search on 2026-10-28 (37 hits read).

The search("gastrin-releasing peptide"[tiab] OR "gastrin releasing peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits are animal and cell studies (itch, circadian rhythm, feeding), radiotracers for its receptor, or receptor antagonists combined with cancer drugs; none studies a drug interaction with gastrin-releasing peptide given to people.

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("gawk"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GDF11None found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("GDF11"[tiab] OR "Growth differentiation factor 11"[tiab] OR "BMP-11"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GDF15Studied

PubMed

  • liraglutide: pharmacological GDF15 and liraglutide acted synergistically on food intake in mice; animal workFrikke-Schmidt H, et al. "GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice." Mol Metab, 2019;21:13-21. PMID: 30685336. PubMed

The other hits concern GDF15 as a biomarker or signalling molecule, not GDF15 given as a drug.

GHK-CuNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("GHK-Cu"[tiab] OR "Copper tripeptide-1"[tiab] OR "Cu-GHK"[tiab] OR "Glycyl-L-histidyl-L-lysine:copper(II)"[tiab] OR "Prezatide copper acetate"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GhrelinStudied

PubMed

  • transdermal estradiol: 21 days of estradiol raised GH responses to low-dose ghrelin about 2.9-fold in postmenopausal women, without changing ghrelin's maximal effectEstrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women (2008). PubMed
  • fulvestrant: three weeks of fulvestrant potentiated ghrelin-stimulated GH secretion in postmenopausal women, an estrogen-like effectEstrogen-like potentiation of ghrelin-stimulated GH secretion by fulvestrant, a putatively selective ER antagonist, in postmenopausal women (2014). PubMed
  • oxytocin infusion: abolished the 29% rise in plasma neuropeptide Y after a ghrelin injection in 12 menOxytocin inhibits the stimulatory effect of ghrelin on circulating neuropeptide Y levels in humans (2008). PubMed

The aliases 'Growth Hormone Releasing Peptide' and 'Hunger Hormone' were excluded as generic phrases; the remaining hits are mostly animal studies and receptor-drug discovery papers.

GHRP-1None found

No interaction study was found in a PubMed search on 2026-10-03 (2 hits read).

The search("GHRP-1"[tiab] OR "KP-101"[tiab] OR "KP 101"[tiab] OR "Growth hormone-releasing peptide-1"[tiab] OR "Ala-His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Neither hit is a human interaction study: 8049717 is a sheep pituitary cell study (cited on the entry) that co-applied GHRP-1 with GRF, and 8374685 is a 1993 structure and kinetics review.

GHRP-2Studied

PubMed

  • L-arginine: supra-additive (synergistic) growth hormone release at rest in men and women, blunted relatively by exerciseSynergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise (2000). PubMed
  • GHRH (1-29): no synergy shown: the combined GH response did not differ from the sum of the separate responsesGH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers (1995). PubMed
GHRP-4None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("GHRP-4"[tiab] OR "GHRP 4"[tiab] OR "Tryptophylalanyltryptophylphenylalaninamide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GHRP-5None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("GHRP-5"[tiab] OR "Momany peptide"[tiab] OR "Tyr-Trp-Ala-Trp-Phe-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GHRP-6Studied

PubMed (human clinical-trial screen)

  • oral arginine: enhanced GHRP-6's GH release in elderly subjects (peak 22.1 against 9.9 µg/L) but not in young subjectsArginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration (1994). PubMed
GIPStudied

PubMed (human clinical-trial screen)

  • sulfonylureas (glimepiride): in carriers of an HNF1A diabetes mutation, GIP plus glimepiride had additive effects on insulin secretionGIP and GLP-1 potentiate sulfonylurea-induced insulin secretion in hepatocyte nuclear factor 1α mutation carriers (2020). PubMed
  • GLP-1: in type 2 diabetes, adding GIP did not enhance GLP-1's insulin response and antagonised its suppression of glucagonGIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes (2011). PubMed
  • GLP-2: given together to 10 healthy men, the two reduced bone resorption additivelyGIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment (2022). PubMed

Native GIP as a research infusion; tirzepatide, which acts on the GIP receptor, has its own entry with label interactions.

No interaction study was found in a PubMed search on 2026-09-30 (18 hits read).

The search("Glatiramer"[tiab] OR "Copaxone"[tiab] OR "Glatopa"[tiab] OR "Copolymer 1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

18 hits: combination-therapy studies of glatiramer with interferon beta in multiple sclerosis (a treatment combination, not a pharmacokinetic interaction), animal models, and reviews of other MS drugs. No human drug interaction study of glatiramer.

GlepaglutideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Glepaglutide"[tiab] OR "ZP1848"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GlicentinNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("glicentin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a rat study of oxyntomodulin and pancreatic secretion; it does not study a drug interaction with glicentin.

GLP-1None found

No interaction study was found in a PubMed search on 2026-11-04 (27 hits read).

The search("GLP-1(7-36)"[tiab] OR "GLP-1 (7-36)"[tiab] OR "glucagon-like peptide-1 (7-36)"[tiab] OR "glucagon-like peptide-1(7-36)"[tiab] OR "GLP-1(7-37)"[tiab] OR "native GLP-1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

The bare names 'GLP-1' and 'glucagon-like peptide-1' were replaced by the native forms (7-36, 7-37, 'native GLP-1') because the bare names return thousands of papers on the GLP-1 drugs, which are other molecules with their own interaction records. The 27 hits are cell and animal studies, reviews and trials of GLP-1 drugs, and human studies that infused GLP-1 together with other gut hormones (GIP, PYY) to compare or combine their effects; none tested native GLP-1 with a medicine people take.

GLP-2Studied

PubMed

  • GIP (glucose-dependent insulinotropic polypeptide): given together by injection to 10 healthy men, the two hormones reduced bone resorption additively, more than either aloneGIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment (2022). PubMed
  • GLP-1 infusion: in 9 short-bowel patients the combination numerically added to intestinal absorption, and GLP-2 eased the nausea and lower appetite seen with GLP-1 aloneAcute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (2013). PubMed

The other hits are animal and cell studies; teduglutide, the approved GLP-2 analogue, has its own entry.

GlucagonFrom the label

FDA label, section 7

  • beta-blockers: transient rise in pulse and blood pressure, which may need treatment in coronary artery diseaseGVOKE (glucagon) injection, US prescribing information, section 7. DailyMed version 2, effective July 7, 2026, read October 5, 2026.
  • indomethacin: glucagon may fail to raise blood glucose or may even cause hypoglycaemia; monitor glucoseGVOKE (glucagon) injection, US prescribing information, section 7. DailyMed version 2, effective July 7, 2026, read October 5, 2026.
  • warfarin: may increase the anticoagulant effect; watch for bruising or bleedingGVOKE (glucagon) injection, US prescribing information, section 7. DailyMed version 2, effective July 7, 2026, read October 5, 2026.
  • insulin: acts antagonistically; monitor glucose when glucagon is used as a diagnostic aidGVOKE (glucagon) injection, US prescribing information, section 7. DailyMed version 2, effective July 7, 2026, read October 5, 2026.
  • anticholinergic drugs: not recommended with the diagnostic-aid use, because of additive slowing of gut motilityGVOKE (glucagon) injection, US prescribing information, section 7. DailyMed version 2, effective July 7, 2026, read October 5, 2026.
GlutathioneNone found

No interaction study was found in a PubMed search on 2026-10-06 (43 hits read).

The search("Glutathione"[tiab] OR "γ-L-glutamyl-L-cysteinylglycine"[tiab] OR "gamma-glutamylcysteinylglycine"[tiab] OR "reduced glutathione"[tiab] OR "L-glutathione"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

Human-trial hits measure glutathione as a marker or deplete it with other drugs; none gives glutathione with another drug and measures an interaction.

GlypromateNone found

No interaction study was found in a PubMed search on 2026-10-28 (3 hits read).

The search("Glypromate"[tiab] OR "Gly-Pro-Glu"[tiab] OR "Glycyl-prolyl-glutamic acid"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hits, all rat studies (2004, 2019, 2024) of glypromate given with beta-amyloid or with its metabolite cycloprolylglycine; none is a drug interaction study in people.

GMA106None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("GMA106"[tiab] OR "GMA-106"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("GnRF Analogue–Diphtheria Toxoid Conjugate"[tiab] OR "Improvac"[tiab] OR "Improvest"[tiab] OR "gonadotropin releasing factor analog-diphtheria toxoid conjugate"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2003 pig study of the vaccine given with porcine somatotropin, which had synergistic and additive effects on growth; an animal-production study, not a drug interaction study in people.

GomesinNone found

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("gomesin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (17645524): none studies a drug interaction with gomesin in people

GonadorelinNone found

No interaction study was found in a PubMed search on 2026-10-06 (43 hits read).

The search("Gonadorelin"[tiab] OR "Factrel"[tiab] OR "Lutrepulse"[tiab] OR "GnRH"[tiab] OR "LHRH"[tiab] OR "LH-RH"[tiab] OR "luteinizing hormone-releasing hormone"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

Hits concern synthetic GnRH analogues (leuprolide, goserelin, elagolix) or GnRH tests, not gonadorelin given with another drug.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Gonadorelin [6-D-Phe]"[tiab] OR "D-Phe-6-GnRH"[tiab] OR "Gonavet"[tiab] OR "Oestracton"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
GoralatideStudied

PubMed

  • captopril (ACE inhibitor): one 50 mg dose blocked 90-99% of Ac-SDKP breakdown and raised plasma Ac-SDKP about 5.5-fold in healthy volunteersAzizi, M. et al. (1996). Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest, 97, 839-844. PubMed
  • ACE inhibitors in chronic renal failure: plasma Ac-SDKP 22 times higher than in untreated patients (4.1 times with normal kidney function)Azizi, M. et al. (1999). Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans. Hypertension, 33, 879-886. PubMed

None of the 11 query hits is a human interaction study (they are animal, enzyme and editorial records). The human studies below, found by the entry's own search, measure how ACE inhibition changes Ac-SDKP levels.

GoserelinNone found

No interaction study was found in a PubMed search on 2026-10-06 (11 hits read).

The search("Goserelin"[tiab] OR "Zoladex"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are trials of goserelin within combination cancer regimens, animal studies, a review, and one case report of transient thyrotoxicosis in a woman on levothyroxine; no interaction study. The Zoladex label reports no confirmed interactions.

GozetotideFrom the label

FDA label, section 7

  • androgen deprivation therapy and androgen-receptor antagonists: can change gozetotide uptake in prostate cancer; effect on scan performance not establishedNovartis. LOCAMETZ (kit for gallium Ga 68 gozetotide) US prescribing information, section 7. DailyMed version of January 15, 2026, read October 3, 2026.
GramicidinNone found

No interaction study was found in a PubMed search on 2026-09-30 (48 hits read).

The search("Gramicidin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

48 hits, essentially all laboratory synergy testing against bacteria or gramicidin used as an ionophore tool in electrophysiology; none is a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-28 (69 hits read).

The search("somatorelin"[tiab] OR "growth hormone-releasing hormone"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 20 most relevant of the 69 hits were read by title: animal and cell studies, studies of GHRH antagonists or analogues, and reviews; none is a human drug-interaction study of GHRH given as a drug.

GuanylinNone found

No interaction study was found in a PubMed search on 2026-10-28 (5 hits read).

The search("guanylin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits are animal kidney or liver studies, a review of the uroguanylin pain pathway and a radiolabelled enterotoxin study; none studies a drug interaction with guanylin given to people.

hBD-1None found

No interaction study was found in a PubMed search on 2026-10-05 (5 hits read).

The search("hBD-1"[tiab] OR "human β-defensin 1"[tiab] OR "DEFB1"[tiab] OR "defensin β1"[tiab] OR "hBD1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory synergy studies with antibiotics and keratinocyte expression studies; no human drug interaction study.

hBD-2None found

No interaction study was found in a PubMed search on 2026-10-05 (12 hits read).

The search("hBD-2"[tiab] OR "human β-defensin 2"[tiab] OR "DEFB4A"[tiab] OR "DEFB4"[tiab] OR "defensin β2"[tiab] OR "hBD2"[tiab] OR "SAP1 — skin-antimicrobial peptide 1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are keratinocyte and airway-cell expression studies and laboratory antimicrobial synergy; no human drug interaction study. The alias 'SAP1' is a gene-style abbreviation and is matched only inside its full phrase.

hBD-3None found

No interaction study was found in a PubMed search on 2026-10-05 (7 hits read).

The search("hBD-3"[tiab] OR "human β-defensin 3"[tiab] OR "DEFB103A"[tiab] OR "DEFB103"[tiab] OR "defensin β3"[tiab] OR "hBD3"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory antimicrobial and synergy studies; no human drug interaction study.

HCGNone found

No interaction study was found in a PubMed search on 2026-10-06 (16 hits read).

The search("HCG"[tiab] OR "human chorionic gonadotropin"[tiab] OR "Pregnyl"[tiab] OR "Novarel"[tiab] OR "Ovidrel"[tiab] OR "choriogonadotropin alfa"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

Hits are combined fertility protocols (GnRH-agonist plus hCG 'dual trigger', growth hormone, letrozole) compared as regimens; none is an interaction study.

HD5None found

No interaction study was found in a PubMed search on 2026-09-30 (3 hits read).

The search("human alpha-defensin 5"[tiab] OR "DEFA5"[tiab] OR "HD5"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are in vitro studies (antimicrobial peptides with antibiotics against Clostridium difficile; Caco-2 cells) and an unrelated ketoconazole formulation paper; no human interaction study.

HD6None found

No interaction study was found in a PubMed search on 2026-10-05 (1 hit read).

The search("human α-defensin 6"[tiab] OR "DEFA6"[tiab] OR "defensin α6"[tiab] OR "enteric α-defensin 6"[tiab] OR "α-defensin-6"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a Caco-2 cell study of green-tea catechin and an anticancer drug's effect on defensin levels; no human interaction study.

No interaction study was found in a PubMed search on 2026-11-06 (6 hits read).

The search("hemopressin"[tiab] OR "haemopressin"[tiab] OR "rvd-hemopressin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

6 hit(s) read October 30, 2026 (37100982, 26475620, 25010019, 24138638, 21271486, 18077343): none studies a drug interaction with hemopressin in people

No interaction study was found in a PubMed search on 2026-11-07 (8 hits read).

The search("hemorphin"[tiab] OR "lvv-hemorphin-7"[tiab] OR "valorphin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

8 hit(s) read October 30, 2026 (27289274, 22484286, 16904236, 15662114, 14980384, 12649370, 11249971, 9437744): none studies a drug interaction with a hemorphin in people

HepcidinNone found

No interaction study was found in a PubMed search on 2026-10-30 (25 hits read).

The search("Hepcidin"[tiab] OR "Hepcidin-25"[tiab] OR "Hepcidin-20"[tiab] OR "LEAP-1"[tiab] OR "Liver-expressed antimicrobial peptide 1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 25 hits measure hepcidin as a marker in animal, cell or review work on other drugs, or concern drugs that act on the hepcidin pathway; none gave hepcidin to people, so no human interaction study exists.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Hexanoyl Dipeptide-3 Norleucine Acetate"[tiab] OR "Hexanoyl-Arg-Ala-Nle-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Hexapeptide-10None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Hexapeptide-10"[tiab] OR "SIKVAV"[tiab] OR "Serilesine"[tiab] OR "Ser-Ile-Lys-Val-Ala-Val"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Hexapeptide-11None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Hexapeptide-11"[tiab] OR "FVAPFP"[tiab] OR "Peptamide 6"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Hexapeptide-33None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Hexapeptide-33"[tiab] OR "SFKLRY"[tiab] OR "Ser-Phe-Lys-Leu-Arg-Tyr"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Hexapeptide-9None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Hexapeptide-9"[tiab] OR "GPQGPQ"[tiab] OR "Gly-Pro-Gln-Gly-Pro-Gln"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
HexarelinStudied

PubMed

  • salbutamol (beta-agonist): blunted hexarelin's GH release; atenolol (beta-blocker) left it unchangedInfluence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man (1996). PubMed
  • pyridostigmine: enhanced the GH response only to a very low hexarelin doseLow hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man (1997). PubMed
HistatinNone found

No interaction study was found in a PubMed search on 2026-10-05 (12 hits read).

The search("Histatin"[tiab] OR "Histatin-5"[tiab] OR "Histatin-3"[tiab] OR "Histatin-1"[tiab] OR "Salivary histatins"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory antifungal and antibacterial synergy studies and cell or animal wound and bone studies; no human drug interaction study.

HistrelinFrom the label

FDA label, section 7 (no formal drug-drug, drug-food or drug-herb studies were performed; the interactions recorded are with laboratory tests)

  • diagnostic tests of pituitary and gonadal function: suppression of the pituitary-gonadal system can affect results during and after treatmentSupprelin LA (histrelin acetate) subcutaneous implant, US prescribing information, section 7. DailyMed version 38, effective September 25, 2025, read September 30, 2026.
  • laboratory IGF-1 and DHEA measurements: mean IGF-1 fell about 11% in one study and DHEA rose in 8 of 36 patients in anotherSupprelin LA (histrelin acetate) subcutaneous implant, US prescribing information, section 7. DailyMed version 38, effective September 25, 2025, read September 30, 2026.
HM15136None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("HM15136"[tiab] OR "efpegerglucagon"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
HM15275None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("HM15275"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
HNP-1None found

No interaction study was found in a PubMed search on 2026-10-05 (3 hits read).

The search("human neutrophil peptide 1"[tiab] OR "human α-defensin 1"[tiab] OR "DEFA1"[tiab] OR "defensin α1"[tiab] OR "myeloid-related sequence peptide 30a"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory antimicrobial and oral-cancer cell studies; no human drug interaction study.

HomocarnosineNone found

No interaction study was found in a PubMed search on 2026-11-07 (6 hits read).

The search("homocarnosine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

6 hit(s) read October 30, 2026 (30572244, 17546663, 12132593, 1803015, 2628039, 5537086): none studies a drug interaction with homocarnosine in people

HRS-9531None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("HRS9531"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
HumaninNone found

No interaction study was found in a PubMed search on 2026-10-05 (8 hits read).

The search("Humanin"[tiab] OR "MTRNR2"[tiab] OR "S14G-Humanin (HNG)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are mouse, rat and cell studies of humanin with other agents (for example dexrazoxane, necrostatin-1); no human interaction study.

PubMed (human clinical-trial screen)

  • doxorubicin or 5-fluorouracil: high-dose intravenous hyaluronic acid did not alter the pharmacokinetics or toxicity of either drugPhase I and pharmacokinetic evaluation of intravenous hyaluronic acid in combination with doxorubicin or 5-fluorouracil (2005). PubMed
HYNIC-TOCNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("HYNIC-TOC"[tiab] OR "HYNIC-Tyr3-octreotide"[tiab] OR "Tektrotyd"[tiab] OR "hydrazinonicotinyl-Tyr3-octreotide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
IcatibantFrom the label

FDA label, section 7

  • ACE inhibitors: as a bradykinin B2 receptor antagonist, icatibant may blunt their blood-pressure-lowering effect; its trials excluded people taking themFirazyr (icatibant) injection, US prescribing information, section 7. DailyMed version 19, effective July 7, 2025, read September 30, 2026.
IcotrokinraNone found

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Icotrokinra"[tiab] OR "JNJ-77242113"[tiab] OR "JNJ-2113"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit, a 2026 review of icotrokinra for psoriasis; not an interaction study.

IGF-1None found

No interaction study was found in a PubMed search on 2026-10-06 (51 hits read).

The search("IGF-1"[tiab] OR "Insulin-like Growth Factor 1"[tiab] OR "Somatomedin C"[tiab] OR "IGF-I"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

Hits measure endogenous IGF-1 as an outcome; mecasermin, the approved recombinant IGF-1, has its own entry.

IGF-1 DES(1-3)None found

No interaction study was found in a PubMed search on 2026-10-05 (2 hits read).

The search("IGF-1 DES(1-3)"[tiab] OR "DES(1-3) IGF-1"[tiab] OR "DES IGF-1"[tiab] OR "des1-3 IGF-1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are rat studies; no human interaction study.

IGF-1 LR3None found

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("IGF-1 LR3"[tiab] OR "Long R3 IGF-1"[tiab] OR "Long Arg3 IGF-1"[tiab] OR "LR3 IGF-1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

FDA label, precautions

  • octreotide (therapeutic doses): may reduce scan sensitivity; consider temporarily suspending octreotide before the scan and monitor for withdrawalCurium. OCTREOSCAN (kit for indium In 111 pentetreotide) US prescribing information, precautions. DailyMed version of February 21, 2022, read October 3, 2026.
IndolicidinNone found

No interaction study was found in a PubMed search on 2026-10-28 (10 hits read).

The search("Indolicidin"[tiab] OR "ILPWKWPWWPWRR-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

10 hits, all laboratory studies of indolicidin combined with antibiotics, antifungals or other peptides; none is a drug interaction study in people.

INSL3None found

No interaction study was found in a PubMed search on 2026-10-30 (7 hits read).

The search("INSL3"[tiab] OR "Insulin-like peptide 3"[tiab] OR "Insulin-like factor 3"[tiab] OR "Insulin-like 3"[tiab] OR "Leydig insulin-like peptide"[tiab] OR "Relaxin-like factor"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 7 hits are rodent toxicology and receptor studies in which INSL3 was measured after other compounds; none gave INSL3 to people.

INSL5None found

No interaction study was found in a PubMed search on 2026-11-03 (0 hits read).

The search("INSL5"[tiab] OR "Insulin-like peptide 5"[tiab] OR "Insulin-like peptide-5"[tiab] OR "Insulin-like factor 5"[tiab] OR "Insulin-like peptide INSL5"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The query returned nothing. INSL5 has never been given to a person, so no human interaction study can exist; the one clinical record that names it measured it as an outcome rather than giving it.

Insulin aspartFrom the label

FDA label, section 7

  • drugs that may increase the risk of hypoglycaemia (other antidiabetic agents, ACE inhibitors, ARBs, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose adjustment and more frequent glucose monitoring may be neededNovo Nordisk. NOVOLOG (insulin aspart) injection, US prescribing information, section 7, Table: clinically significant drug interactions. DailyMed version of January 22, 2025, read September 30, 2026.
  • drugs that may decrease the glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics, thyroid hormones): dose adjustment and more frequent glucose monitoring may be neededNovo Nordisk. NOVOLOG (insulin aspart) injection, US prescribing information, section 7, Table: clinically significant drug interactions. DailyMed version of January 22, 2025, read September 30, 2026.
  • alcohol, beta-blockers, clonidine, lithium salts: may increase or decrease the glucose-lowering effectNovo Nordisk. NOVOLOG (insulin aspart) injection, US prescribing information, section 7, Table: clinically significant drug interactions. DailyMed version of January 22, 2025, read September 30, 2026.
Insulin degludecFrom the label

FDA label, section 7

  • drugs that raise the risk of low blood sugar (other diabetes drugs, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose reduction and more frequent glucose monitoring may be neededTresiba (insulin degludec) injection, US prescribing information, section 7. DailyMed version 14, effective July 1, 2022, read September 30, 2026.
  • drugs that weaken its glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics such as albuterol, epinephrine and terbutaline, thyroid hormones): dose increases and more frequent glucose monitoring may be neededTresiba (insulin degludec) injection, US prescribing information, section 7. DailyMed version 14, effective July 1, 2022, read September 30, 2026.
  • alcohol, beta-blockers, clonidine and lithium salts: may raise or lower the glucose-lowering effect; pentamidine may cause low blood sugar sometimes followed by high blood sugarTresiba (insulin degludec) injection, US prescribing information, section 7. DailyMed version 14, effective July 1, 2022, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine and reserpine: may blunt or hide the warning signs of low blood sugarTresiba (insulin degludec) injection, US prescribing information, section 7. DailyMed version 14, effective July 1, 2022, read September 30, 2026.

FDA label, section 7

  • drugs that raise the risk of low blood sugar (other diabetes drugs, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose reduction and more frequent glucose monitoring may be neededXultophy 100/3.6 (insulin degludec and liraglutide) injection, US prescribing information, section 7. DailyMed version 14, effective October 14, 2025, read September 30, 2026.
  • drugs that weaken its glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics such as albuterol, epinephrine and terbutaline, thyroid hormones): dose increases and more frequent glucose monitoring may be neededXultophy 100/3.6 (insulin degludec and liraglutide) injection, US prescribing information, section 7. DailyMed version 14, effective October 14, 2025, read September 30, 2026.
  • alcohol, beta-blockers, clonidine and lithium salts: may raise or lower the glucose-lowering effect; pentamidine may cause low blood sugar sometimes followed by high blood sugarXultophy 100/3.6 (insulin degludec and liraglutide) injection, US prescribing information, section 7. DailyMed version 14, effective October 14, 2025, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine and reserpine: may blunt or hide the warning signs of low blood sugarXultophy 100/3.6 (insulin degludec and liraglutide) injection, US prescribing information, section 7. DailyMed version 14, effective October 14, 2025, read September 30, 2026.
  • oral medicines: the liraglutide component delays stomach emptying, which may affect their absorptionXultophy 100/3.6 (insulin degludec and liraglutide) injection, US prescribing information, section 7. DailyMed version 14, effective October 14, 2025, read September 30, 2026.
Insulin detemirFrom the label

FDA label, drug interactions subsection

  • drugs that lower the blood-glucose-lowering effect (corticosteroids, danazol, diuretics, sympathomimetics such as epinephrine, albuterol and terbutaline, isoniazid, phenothiazines, somatropin, thyroid hormones, estrogens and progestogens): insulin dose adjustment and closer monitoring may be neededLevemir (insulin detemir) injection, US prescribing information, Precautions: Drug Interactions. DailyMed version 1, effective September 14, 2011 — the only Levemir label DailyMed still carries, distributed by a repackager; read September 30, 2026.
  • drugs that raise the risk of low blood sugar (oral antidiabetic drugs, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, propoxyphene, salicylates, octreotide, sulfonamide antibiotics): hypoglycaemia risk rises; dose adjustment may be neededLevemir (insulin detemir) injection, US prescribing information, Precautions: Drug Interactions. DailyMed version 1, effective September 14, 2011 — the only Levemir label DailyMed still carries, distributed by a repackager; read September 30, 2026.
  • beta-blockers, clonidine, lithium and alcohol: may strengthen or weaken the glucose-lowering effect; beta-blockers, clonidine, guanethidine and reserpine can also mask the warning signs of hypoglycaemiaLevemir (insulin detemir) injection, US prescribing information, Precautions: Drug Interactions. DailyMed version 1, effective September 14, 2011 — the only Levemir label DailyMed still carries, distributed by a repackager; read September 30, 2026.
  • pentamidine: may cause hypoglycaemia, sometimes followed by hyperglycaemiaLevemir (insulin detemir) injection, US prescribing information, Precautions: Drug Interactions. DailyMed version 1, effective September 14, 2011 — the only Levemir label DailyMed still carries, distributed by a repackager; read September 30, 2026.

Levemir has been discontinued in the US; the label text is the manufacturer's, as carried by the one remaining DailyMed listing. It also states no clinically relevant interaction with fatty acids or other protein-bound drugs.

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Insulin efsitora alfa"[tiab] OR "efsitora"[tiab] OR "efsitora alfa"[tiab] OR "LY3209590"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Insulin glargineFrom the label

FDA label, section 7

  • drugs that raise the risk of low blood sugar (other diabetes drugs, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose reduction and more frequent glucose monitoring may be neededLantus (insulin glargine) injection, US prescribing information, section 7. DailyMed version 35, effective June 2, 2025, read September 30, 2026.
  • drugs that weaken its glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics such as albuterol, epinephrine and terbutaline, thyroid hormones): dose increases and more frequent glucose monitoring may be neededLantus (insulin glargine) injection, US prescribing information, section 7. DailyMed version 35, effective June 2, 2025, read September 30, 2026.
  • alcohol, beta-blockers, clonidine and lithium salts: may raise or lower the glucose-lowering effect; pentamidine may cause low blood sugar sometimes followed by high blood sugarLantus (insulin glargine) injection, US prescribing information, section 7. DailyMed version 35, effective June 2, 2025, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine and reserpine: may blunt or hide the warning signs of low blood sugarLantus (insulin glargine) injection, US prescribing information, section 7. DailyMed version 35, effective June 2, 2025, read September 30, 2026.

FDA label, section 7

  • drugs that affect glucose metabolism: dose adjustment may be needed; monitor blood glucose closelySanofi-Aventis U.S. SOLIQUA 100/33 (insulin glargine and lixisenatide injection), US prescribing information, section 7. DailyMed version effective March 18, 2026, read September 30, 2026.
  • antiadrenergic drugs (beta-blockers, clonidine, guanethidine, reserpine): signs and symptoms of hypoglycaemia may be reducedSanofi-Aventis U.S. SOLIQUA 100/33 (insulin glargine and lixisenatide injection), US prescribing information, section 7. DailyMed version effective March 18, 2026, read September 30, 2026.
  • oral medications, including oral contraceptives, antibiotics and acetaminophen: lixisenatide delays gastric emptying; take them at least 1 hour before or 11 hours after the injectionSanofi-Aventis U.S. SOLIQUA 100/33 (insulin glargine and lixisenatide injection), US prescribing information, section 7. DailyMed version effective March 18, 2026, read September 30, 2026.
Insulin glulisineFrom the label

FDA label, section 7

  • drugs that raise the risk of low blood sugar (other diabetes drugs, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose reduction and more frequent glucose monitoring may be neededApidra (insulin glulisine) injection, US prescribing information, section 7. DailyMed version 28, effective November 25, 2025, read September 30, 2026.
  • drugs that weaken its glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics such as albuterol, epinephrine and terbutaline, thyroid hormones): dose increases and more frequent glucose monitoring may be neededApidra (insulin glulisine) injection, US prescribing information, section 7. DailyMed version 28, effective November 25, 2025, read September 30, 2026.
  • alcohol, beta-blockers, clonidine and lithium salts: may raise or lower the glucose-lowering effect; pentamidine may cause low blood sugar sometimes followed by high blood sugarApidra (insulin glulisine) injection, US prescribing information, section 7. DailyMed version 28, effective November 25, 2025, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine and reserpine: may blunt or hide the warning signs of low blood sugarApidra (insulin glulisine) injection, US prescribing information, section 7. DailyMed version 28, effective November 25, 2025, read September 30, 2026.
Insulin icodecFrom the label

FDA label, section 7

  • drugs that raise the risk of low blood sugar (other diabetes drugs, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose reduction and more frequent glucose monitoring may be neededAwiqli (insulin icodec) injection, US prescribing information, section 7. DailyMed version 1, effective March 26, 2026, read September 30, 2026.
  • drugs that weaken its glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics such as albuterol, epinephrine and terbutaline, thyroid hormones): dose increases and more frequent glucose monitoring may be neededAwiqli (insulin icodec) injection, US prescribing information, section 7. DailyMed version 1, effective March 26, 2026, read September 30, 2026.
  • alcohol, beta-blockers, clonidine and lithium salts: may raise or lower the glucose-lowering effect; pentamidine may cause low blood sugar sometimes followed by high blood sugarAwiqli (insulin icodec) injection, US prescribing information, section 7. DailyMed version 1, effective March 26, 2026, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine and reserpine: may blunt or hide the warning signs of low blood sugarAwiqli (insulin icodec) injection, US prescribing information, section 7. DailyMed version 1, effective March 26, 2026, read September 30, 2026.
Insulin lisproFrom the label

FDA label, section 7

  • drugs that raise the risk of low blood sugar (other diabetes drugs, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose reduction and more frequent glucose monitoring may be neededHumalog (insulin lispro) injection, US prescribing information, section 7. DailyMed version 87, effective June 16, 2026, read September 30, 2026.
  • drugs that weaken its glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics such as albuterol, epinephrine and terbutaline, thyroid hormones): dose increases and more frequent glucose monitoring may be neededHumalog (insulin lispro) injection, US prescribing information, section 7. DailyMed version 87, effective June 16, 2026, read September 30, 2026.
  • alcohol, beta-blockers, clonidine and lithium salts: may raise or lower the glucose-lowering effect; pentamidine may cause low blood sugar sometimes followed by high blood sugarHumalog (insulin lispro) injection, US prescribing information, section 7. DailyMed version 87, effective June 16, 2026, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine and reserpine: may blunt or hide the warning signs of low blood sugarHumalog (insulin lispro) injection, US prescribing information, section 7. DailyMed version 87, effective June 16, 2026, read September 30, 2026.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("insulin peglispro"[tiab] OR "LY2605541"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • metformin: a randomised crossover study in healthy volunteers measured the effect of tregopil and its permeation enhancer on metformin pharmacokineticsKhedkar A, et al. (2019). Impact of Insulin Tregopil and Its Permeation Enhancer on Pharmacokinetics of Metformin in Healthy Volunteers: Randomized, Open-Label, Placebo-Controlled, Crossover Study. Clin Transl Sci. PubMed
IpamorelinIn the checker

No interaction study was found in a PubMed search on 2026-10-27 (1 hit read).

The search("Ipamorelin"[tiab] OR "NNC 26-0161"[tiab] OR "NNC 260161"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Not studied in people. The one hit is a rat study in which ipamorelin countered prednisolone-induced nitrogen wasting (PMID 19231263). Pairs with other peptides are rated in the Interaction Checker.

IrisinNone found

No interaction study was found in a PubMed search on 2026-10-28 (9 hits read).

The search("irisin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 9 hits are animal or cell studies, or human studies that measured irisin as an outcome of other drugs; none gives irisin as a drug with another drug in people.

IsegananNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Iseganan"[tiab] OR "IB-367"[tiab] OR "IB 367"[tiab] OR "iseganan hydrochloride"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: laboratory studies of IB-367 combined with antifungal agents against dermatophytes and Candida isolates; neither is a drug interaction study in people.

KatacalcinNone found

No interaction study was found in a PubMed search on 2026-11-03 (0 hits read).

The search("katacalcin"[tiab] OR "PDN-21"[tiab] OR "katakalcin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No hits; katacalcin has not been given to people, only measured in blood and tissue.

PubMed

  • gonadotropin-inhibitory hormone (GnIH): in four men, an infusion of GnIH did not change the LH response to a kisspeptin-10 bolusGeorge JT, et al. "Effect of gonadotropin-inhibitory hormone on luteinizing hormone secretion in humans." Clin Endocrinol (Oxf), 2017;86(5):731-738. PMID: 28186349. PubMed
  • oestrogen and progesterone: studied for their effect on kisspeptin-10's stimulation of LH and growth hormone in cows; animal workWhitlock BK, et al. "Interaction of estrogen and progesterone on kisspeptin-10-stimulated luteinizing hormone and growth hormone in ovariectomized cows." Neuroendocrinology, 2008;88(3):212-5. PMID: 18635924. PubMed
  • methotrexate: given with methotrexate to rats to test protection against sperm damage; animal workGüvenç M, et al. "Ameliorating effect of kisspeptin-10 on methotrexate-induced sperm damages and testicular oxidative stress in rats." Andrologia, 2018;50(8):e13057. PMID: 29862548. PubMed

PubMed

  • neurokinin B and naltrexone: co-administered to healthy men to test the KNDy hypothesis: every kisspeptin- and naltrexone-containing regimen potently increased LH and LH pulsatility against vehicleNarayanaswamy S, et al. "Investigating the KNDy Hypothesis in Humans by Coadministration of Kisspeptin, Neurokinin B, and Naltrexone in Men." J Clin Endocrinol Metab, 2016;101(9):3429-36. PMID: 27379743. PubMed
Klotho PeptideNone found

No interaction study was found in a PubMed search on 2026-10-05 (2 hits read).

The search("Klotho Peptide"[tiab] OR "KL-VS"[tiab] OR "Soluble Klotho"[tiab] OR "α-Klotho"[tiab] OR "S-Klotho"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are about soluble klotho as an endogenous protein (lung fibrosis biology, a mouse heart study); no drug interaction study.

KN056None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("KN056"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
KPVNone found

No interaction study was found in a PubMed search on 2026-10-05 (3 hits read).

The search("KPV"[tiab] OR "Lys-Pro-Val"[tiab] OR "α-MSH(11-13)"[tiab] OR "tripeptide KPV"[tiab] OR "lysine-proline-valine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are a 1976 lipolysis study of ACTH fragments, a dog amino-acid study and a macrophage study; none is a human interaction study.

KR-12None found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("KR-12"[tiab] OR "LL-37(18-29)"[tiab] OR "KRIVQRIKDFLR"[tiab] OR "minimal LL-37 antimicrobial fragment"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
KyotorphinNone found

No interaction study was found in a PubMed search on 2026-10-28 (11 hits read).

The search("Kyotorphin"[tiab] OR "L-tyrosyl-L-arginine"[tiab] OR "Tyr-Arg"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

11 hits, all animal or cell studies (kyotorphin with nitric oxide modulators, glucocorticoids, TRH and other neuropeptides); none is a drug interaction study in people.

LactoferricinNone found

No interaction study was found in a PubMed search on 2026-10-05 (21 hits read).

The search("Lactoferricin"[tiab] OR "Lactoferricin B"[tiab] OR "LfcinB"[tiab] OR "Lactoferricin H"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory synergy studies with antibiotics, antifungals and antivirals (for example acyclovir) and cell studies; no human drug interaction study.

LancovutideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("lancovutide"[tiab] OR "duramycin"[tiab] OR "Moli1901"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No human interaction study was found. Its trials gave it alone, on top of each patient's usual cystic fibrosis treatment, and reported no interaction analysis; the inhaled peptide was undetectable in plasma in both the healthy-volunteer pharmacokinetic study and the phase 2 trial, so there is no systemic exposure for an interaction to act on.

LanreotideFrom the label

FDA label, section 7

  • insulin and oral hypoglycaemic drugs: lanreotide inhibits insulin and glucagon secretion; monitor glucose and adjust antidiabetic treatmentSOMATULINE DEPOT (lanreotide), US prescribing information, section 7. DailyMed version 16, effective October 11, 2024, read October 5, 2026.
  • cyclosporine: may decrease cyclosporine absorption; its dose may need adjustingSOMATULINE DEPOT (lanreotide), US prescribing information, section 7. DailyMed version 16, effective October 11, 2024, read October 5, 2026.
  • bromocriptine: may increase bromocriptine absorptionSOMATULINE DEPOT (lanreotide), US prescribing information, section 7. DailyMed version 16, effective October 11, 2024, read October 5, 2026.
  • bradycardia-inducing drugs (e.g., beta-blockers): additive slowing of heart rate; doses may need adjustingSOMATULINE DEPOT (lanreotide), US prescribing information, section 7. DailyMed version 16, effective October 11, 2024, read October 5, 2026.
  • CYP3A4-metabolised drugs with a low therapeutic index (e.g., quinidine): clearance may fall; avoid such drugs and consider lower doses of drugs metabolised by the liverSOMATULINE DEPOT (lanreotide), US prescribing information, section 7. DailyMed version 16, effective October 11, 2024, read October 5, 2026.
LarazotideNone found

No interaction study was found in a PubMed search on 2026-09-30 (4 hits read).

The search("Larazotide"[tiab] OR "AT-1001"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All four hits are about a different compound that shares the code AT-1001, an alpha3beta4 nicotinic receptor ligand; none concerns larazotide.

LecirelinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Lecirelin"[tiab] OR "Dalmarelin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
LeconotideNone found

No interaction study was found in a PubMed search on 2026-11-04 (2 hits read).

The search("leconotide"[tiab] OR "AM336"[tiab] OR "AM-336"[tiab] OR "CNSB004"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hit(s) read November 4, 2026 (21539704, 20002322): rat studies that combined leconotide with morphine or flupirtine; none studies a drug interaction with leconotide in people

LepirudinNone found

No interaction study was found in a PubMed search on 2026-10-28 (8 hits read).

The search("Lepirudin"[tiab] OR "Refludan"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

8 hits: in vitro and laboratory studies (complement and CD14 inhibition in whole blood; heparin-induced thrombocytopenia assays; a 2002 study of how lepirudin, argatroban and melagatran change the prothrombin time with oral anticoagulation, which has no abstract), a 2007 report of direct thrombin inhibition during coronary intervention, a review of argatroban and a case of fatal anaphylaxis; none is a controlled drug interaction study.

LeuphasylNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Leuphasyl"[tiab] OR "Pentapeptide-18"[tiab] OR "Tyr-D-Ala-Gly-Phe-Leu"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
LeuprolideStudied

PubMed (human clinical-trial screen)

  • tibolone (add-back): reversed the cognitive effects of leuprolide depot and improved mood and quality of life more than leuprolide aloneTibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas (2008). PubMed

The Lupron Depot label lists only laboratory-test effects (pituitary-gonadal suppression) in its interactions section.

LinaclotideFrom the label

FDA label: no interactions section; the boxed warning and contraindication are an age limit, not a drug interaction

  • no drug: the label carries no drug interactions section; linaclotide acts in the gut lumen and is minimally absorbedLinzess (linaclotide) capsules, US prescribing information, boxed warning and section 4. DailyMed version 40, effective October 9, 2026, read October 27, 2026.

The label's boxed warning contraindicates use under 2 years of age because neonatal mice died of dehydration at a clinically relevant adult dose. That is an age contraindication, not an interaction.

LiraglutideFrom the label

FDA label, section 7

  • oral medications: delayed gastric emptying may affect their absorption; tested drugs were not affected to a clinically relevant degree, but caution is advisedVICTOZA (liraglutide), US prescribing information, section 7. DailyMed version 31, effective October 14, 2025, read October 5, 2026.
  • insulin secretagogues (e.g., sulfonylureas) or insulin: higher risk of hypoglycaemia, including severe; consider lowering their doseVICTOZA (liraglutide), US prescribing information, section 7. DailyMed version 31, effective October 14, 2025, read October 5, 2026.
LivagenNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Livagen"[tiab] OR "Lys-Glu-Asp-Ala"[tiab] OR "KEDA"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
LivoletideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("livoletide"[tiab] OR "AZP-531"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • oral medicines that need a target peak concentration or a rapid onset: GLP-1 receptor agonists lowered peak concentrations in 10 of the reviewed studies and delayed the time to peak in 14, so clinically meaningful interactions are possible; total exposure was equivalent in 11 of 15 interactions studiedHurren KM, Pinelli NR. "Drug-drug interactions with glucagon-like peptide-1 receptor agonists." Ann Pharmacother. 2012;46(5):710-7. PMID: 22510669. PubMed

Adlyxin has no current label on DailyMed (discontinued in the US), so this record rests on the published review of GLP-1 receptor agonist interactions, which searched lixisenatide by name.

LixivaptanNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Lixivaptan"[tiab] OR "VPA-985"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study found; development stopped in 2022 before any label existed. Tolvaptan, the approved drug of its class, carries CYP3A interactions on its label, which were never characterised for lixivaptan.

LL-37None found

No interaction study was found in a PubMed search on 2026-10-05 (55 hits read).

The search("LL-37"[tiab] OR "Cathelicidin LL-37"[tiab] OR "human cationic antimicrobial protein 18 (hCAP18)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory synergy studies of LL-37 with antibiotics against bacteria, and immunology studies of the endogenous peptide; no human drug interaction study. Alias 'CAMP' (the gene symbol) was excluded because it matches cAMP.

LonapegsomatropinFrom the label

FDA label, section 7

  • glucocorticoid replacement, especially cortisone acetate and prednisone: growth hormone inhibits 11β-HSD-1 and can lower serum cortisol; maintenance or stress doses may need raisingSkytrofa (lonapegsomatropin-tcgd) for injection, US prescribing information, section 7. DailyMed version 14, effective October 21, 2026, read October 27, 2026.
  • pharmacologic or supraphysiologic glucocorticoids: may blunt the growth-promoting effect in children; adjust replacement dosing carefullySkytrofa (lonapegsomatropin-tcgd) for injection, US prescribing information, section 7. DailyMed version 14, effective October 21, 2026, read October 27, 2026.
  • drugs metabolised by cytochrome P450 enzymes: somatropin increases CYP450-mediated clearance; monitor carefullySkytrofa (lonapegsomatropin-tcgd) for injection, US prescribing information, section 7. DailyMed version 14, effective October 21, 2026, read October 27, 2026.
  • oral oestrogen: may reduce the IGF-1 response; higher doses may be neededSkytrofa (lonapegsomatropin-tcgd) for injection, US prescribing information, section 7. DailyMed version 14, effective October 21, 2026, read October 27, 2026.
  • insulin and other glucose-lowering drugs: may reduce insulin sensitivity, particularly at higher doses; diabetes treatment may need adjustingSkytrofa (lonapegsomatropin-tcgd) for injection, US prescribing information, section 7. DailyMed version 14, effective October 21, 2026, read October 27, 2026.
LSALT peptideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("LSALT peptide"[tiab] OR "Metablok"[tiab] OR "LSALT"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
LucinactantNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Lucinactant"[tiab] OR "Surfaxin"[tiab] OR "KL4 surfactant"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
LunasinNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Lunasin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2014 laboratory study of lunasin with cytokines in lymphoma immunotherapy; not a drug interaction study in people.

LusupultideNone found

No interaction study was found in a PubMed search on 2026-11-03 (3 hits read).

The search("lusupultide"[tiab] OR "Venticute"[tiab] OR "rSP-C"[tiab] OR "recombinant surfactant protein C"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The three hits are rat lung-lavage studies that added dexamethasone, roflumilast or a COX inhibitor to the surfactant to look for added benefit (PMIDs 10715602, 10806144, 12940630); no human interaction study.

Lutetium-177 DOTATATEFrom the label

FDA label, section 7

  • long-acting somatostatin analogues: compete for somatostatin receptors and may reduce efficacy; discontinue at least 4 weeks before each doseLutathera (lutetium Lu 177 dotatate) injection, US prescribing information, section 7. DailyMed version 12, effective January 15, 2026, read September 30, 2026.
  • short-acting octreotide: same competition; discontinue at least 24 hours before each doseLutathera (lutetium Lu 177 dotatate) injection, US prescribing information, section 7. DailyMed version 12, effective January 15, 2026, read September 30, 2026.
  • high-dose glucocorticoids: can down-regulate somatostatin receptor subtype 2; avoid repeated high doses during treatmentLutathera (lutetium Lu 177 dotatate) injection, US prescribing information, section 7. DailyMed version 12, effective January 15, 2026, read September 30, 2026.
Lutropin alfaNone found

No interaction study was found in a PubMed search on 2026-09-30 (2 hits read).

The search("lutropin alfa"[tiab] OR "Luveris"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are efficacy trials in which lutropin alfa was given with follitropin alfa by design, the combination it is always used in; neither studies an interaction.

LypressinStudied

PubMed

  • glibenclamide: decreased antidiuretic response to lysine vasopressin in healthy subjectsRadó, J.P. et al. (1974). Decreased antidiuretic response to lysine-vasopressin after acute administration of glibenclamide in healthy subjects. Acta Diabetol Lat, 11, 18-21. PubMed
  • chlorpropamide, carbamazepine or clofibrate: after brief antidiuresis, a lysine vasopressin bolus caused increased water diuresis for 12-24 hours or longer in diabetes insipidus patients taking these drugsMeinders, A.E. et al. (1975). Paradoxical diuresis after vasopressin administration to patients with neurohypophyseal diabetes insipidus treated with chlorpropamide, carbamazepine or clofibrate. Clin Sci Mol Med, 49, 283-290. PubMed

Most of the 20 hits are endocrine test protocols combining lysine vasopressin with releasing hormones. The two human interaction studies are below; 4216226 has no abstract and is described from its title.

MacimorelinFrom the label

FDA label, section 7

  • drugs that prolong the QT interval (antipsychotics, moxifloxacin, class IA and III antiarrhythmics): may lead to torsade de pointes; avoid together and allow a washout firstMacrilen (macimorelin) granules for oral solution, US prescribing information, section 7. DailyMed version 3, effective February 18, 2026, read September 30, 2026.
  • strong CYP3A4 inducers (carbamazepine, phenytoin, rifampin, St John's wort and others): lower macimorelin levels and may cause a false positive test; discontinue before the testMacrilen (macimorelin) granules for oral solution, US prescribing information, section 7. DailyMed version 3, effective February 18, 2026, read September 30, 2026.
  • drugs affecting growth hormone release (somatostatin, insulin, glucocorticoids, aspirin and indomethacin; clonidine and levodopa; atropine, propylthiouracil and growth hormone products): may distort the diagnostic test; growth hormone products are stopped at least a week beforehandMacrilen (macimorelin) granules for oral solution, US prescribing information, section 7. DailyMed version 3, effective February 18, 2026, read September 30, 2026.
MagaininNone found

No interaction study was found in a PubMed search on 2026-10-05 (45 hits read).

The search("Magainin"[tiab] OR "Magainin 2"[tiab] OR "MSI-78"[tiab] OR "Pexiganan"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory and membrane-model synergy studies (with PGLa, antibiotics and other peptides); no human interaction study. Pexiganan, a magainin analogue, has its own entry.

ManserinNone found

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("manserin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
MaraciclatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Maraciclatide"[tiab] OR "NC100692"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("Maridebart cafraglutide"[tiab] OR "MariTide"[tiab] OR "AMG 133"[tiab] OR "AMG-133"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
MastoparanNone found

No interaction study was found in a PubMed search on 2026-11-07 (15 hits read).

The search("mastoparan"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

15 hit(s) read October 30, 2026 (35202419, 31867293, 27693190, 22561066, 19940980, 17320058, 16127206, 15781274, 12205136, 11069902, 10905478, 9271235, 1354116, 1709171, 2579318): none studies a drug interaction with mastoparan in people

MazdutideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Mazdutide"[tiab] OR "IBI362"[tiab] OR "LY3305677"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
MecaserminStudied

PubMed (human clinical-trial screen)

  • somatropin (rhGH): coadministration accelerated growth more than rhGH alone, with a similar safety profileRecombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency (2015). PubMed

PubMed

  • insulin: in 52 insulin-treated people with type 2 diabetes, 14 days of the complex cut insulin requirements by 54% to 82% and fasting glucose by 32% to 37%, so insulin doses fall and hypoglycaemia becomes the risk when the two are combinedClemmons DR, et al. "Rh/IGF-I/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose." Growth Horm IGF Res, 2005;15(4):265-74. PMID: 16005252. PubMed

The other hits are a review and a 2022 study of its compatibility with administration equipment for infusion, which is not a drug interaction.

No interaction study was found in a PubMed search on 2026-10-30 (19 hits read).

The search("Melanin-concentrating hormone"[tiab] OR "pro-MCH"[tiab] OR "pmch"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All 19 hits are animal or cell studies (feeding and nucleus-accumbens pharmacology, receptor-antagonist toxicity, cannabinoid co-administration in rodents); none is a human drug-drug interaction study. Melanin-concentrating hormone is not administered to people.

No interaction study was found in a PubMed search on 2026-10-30 (4 hits read).

The search("Melanocyte-stimulating hormone beta"[tiab] OR "beta-MSH"[tiab] OR "beta-melanocyte-stimulating hormone"[tiab] OR "beta-melanotropin"[tiab] OR "melanotropin beta"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The four hits are animal or cell studies (meibomian-gland lipogenesis, brain inflammation via MC3/MC4 receptors, lipolysis, and morphine antagonism in animals); none is a human drug-drug interaction study.

Melanotan IINone found

No interaction study was found in a PubMed search on 2026-10-05 (6 hits read).

The search("Melanotan II"[tiab] OR "melanotan 2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are rodent and vole studies combining melanotan II with other agents (for example naltrexone, NPY); no human interaction study. Aliases 'MT-II' and 'MT-2' were excluded because they match melatonin receptor MT2, and 'Barbie drug' as a slang term.

MelatoninStudied

PubMed (human clinical-trial screen)

  • fluvoxamine: increased oral melatonin's bioavailability by inhibiting its eliminationIncreased bioavailability of oral melatonin after fluvoxamine coadministration (2000). PubMed
  • nifedipine: melatonin raised blood pressure and heart rate in patients controlled on nifedipine, impairing its effectCardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study (2000). PubMed
MelittinNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Melittin"[tiab] OR "Bee venom peptide"[tiab] OR "Apis mellifera peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Melphalan Flufenamide"[tiab] OR "Melflufen"[tiab] OR "Pepaxto"[tiab] OR "Pepaxti"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: laboratory and animal antitumour studies in leukaemia and myeloma; neither is a drug interaction study in people.

MenotropinNone found

No interaction study was found in a PubMed search on 2026-10-06 (19 hits read).

The search("Menotropin"[tiab] OR "Menopur"[tiab] OR "Repronex"[tiab] OR "Humegon"[tiab] OR "human menopausal gonadotropin"[tiab] OR "highly purified hMG"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are animal studies and combined fertility-protocol studies (clomiphene, growth hormone, letrozole); none is an interaction study. The Menopur label says no human interaction studies were done.

MetreleptinFrom the label

FDA label, section 7

  • drugs metabolised by CYP450 with a narrow therapeutic index (for example warfarin, cyclosporine, theophylline) and oral contraceptives: no formal interaction studies; leptin is a cytokine that may alter CYP450 formation, so the label advises monitoring effect or drug levels and adjusting those drugs when metreleptin is started or stoppedMYALEPT (metreleptin), US prescribing information, section 7. DailyMed version 18, effective March 25, 2024, read October 28, 2026.
MGFNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Mechano Growth Factor"[tiab] OR "IGF-1Ec"[tiab] OR "IGF-1 Ec variant"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
MicafunginFrom the label

FDA label, section 7

  • sirolimus, itraconazole, nifedipine: monitor for toxicity of these drugs and reduce their dose if necessaryBaxter. Micafungin in Sodium Chloride Injection US prescribing information, section 7. DailyMed version of September 29, 2023, read October 3, 2026.
  • cyclosporine, itraconazole, voriconazole, fluconazole, rifampin, ritonavir: did not alter micafungin pharmacokineticsBaxter. Micafungin in Sodium Chloride Injection US prescribing information, section 7. DailyMed version of September 29, 2023, read October 3, 2026.

PubMed

  • high-dose methotrexate: no significant change in methotrexate exposure (median AUC24-72 67.6 vs 84.5 umol*h/L, P = 0.61) in 11 children given mifamurtide; retrospective, 21 patientsAntebi, M. et al. (2026). Does mifamurtide affect the elimination of high-dose methotrexate in children with osteosarcoma? Cancer Chemother Pharmacol, 96, 36. PubMed

The other three hits are animal or cell studies (diclofenac, doxorubicin).

MK-677None found

No interaction study was found in a PubMed search on 2026-10-06 (3 hits read).

The search("MK-677"[tiab] OR "Ibutamoren"[tiab] OR "Ibutamoren mesylate"[tiab] OR "MK-0677"[tiab] OR "MK0677"[tiab] OR "LUM-201"[tiab] OR "Nutrobal"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are a case study of combined use with LGD-4033 and two laboratory papers; no interaction study.

Mod GRF 1-29In the checker

No interaction study was found in a PubMed search on 2026-10-27 (0 hits read).

The search("Modified GRF(1-29)"[tiab] OR "CJC-1295 without DAC"[tiab] OR "CJC-1295 no DAC"[tiab] OR "mod GRF"[tiab] OR "tetrasubstituted GRF"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Not studied: no published interaction study. Pairs with other peptides are rated in the Interaction Checker.

ModimelanotideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("modimelanotide"[tiab] OR "AP214"[tiab] OR "ABT-719"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
MontirelinNone found

No interaction study was found in a PubMed search on 2026-11-05 (5 hits read).

The search("montirelin"[tiab] OR "NS-3"[tiab] OR "CG-3703"[tiab] OR "CG3703"[tiab] OR "CNK-602A"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

5 hit(s) read October 30, 2026 (28882564, 26622169, 25787025, 8799658, 1665210): none studies a drug interaction with montirelin in people

MorphiceptinNone found

No interaction study was found in a PubMed search on 2026-11-07 (12 hits read).

The search("morphiceptin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

12 hit(s) read October 30, 2026 (22960407, 22047797, 11488440, 10069492, 8867918, 7832296, 8396630, 1851839, 1972664, 2548877, 6619826, 6286328): none studies a drug interaction with morphiceptin in people

MotilinNone found

No interaction study was found in a PubMed search on 2026-10-28 (26 hits read).

The search("motilin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits are animal or tissue studies of motilin, or concern erythromycin, a macrolide that acts on the motilin receptor and has its own interactions; none studies a drug interaction with motilin given as a drug.

MotixafortideNone found

No interaction study was found in a PubMed search on 2026-10-03 (2 hits read).

The search("Motixafortide"[tiab] OR "Aphexda"[tiab] OR "BL-8040"[tiab] OR "BKT140"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits concern BKT140 (motixafortide's code) but are not interaction studies: an in vitro study combining it with imatinib in leukaemia cells and a stem-cell mobilisation safety study. The Aphexda label (DailyMed June 4, 2026) has no drug interactions section.

MOTS-cNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("MOTS-c"[tiab] OR "MOTSc"[tiab] OR "Mitochondrial ORF of 12S rRNA-c"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
MurabutideStudied

PubMed

  • interferon-alpha: given together to healthy volunteers with increasing interferon-alpha doses, the combination was well tolerated, with side effects similar to interferon-alpha aloneDarcissac, E. C. et al. (2001). Clinical tolerance and profile of cytokine induction in healthy volunteers following the simultaneous administration of ifn-alpha and the synthetic immunomodulator murabutide. J Interferon Cytokine Res, 21, 655-61. PubMed

6 hits: five are laboratory or animal studies with interferons or interleukin-2; one is a human co-administration study with interferon-alpha, read in full abstract.

No interaction study was found in a PubMed search on 2026-10-28 (82 hits read).

The search("Muramyl Dipeptide"[tiab] OR "N-acetylmuramyl-L-alanyl-D-isoglutamine"[tiab] OR "N-acetylmuramyl dipeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

82 hits; the 40 most recent titles were screened. They are animal and cell studies of muramyl dipeptide with lipopolysaccharide, other Toll-like receptor ligands or cytokines, and muramyl dipeptide-paclitaxel conjugates; none is a drug interaction study in people.

MurepavadinNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Murepavadin"[tiab] OR "POL7080"[tiab] OR "POL-7080"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2026 laboratory study of murepavadin enhancing conventional antibiotics against biofilms; not a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Myristoyl Hexapeptide-16"[tiab] OR "Myr-LKKALK"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Myristoyl Pentapeptide-17"[tiab] OR "Myr-KLAKK-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Myristoyl Tetrapeptide-12"[tiab] OR "Myr-KAKA-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("NA-Selank Amidate"[tiab] OR "N-Acetyl Selank Amidate"[tiab] OR "Acetylated Selank"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
NAD+In the checker

No interaction study was found in a PubMed search on 2026-10-27 (6 hits read).

The search("Nicotinamide Adenine Dinucleotide"[tiab] OR "NAD+"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab]) AND (infusion[tiab] OR intravenous[tiab] OR injection[tiab] OR subcutaneous[tiab]) AND humans[MeSH Terms]

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Not studied as a drug given with other drugs. NAD+ is a coenzyme in every cell, so the standard query returns 474 laboratory and metabolic papers; restricted to people and to injected or infused use it returns 6, none of which gives NAD+ with another drug (they are cell and animal studies and trials of other drugs that measure NAD+). Pairs with other peptides are rated in the Interaction Checker.

NafarelinNone found

No interaction study was found in a PubMed search on 2026-10-06 (3 hits read).

The search("Nafarelin"[tiab] OR "Synarel"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are a review, a trial of parathyroid hormone for bone loss and an animal study; no interaction study. The Synarel label says no pharmacokinetic interaction studies were done.

NangibotideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Nangibotide"[tiab] OR "LR12"[tiab] OR "LR-12"[tiab] OR "Motrem"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
NavepegritideNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Navepegritide"[tiab] OR "TransCon CNP"[tiab] OR "Yuviwel"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Nelipepimut-SNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Nelipepimut-S"[tiab] OR "NeuVax"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
NemifitideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Nemifitide"[tiab] OR "INN 00835"[tiab] OR "INN-00835"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("PEN-221"[tiab] OR "PEN 221"[tiab] OR "PEN221"[tiab] OR "nendratareotide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
NeoBNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("NeoB"[tiab] OR "NeoBOMB1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits, both unrelated: 'NeoB' there abbreviates neoechinulin B, a fungal compound, and another 1986 term in a mouse dopamine study.

NerinetideStudied

PubMed

  • alteplase: nerinetide is cleaved by plasmin when given after alteplase, which nullifies its benefit; in rats, giving nerinetide before alteplase preserved its effectMayor-Nunez, D. et al. (2021). Plasmin-resistant PSD-95 inhibitors resolve effect-modifying drug-drug interactions between alteplase and nerinetide in acute stroke. Sci Transl Med, 13, eabb1498. PubMed

Most of the 25 hits match on 'NA-1' or 'NA1' in unrelated contexts. The relevant record is below; the ESCAPE-NA1 trial cited on the entry is the human finding it explains.

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("nerp-2"[tiab] OR "neuroendocrine regulatory peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Nesfatin-1None found

No interaction study was found in a PubMed search on 2026-10-28 (6 hits read).

The search("nesfatin-1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All 6 hits are animal or cell studies (nesfatin-1 with other neuropeptides or drugs in rats); none is a human drug-interaction study.

NesiritideStudied

PubMed

  • levosimendan: studied as a combination in a 120-patient randomised trial in acute decompensated heart failure; clinical effectiveness at nine days was better with the combination than with controlJia Z, et al. "Levosimendan and nesiritide as a combination therapy in patients with acute heart failure." Am J Med Sci, 2015;349(5):398-405. PMID: 25853935. PubMed
  • milrinone: used together in decompensated heart failure, examined in a 2005 report of concomitant useSmull DL, et al. "Concomitant use of nesiritide and milrinone in decompensated congestive heart failure." Am J Health Syst Pharm, 2005;62(3):291-5. PMID: 15719588. PubMed
  • heparin, including heparin-coated catheters: nesiritide is incompatible with unfractionated heparin, and a case report examined loss of effect through a heparin-coated pulmonary artery lineBaroletti SA, et al. "Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure." Pharmacotherapy, 2004;24(11):1634-7. PMID: 15537565. PubMed

Nesiritide is recombinant B-type natriuretic peptide, the same molecule as the BNP entry, whose record carries the milrinone and heparin-catheter findings too.

PubMed

  • neutral endopeptidase inhibitors (inhaled phosphoramidon): blocking the enzyme that degrades neurokinin A potentiated its bronchoconstriction in asthmatic patientsCrimi N, et al. Inhibition of neutral endopeptidase potentiates bronchoconstriction induced by neurokinin A in asthmatic patients. Clin Exp Allergy, 1994;24(2):115-9. PMID: 8187026. PubMed

Most of the 89 hits are animal or in-vitro tachykinin pharmacology; the human interaction studies are the enzyme-inhibitor potentiation challenges.

PubMed

  • kisspeptin-54 (co-infused in healthy men): co-infused neurokinin B gave a significantly smaller rise in LH and FSH than kisspeptin alone; neurokinin B alone did not change gonadotropinsNarayanaswamy S, et al. Investigating the KNDy Hypothesis in Humans by Coadministration of Kisspeptin, Neurokinin B, and Naltrexone in Men. J Clin Endocrinol Metab, 2016;101(8):3058-67. PMID: 27379743. PubMed

The other hits are animal, in-vitro or receptor-antagonist pharmacology; this is the human co-administration study.

Neuromedin BNone found

No interaction study was found in a PubMed search on 2026-11-06 (9 hits read).

The search("neuromedin b"[tiab] OR "neuromedin-b"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

9 hit(s) read October 30, 2026 (24092425, 23826298, 15837132, 12493572, 10727528, 8853193, 8822518, 2328688, 2545989): none studies a drug interaction with neuromedin B in people

No interaction study was found in a PubMed search on 2026-11-06 (7 hits read).

The search("neuromedin n"[tiab] OR "neuromedin-n"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

7 hit(s) read October 30, 2026 (10525068, 9786410, 8106558, 1685934, 2323345, 2855314, 3416919): none studies a drug interaction with neuromedin N in people

Neuromedin SNone found

No interaction study was found in a PubMed search on 2026-11-03 (2 hits read).

The search("neuromedin S"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The bare abbreviation NMS is excluded because it mostly means neuroleptic malignant syndrome. Both hits are animal studies that gave neuromedin S into the brain together with receptor blockers or other feeding peptides to map its pathways, one in rats and one in chicks; neither tested a medicine people take, and neuromedin S has never been given to people, so no human interaction study exists.

Neuromedin UNone found

No interaction study was found in a PubMed search on 2026-10-28 (6 hits read).

The search("neuromedin U"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 6 hits are animal and cell studies of neuromedin signalling; none is a human drug-interaction study.

No interaction study was found in a PubMed search on 2026-11-06 (2 hits read).

The search("neuropeptide af"[tiab] OR "npaf"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hit(s) read October 30, 2026 (16515821, 11481330): none studies a drug interaction with neuropeptide AF in people

No interaction study was found in a PubMed search on 2026-11-06 (3 hits read).

The search("neuropeptide b"[tiab] OR "neuropeptide-b"[tiab] OR "npb23"[tiab] OR "npb29"[tiab] OR "npb-23"[tiab] OR "npb-29"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (33639195, 18760311, 15910767): none studies a drug interaction with neuropeptide B in people

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("neuropeptide ei"[tiab] OR "neuropeptide glutamic acid-isoleucine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-11-06 (31 hits read).

The search("neuropeptide ff"[tiab] OR "neuropeptide-ff"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

31 hit(s) read October 30, 2026 (41910723, 38395375, 30626554, 27018797, 26273748, 25459291, 22960407, 21121889, 19821834, 18406009, 18295932, 18276024, 17107711, 17011599, 16515821, 16299503, 12600686, 12065675, 11958872, 11835998): none studies a drug interaction with neuropeptide FF in people

Neuropeptide SNone found

No interaction study was found in a PubMed search on 2026-10-28 (9 hits read).

The search("Neuropeptide S"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

9 hits, all animal studies of neuropeptide S or NPS-receptor drugs with alcohol, cocaine, escitalopram, cannabidiol or adenosine antagonists; none is a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-11-06 (2 hits read).

The search("neuropeptide w"[tiab] OR "neuropeptide-w"[tiab] OR "npw"[tiab] OR "npw23"[tiab] OR "npw30"[tiab] OR "npw-23"[tiab] OR "npw-30"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hit(s) read October 30, 2026 (33639195, 15910767): none studies a drug interaction with neuropeptide W in people

PubMed (human clinical-trial screen)

  • phenylephrine (alpha1-agonist): in 12 healthy volunteers, the higher NPY infusion shifted blood-pressure responses 2.4-fold toward lower phenylephrine dosesHuman neuropeptide Y potentiates alpha1-adrenergic blood pressure responses in vivo (1998). PubMed
  • sitagliptin (DPP-4 inhibitor) with enalaprilat or valsartan: sitagliptin significantly potentiated NPY-induced forearm vasoconstrictionDPP-4 inhibition potentiates the vasoconstrictor response to NPY in humans during renin-angiotensin-aldosterone system inhibition (2018). PubMed

Human research-infusion studies; NPY is not a marketed medicine.

NeurotensinNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Neurotensin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])
NisinStudied

PubMed

  • conventional antibiotics such as ceftiofur: sub-inhibitory nisin enhanced ceftiofur's activity against resistant Staphylococcus aureus from bovine mastitis in vitroSánchez-Ceja MG, et al. "Nisin or Chitosan Enhance the Antimicrobial Activity of Ceftiofur Against Antibiotic-Resistant Staphylococcus aureus and Have Antibiofilm Effects." Pathogens, 2025;14(12). PMID: 41471173. PubMed
  • lysozyme: the two are analysed as a synergistic pair against Listeria biofilms, the combination used in food preservationPolegodage DSR, et al. "The "One-Two Punch": a conceptual analysis of nisin and lysozyme synergy against Listeria monocytogenes biofilms and their dependence on environmental factors." J Appl Microbiol, 2026;137(9). PMID: 42642043. PubMed

Nisin's interaction literature is food preservation and laboratory antimicrobial synergy; no drug interaction study in people was found.

NociceptinNone found

No interaction study was found in a PubMed search on 2026-10-28 (145 hits read).

The search("Nociceptin"[tiab] OR "Orphanin FQ"[tiab] OR "N/OFQ"[tiab] OR "nociceptin/orphanin FQ"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

145 hits; the 40 most recent titles were screened. They are animal and cell studies of nociceptin or NOP-receptor ligands given with opioids, cannabinoids, antidepressants or alcohol, and one 2026 human study of alcohol with sunobinop, a different drug that acts on the same receptor. None tests nociceptin itself with a medicine in people.

No interaction study was found in a PubMed search on 2026-11-06 (12 hits read).

The search("nocistatin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

12 hit(s) read October 30, 2026 (23792038, 17267127, 16384642, 16006036, 12423668, 11755218, 11516423, 11074165, 10619666, 10604967, 10218885, 10078987): none studies a drug interaction with nocistatin in people

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("NODAGA-exendin-4"[tiab] OR "68Ga-NODAGA-exendin-4"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Nonapeptide-1None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Nonapeptide-1"[tiab] OR "Melanostatine 5"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
NoopeptNone found

No interaction study was found in a PubMed search on 2026-09-30 (3 hits read).

The search("Noopept"[tiab] OR "GVS-111"[tiab] OR "Omberacetam"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are a rat EEG study, a mouse study of valproate's anticonvulsant effect, and a review; no human interaction study.

NosiheptideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Nosiheptide"[tiab] OR "RP 9671"[tiab] OR "RP-9671"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("NPAS3 Research Peptide"[tiab] OR "Neuronal PAS domain protein 3 fragment"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

FDA label, section 7

  • drugs that raise the risk of low blood sugar (other diabetes drugs, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues such as octreotide, sulfonamide antibiotics): dose reduction and more frequent glucose monitoring may be neededHumulin N (insulin human) injection, US prescribing information, section 7. DailyMed version 50, effective December 19, 2025, read September 30, 2026.
  • drugs that weaken its glucose-lowering effect (atypical antipsychotics, corticosteroids, danazol, diuretics, oestrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics such as albuterol, epinephrine and terbutaline, thyroid hormones): dose increases and more frequent glucose monitoring may be neededHumulin N (insulin human) injection, US prescribing information, section 7. DailyMed version 50, effective December 19, 2025, read September 30, 2026.
  • alcohol, beta-blockers, clonidine and lithium salts: may raise or lower the glucose-lowering effect; pentamidine may cause low blood sugar sometimes followed by high blood sugarHumulin N (insulin human) injection, US prescribing information, section 7. DailyMed version 50, effective December 19, 2025, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine and reserpine: may blunt or hide the warning signs of low blood sugarHumulin N (insulin human) injection, US prescribing information, section 7. DailyMed version 50, effective December 19, 2025, read September 30, 2026.
ObestatinNone found

No interaction study was found in a PubMed search on 2026-10-28 (9 hits read).

The search("obestatin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All 9 hits are animal, fish or cell studies of obestatin with ghrelin, CCK or other agents; none is a human drug-interaction study.

ObinepitideNone found

No interaction study was found in a PubMed search on 2026-11-05 (0 hits read).

The search("obinepitide"[tiab] OR "TM30338"[tiab] OR "TM-30338"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Octapeptide-2None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Octapeptide-2"[tiab] OR "KLKKTETQ"[tiab] OR "Prohairlin-beta4"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
OctreotideFrom the label

FDA label, section 7

  • cyclosporine: may lower cyclosporine levels and lead to transplant rejectionSandostatin (octreotide) injection, US prescribing information, section 7. DailyMed version 23, effective July 22, 2026, read October 5, 2026.
  • insulin and oral hypoglycaemic drugs: octreotide inhibits insulin and glucagon secretion; monitor glucose and adjust treatmentSandostatin (octreotide) injection, US prescribing information, section 7. DailyMed version 23, effective July 22, 2026, read October 5, 2026.
  • bromocriptine: increases bromocriptine availabilitySandostatin (octreotide) injection, US prescribing information, section 7. DailyMed version 23, effective July 22, 2026, read October 5, 2026.
  • bradycardia-inducing drugs (e.g., beta-blockers): additive slowing of heart rate; doses may need adjustingSandostatin (octreotide) injection, US prescribing information, section 7. DailyMed version 23, effective July 22, 2026, read October 5, 2026.
  • CYP3A4-metabolised drugs with a low therapeutic index (e.g., quinidine): clearance may fall; use with cautionSandostatin (octreotide) injection, US prescribing information, section 7. DailyMed version 23, effective July 22, 2026, read October 5, 2026.
  • lutetium Lu 177 dotatate: octreotide may interfere with its efficacy; stop octreotide at least 24 hours before each doseSandostatin (octreotide) injection, US prescribing information, section 7. DailyMed version 23, effective July 22, 2026, read October 5, 2026.
OlatorepatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("olatorepatide"[tiab] OR "HS-20094"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Oligopeptide-68None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Oligopeptide-68"[tiab] OR "GRGDYIWSLDTQ"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
OmigananStudied

PubMed

  • imiquimod (topical): in 16 healthy volunteers, adding topical omiganan enhanced imiquimod-induced inflammatory responses in the skin (a pharmacodynamic interaction)Niemeyer-van der Kolk, T. et al. (2020). Omiganan Enhances Imiquimod-Induced Inflammatory Responses in Skin of Healthy Volunteers. Clin Transl Sci, 13, 573-579. PubMed

The other two hits are an acne review and a study of a different antimicrobial peptide (DP7).

OncocinNone found

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("oncocin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (27285299): none studies a drug interaction with oncocin in people

OpiorphinNone found

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("opiorphin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (31568834): none studies a drug interaction with opiorphin in people

Orexin-ANone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Orexin-A"[tiab] OR "Hypocretin-1"[tiab] OR "OX-A"[tiab] OR "HCRT-1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])
Orexin-BNone found

No interaction study was found in a PubMed search on 2026-10-05 (23 hits read).

The search("Orexin-B"[tiab] OR "Hypocretin-2"[tiab] OR "OX-B"[tiab] OR "HCRT-2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are rodent, cell and receptor-drug studies of the endogenous orexins; no human interaction study.

OrforglipronFrom the label

FDA label, section 7

  • strong CYP3A4 inhibitors: maximum orforglipron dose 9 mg once daily; avoid strong CYP3A4 inhibitors that also inhibit OATP1BEli Lilly. FOUNDAYO (orforglipron) tablets, US prescribing information, section 7. DailyMed version effective July 29, 2026, read September 30, 2026.
  • CYP3A4 inducers: avoid strong inducers; with moderate inducers, monitor effectiveness and escalate the dose as neededEli Lilly. FOUNDAYO (orforglipron) tablets, US prescribing information, section 7. DailyMed version effective July 29, 2026, read September 30, 2026.
  • simvastatin: do not exceed simvastatin 20 mg once dailyEli Lilly. FOUNDAYO (orforglipron) tablets, US prescribing information, section 7. DailyMed version effective July 29, 2026, read September 30, 2026.
  • oral medications: orforglipron delays gastric emptying and may affect their absorptionEli Lilly. FOUNDAYO (orforglipron) tablets, US prescribing information, section 7. DailyMed version effective July 29, 2026, read September 30, 2026.
OritavancinFrom the label

FDA label, section 7

  • drugs predominantly metabolised by CYP2C9, CYP2C19, CYP3A4 or CYP2D6: oritavancin is a weak nonspecific inhibitor or inducer of these enzymes; the label says to avoid co-administration or monitor for toxicity or lack of efficacyMelinta. ORBACTIV (oritavancin) for injection, US prescribing information, section 7. DailyMed version effective September 15, 2026, read October 3, 2026.
  • warfarin: no effect on S-warfarin exposure in a study, but the label advises monitoring for bleedingMelinta. ORBACTIV (oritavancin) for injection, US prescribing information, section 7. DailyMed version effective September 15, 2026, read October 3, 2026.
  • phospholipid-dependent clotting tests: artificially prolongs aPTT for up to 120 hours, PT and INR up to 12 hours, and other tests for up to 72 hours; a chromogenic factor Xa assay is unaffectedMelinta. ORBACTIV (oritavancin) for injection, US prescribing information, section 7. DailyMed version effective September 15, 2026, read October 3, 2026.
  • blood cross-matching: positive indirect and direct antiglobulin tests were seen, which may interfere with cross-matching before transfusionMelinta. ORBACTIV (oritavancin) for injection, US prescribing information, section 7. DailyMed version effective September 15, 2026, read October 3, 2026.
OrnipressinNone found

No interaction study was found in a PubMed search on 2026-10-28 (6 hits read).

The search("ornipressin"[tiab] OR "POR 8"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 6 hits are animal studies (ornipressin with nitroglycerin in dogs, with lignocaine in rats) and 1970s regional-anaesthesia trials using it as a vasoconstrictor added to local anaesthetic; none measures a human drug-drug interaction.

OsteocalcinNone found

No interaction study was found in a PubMed search on 2026-10-28 (157 hits read).

The search("osteocalcin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits use osteocalcin as a marker of bone formation in studies of other drugs and growth factors given together (bisphosphonates, BMP-2, vitamins D and K), almost all in animals or cells; none studies a drug interaction with osteocalcin given as a drug.

No interaction study was found in a PubMed search on 2026-10-28 (4 hits read).

The search("osteogenic growth peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All 4 hits are cell, animal or biomaterial studies of OGP combined with other factors; no human drug-interaction study.

OvagenNone found

No interaction study was found in a PubMed search on 2026-10-05 (2 hits read).

The search("Ovagen"[tiab] OR "Glu-Asp-Leu"[tiab] OR "EDL tripeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits concern 'Ovagen', an ovine FSH product used in animal superovulation, not the Khavinson tripeptide (a known name collision); no interaction study of the peptide.

OxyntomodulinNone found

No interaction study was found in a PubMed search on 2026-10-03 (11 hits read).

The search("Oxyntomodulin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No drug interaction study in people. The human hits are hormone co-infusions (PYY3-36 added to oxyntomodulin cut intake 42.7%, PubMed 20357366; glucagon and GLP-1 comparisons) and a GPR40/GPR119 agonist trial; the rest are animal and cell studies.

OxytocinFrom the label

FDA label, precautions (drug interactions)

  • prophylactic vasoconstrictors given with caudal block anaesthesia: severe hypertension reported when oxytocin was given three to four hours laterPar Health. PITOCIN (oxytocin injection), US prescribing information, Precautions: Drug Interactions. DailyMed version effective May 5, 2026, read September 30, 2026.
  • cyclopropane anaesthesia: may modify oxytocin's cardiovascular effects, producing unexpected hypotension; maternal sinus bradycardia with abnormal atrioventricular rhythms has been notedPar Health. PITOCIN (oxytocin injection), US prescribing information, Precautions: Drug Interactions. DailyMed version effective May 5, 2026, read September 30, 2026.
OzarelixNone found

No interaction study was found in a PubMed search on 2026-11-04 (1 hit read).

The search("ozarelix"[tiab] OR "D-63153"[tiab] OR "D63153"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read November 4, 2026 (20623634): the cell study that combined ozarelix with TRAIL in prostate cancer cell lines; none studies a drug interaction with ozarelix in people

P21None found

No interaction study was found in a PubMed search on 2026-10-05 (4 hits read).

The search("P21"[tiab] OR "Cerebrolysin-derived peptide 21"[tiab] OR "Cognitive enhancer peptide-21"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab]) AND humans[mh] AND (clinical trial[pt] OR randomized controlled trial[pt])

The 4 human-trial hits concern the cell-cycle protein p21 (CDKN1A), a name collision, not the research peptide.

PACAPStudied

PubMed

  • sumatriptan: early sumatriptan reduced PACAP-38-induced migraine attacks (15% vs 42%) and constricted the dilated temporal arteryWienholtz, N.K.F. et al. (2021). Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial. Cephalalgia, 41, 731-748. PubMed
  • eptinezumab (CGRP antibody): did not reduce PACAP-38-induced migraine attacks (53% vs 63%, P = 0.74)Al-Karagholi, M.A. et al. (2025). PACAP38-induced migraine attacks are independent of CGRP signaling: a randomized controlled trial. J Headache Pain, 26, 79. PubMed
  • glibenclamide: did not change PACAP-38-induced headache or haemodynamic changes in healthy volunteersKokoti, L. et al. (2022). Effect of K(ATP) channel blocker glibenclamide on PACAP38-induced headache and hemodynamic. Cephalalgia, 42, 846-858. PubMed

The 101 query hits are animal and cell studies by title. The human studies below, all cited on the entry, gave drugs together with PACAP-38 infusion.

Pal-GHKNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Palmitoyl tripeptide-1"[tiab] OR "Pal-GHK"[tiab] OR "Palmitoyl oligopeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Dipeptide-10"[tiab] OR "Pal-Ala-His"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Dipeptide-5 Diaminobutyroyl Hydroxythreonine"[tiab] OR "Pal-Lys-Val-Dab-Thr"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Dipeptide-5 Diaminohydroxybutyrate"[tiab] OR "Pal-Lys-Val-Dab"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Palmitoyl Dipeptide-7"[tiab] OR "Pal-KT"[tiab] OR "Palmitoyl-Lys-Thr"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2021 cell study of peptide combinations with niacinamide on skin cells; not a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Palmitoyl Hexapeptide-12"[tiab] OR "Biopeptide EL"[tiab] OR "Pal-VGVAPG"[tiab] OR "Pal-Val-Gly-Val-Ala-Pro-Gly"[tiab] OR "Elastin spring-fragment peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Hexapeptide-14"[tiab] OR "Palmitoyl Hexapeptide-6"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (2 hits read).

The search("Palmitoyl Pentapeptide-4"[tiab] OR "Matrixyl"[tiab] OR "Pal-KTTKS"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The two hits are in vitro skin-cell studies of peptide combinations, not drug interactions.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Tetrapeptide-10"[tiab] OR "Pal-KTFK"[tiab] OR "N-Palmitoyl-Lys-Thr-Phe-Lys"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Tetrapeptide-20"[tiab] OR "Pal-PEKK"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("palmitoyl tetrapeptide-7"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Tripeptide-28"[tiab] OR "Pal-Arg-Phe-Lys"[tiab] OR "Pal-RFK"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Palmitoyl Tripeptide-38"[tiab] OR "Matrixyl Synthe'6"[tiab] OR "Matrixyl S6"[tiab] OR "Pal-KMO2K"[tiab] OR "Pal-Lys-Met(O2)-Lys"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Palmitoyl Tripeptide-5"[tiab] OR "Syn-Coll"[tiab] OR "SYN-COLL"[tiab] OR "Pal-Lys-Val-Lys"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a cosmetic microneedle study, not an interaction study.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Palmitoyl Tripeptide-8"[tiab] OR "Pal-His-D-Phe-Arg-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("Palopegteriparatide"[tiab] OR "Yorvipath"[tiab] OR "TransCon PTH"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("proadrenomedullin n-terminal 20 peptide"[tiab] OR "pamp-12"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PancragenNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Pancragen"[tiab] OR "Lys-Glu-Asp-Trp-NH2"[tiab] OR "KEDW-NH2"[tiab] OR "KEDW"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PancreastatinNone found

No interaction study was found in a PubMed search on 2026-11-06 (4 hits read).

The search("pancreastatin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hit(s) read October 30, 2026 (9843749, 8335081, 1352680, 2890162): none studies a drug interaction with pancreastatin in people

No interaction study was found in a PubMed search on 2026-10-28 (27 hits read).

The search("pancreatic polypeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits measure pancreatic polypeptide as a marker of other drugs' effects, test it with other NPY-family peptides in animals, or are cell studies; one study in mice and 16 volunteers gave it together with PYY 3-36 and found no added effect on feeding, a combination study rather than a drug interaction.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Natpara"[tiab] OR "rhPTH(1-84)"[tiab] OR "parathyroid hormone (1-84)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (30 hits read).

The search("parathyroid hormone-related protein"[tiab] OR "PTHrP"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 20 most relevant of the 30 hits were read by title: cell, animal and fish studies of PTHrP signalling with other agents; none is a human drug-interaction study of PTHrP given as a drug.

PasireotideFrom the label

FDA label, section 7

  • drugs that prolong the QT interval: additive QT prolongation; use with caution in anyone at significant riskSignifor (pasireotide) injection, US prescribing information, section 7. DailyMed version 20, effective February 17, 2026, read September 30, 2026.
  • cyclosporine: may lower cyclosporine's relative bioavailability; its dose may need adjusting to hold therapeutic levelsSignifor (pasireotide) injection, US prescribing information, section 7. DailyMed version 20, effective February 17, 2026, read September 30, 2026.
  • bromocriptine: somatostatin analogues may raise bromocriptine levels; a dose reduction may be neededSignifor (pasireotide) injection, US prescribing information, section 7. DailyMed version 20, effective February 17, 2026, read September 30, 2026.
PB-718None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("PB-718"[tiab] OR "PB718"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PE-22-28None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("PE-22-28"[tiab] OR "PE22-28"[tiab] OR "spadin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PeforelinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Peforelin"[tiab] OR "Maprelin"[tiab] OR "lamprey GnRH-III"[tiab] OR "l-GnRH-III"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PEG-MGFNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("PEG-MGF"[tiab] OR "Pegylated MGF"[tiab] OR "PEGylated mechano-growth factor"[tiab] OR "PEG Mechano Growth Factor"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PegbelferminNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("pegbelfermin"[tiab] OR "BMS-986036"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PegbovigrastimNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Pegbovigrastim"[tiab] OR "Imrestor"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2019 preliminary cattle study of enrofloxacin, flunixin meglumine and pegbovigrastim in Mycoplasma bovis pneumonia; not a drug interaction study in people.

PegcetacoplanNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Pegcetacoplan"[tiab] OR "Empaveli"[tiab] OR "Syfovre"[tiab] OR "APL-2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The Empaveli label (DailyMed August 21, 2026) has no drug interactions section.

PeginesatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Peginesatide"[tiab] OR "Omontys"[tiab] OR "AF37702"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PegmolesatideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Pegmolesatide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PegozaferminNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("pegozafermin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PegsebrenatideNone found

No interaction study was found in a PubMed search on 2026-10-30 (0 hits read).

The search("pegsebrenatide"[tiab] OR "NLY01"[tiab] OR "NLY-01"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PegvisomantFrom the label

FDA label, section 7

  • insulin and/or oral hypoglycaemic agents: patients with acromegaly and diabetes may need careful monitoring and dose reductionsSOMAVERT (pegvisomant), US prescribing information, section 7. DailyMed version 13, effective December 18, 2025, read October 5, 2026.
  • opioids: patients on opioids may need higher pegvisomant doses to suppress IGF-1SOMAVERT (pegvisomant), US prescribing information, section 7. DailyMed version 13, effective December 18, 2025, read October 5, 2026.
PemvidutideNone found

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("Pemvidutide"[tiab] OR "ALT-801"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PentagastrinNone found

No interaction study was found in a PubMed search on 2026-10-05 (162 hits read).

The search("Pentagastrin"[tiab] OR "Peptavlon"[tiab] OR "ICI 50123"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Pentagastrin is used to acidify the stomach in dog models of drug absorption; the hits study other drugs' absorption, not pentagastrin interactions in people.

Pentapeptide-3None found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Pentapeptide-3"[tiab] OR "Vialox"[tiab] OR "Pentapeptide-3V"[tiab] OR "Gly-Pro-Arg-Pro-Ala-NH2"[tiab] OR "GPRPA"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Pentapeptide-31None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Pentapeptide-31"[tiab] OR "AGELS-NH2"[tiab] OR "Ala-Gly-Glu-Leu-Ser-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-11-07 (0 hits read).

The search("pentigetide"[tiab] OR "ige pentapeptide"[tiab] OR "pentyde"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PentixaforNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Pentixafor"[tiab] OR "boclatixafortide"[tiab] OR "CPCR4-2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2024 study of a second-generation fluorine-18 D-amino-acid peptide for CXCR4 imaging; not a drug interaction study.

PentixatherNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Pentixather"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PEPITEMNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("PEPITEM"[tiab] OR "Peptide inhibitor of trans-endothelial migration"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Peptide YYStudied

PubMed (human clinical-trial screen)

  • GLP-1: in 10 lean volunteers, PYY3-36 plus GLP-1 cut buffet-meal energy intake by 27%, more than either alonePeptide YY3-36 and glucagon-like peptide-1(7-36) inhibit food intake additively (2005). PubMed
  • oxyntomodulin: in 12 overweight or obese volunteers, the combination cut energy intake by 42.7% against saline, more than either alonePYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans (2010). PubMed

Research infusions; a further trial found no additive effect of pancreatic polypeptide with PYY3-36 (PMID 18607381).

PetrelintideNone found

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("Petrelintide"[tiab] OR "ZP8396"[tiab] OR "Zealand amylin analog"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PexigananNone found

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Pexiganan"[tiab] OR "Locilex"[tiab] OR "MSI-78"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit is an in vitro study of MSI-78 combined with voriconazole and amphotericin B; no human interaction study.

PHM-27Studied

PubMed

  • corticotropin-releasing hormone: PHM alone did not change basal ACTH or cortisol but strongly increased the ACTH release produced by CRH in healthy peoplePotentiation of peptide histidine methionine (PHM) on corticotropin-releasing hormone (CRH) induced ACTH secretion in humans (1987). PubMed
  • corticotropin-releasing hormone (Cushing's disease): giving PHM together with CRH produced additive rises in ACTH and cortisol in patients with Cushing's diseaseStimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP. (1994). PubMed

Of the 7 hits, two are the human CRH co-administration studies cited above; the rest are isolated-tissue, cell-line or gene-expression studies, or concern VIP or other peptides.

PhoenixinNone found

No interaction study was found in a PubMed search on 2026-11-05 (1 hit read).

The search("phoenixin"[tiab] OR "phoenixin-14"[tiab] OR "phoenixin-20"[tiab] OR "PNX-14"[tiab] OR "PNX-20"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (34673032): none studies a drug interaction with phoenixin in people

Piflufolastat F 18From the label

FDA label, section 7

  • androgen deprivation therapy and other therapies targeting the androgen pathway: may change piflufolastat F 18 uptake in prostate cancerPylarify (piflufolastat F 18) injection, US prescribing information, section 7. DailyMed set a00e5cbc, version 11, effective February 18, 2026, read October 28, 2026.
PinealonNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Pinealon"[tiab] OR "Glu-Asp-Arg"[tiab] OR "EDR tripeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PiscidinNone found

No interaction study was found in a PubMed search on 2026-11-07 (4 hits read).

The search("piscidin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hit(s) read October 30, 2026 (30551662, 25992774, 21091726, 15193922): none studies a drug interaction with a piscidin in people

PlantaricinNone found

No interaction study was found in a PubMed search on 2026-11-07 (3 hits read).

The search("plantaricin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (30648887, 22138996, 9603847): none studies a drug interaction with a plantaricin in people

PlecanatideNone found

No interaction study was found in a PubMed search on 2026-10-06 (0 hits read).

The search("Plecanatide"[tiab] OR "Trulance"[tiab] OR "SP-304"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PlectasinNone found

No interaction study was found in a PubMed search on 2026-10-28 (4 hits read).

The search("Plectasin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hits: laboratory studies of plectasin-derived peptides (NZ2114 and others) combined with antibiotics or lipid nanocapsules; none is a drug interaction study in people.

PleurocidinNone found

No interaction study was found in a PubMed search on 2026-11-07 (6 hits read).

The search("pleurocidin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

6 hit(s) read October 30, 2026 (39422704, 22921812, 20580756, 12620872, 11302792, 10898673): none studies a drug interaction with a pleurocidin in people

PlitidepsinNone found

No interaction study was found in a PubMed search on 2026-10-28 (6 hits read).

The search("Plitidepsin"[tiab] OR "Aplidin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

6 hits: a 2023 phase 1 study of plitidepsin with bortezomib and dexamethasone that set a recommended combination dose but does not report a pharmacokinetic interaction, a population pharmacokinetic meta-analysis, a phase 2 study with L-carnitine, and laboratory studies; none is a dedicated drug interaction study.

PNC-27None found

No interaction study was found in a PubMed search on 2026-10-05 (1 hit read).

The search("PNC-27"[tiab] OR "PNC27"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a laboratory and animal study of PNC-27 with paclitaxel in ovarian cancer; no human interaction study.

PolaprezincNone found

No interaction study was found in a PubMed search on 2026-10-28 (9 hits read).

The search("polaprezinc"[tiab] OR "zinc carnosine"[tiab] OR "zinc L-carnosine"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The human hits give polaprezinc alongside low-dose aspirin (to treat the small-bowel injury aspirin causes) or zinc alongside interferon in hepatitis C; the rest are cell or animal studies and a review. None reports a pharmacokinetic interaction.

PubMed

  • warfarin: no effect on R- or S-warfarin exposure or on INR and prothrombin time after weekly 200 µg doses in 16 healthy menZhou H, et al. (2025). Warfarin pharmacokinetics and pharmacodynamics are not affected by concomitant administration of the long-acting GLP-1 receptor agonist polyethylene glycol loxenatide. Int J Clin Pharmacol Ther. PubMed
Polymyxin BNone found

No interaction study was found in a PubMed search on 2026-09-30 (385 hits read).

The search("Polymyxin B"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

385 hits, overwhelmingly in vitro synergy testing of polymyxin B with other antibiotics and compounds against resistant Gram-negative bacteria; none of the top results is a human drug interaction study.

PonericinNone found

No interaction study was found in a PubMed search on 2026-11-08 (0 hits read).

The search("ponericin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Porcine FSHNone found

No interaction study was found in a PubMed search on 2026-10-28 (4 hits read).

The search("Porcine FSH"[tiab] OR "pFSH"[tiab] OR "Folltropin"[tiab] OR "porcine follicle stimulating hormone"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hits: cell-culture studies of hormones acting on porcine granulosa cells and a 1990 comparison of commercial gonadotrophin preparations in immature rats; none is a drug interaction study.

FDA veterinary label, Drug Interactions

  • medications given during the US clinical studies (antimicrobials, NSAIDs, thyroid and anti-thyroid drugs, diuretics, parasiticides, vaccines and others): no medication interactions were reported; the drug was not studied in dogs receiving corticosteroidsVetsulin (porcine insulin zinc suspension), US FDA-approved veterinary label, Drug Interactions. DailyMed set 4472644f, version 10, effective October 20, 2026, read October 28, 2026.
PosatirelinNone found

No interaction study was found in a PubMed search on 2026-10-28 (4 hits read).

The search("Posatirelin"[tiab] OR "RGH 2202"[tiab] OR "RGH-2202"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hits, 1990-1992 animal studies of the TRH analogue RGH 2202 against morphine-induced respiratory depression and with narcotic analgesics; none is a drug interaction study in people.

PramlintideFrom the label

FDA label, section 7

  • insulin (in the same syringe): mixing alters pramlintide's pharmacokinetics; give as separate injectionsSYMLIN (pramlintide), US prescribing information, section 7. DailyMed version 18, effective December 18, 2019, read October 5, 2026.
  • oral medications where onset matters (e.g., analgesics, antibiotics, oral contraceptives): absorption may be delayed; take them at least 1 hour before or 2 hours after the injectionSYMLIN (pramlintide), US prescribing information, section 7. DailyMed version 18, effective December 18, 2019, read October 5, 2026.
  • drugs that alter gut motility (e.g., atropine) or slow nutrient absorption (e.g., alpha-glucosidase inhibitors): pramlintide should not be considered; these patients were not studiedSYMLIN (pramlintide), US prescribing information, section 7. DailyMed version 18, effective December 18, 2019, read October 5, 2026.
  • drugs that raise hypoglycaemia risk (antidiabetics, ACE inhibitors, fibrates, fluoxetine, MAO inhibitors, salicylates, somatostatin analogues, sulfonamides and others): use together with cautionSYMLIN (pramlintide), US prescribing information, section 7. DailyMed version 18, effective December 18, 2019, read October 5, 2026.

SYMLIN is discontinued in the US (Q424); the interactions are from its last label.

PreptinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("preptin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-11-06 (1 hit read).

The search("prokineticin 1"[tiab] OR "prokineticin-1"[tiab] OR "prok1"[tiab] OR "eg-vegf"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (16793879): none studies a drug interaction with prokineticin 1 in people

Prokineticin 2None found

No interaction study was found in a PubMed search on 2026-11-06 (6 hits read).

The search("prokineticin 2"[tiab] OR "prokineticin-2"[tiab] OR "prok2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

6 hit(s) read October 30, 2026 (40841926, 26435025, 22642848, 19933997, 17284183, 16793879): none studies a drug interaction with prokineticin 2 in people

No interaction study was found in a PubMed search on 2026-11-03 (10 hits read).

The search"prolactin-releasing peptide"[tiab] AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

10 hits, all rat, mouse or cell experiments giving PrRP with other signalling molecules (cholecystokinin, leptin, TRH, opioid and NPFF receptor ligands); prolactin-releasing peptide has never been given to people, so no human interaction study exists.

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Prolyl-Hydroxyproline"[tiab] OR "Pro-Hyp"[tiab] OR "Prolylhydroxyproline"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits, both animal studies of bradykinin antagonists whose sequences contain Pro-Hyp (1988, 1993); neither concerns the dipeptide itself.

ProstamaxNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Prostamax"[tiab] OR "Prostagen"[tiab] OR "Prostate peptide bioregulator"[tiab] OR "KEDP tetrapeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ProstatilenNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Prostatilen"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ProtegrinNone found

No interaction study was found in a PubMed search on 2026-11-07 (9 hits read).

The search("protegrin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

9 hit(s) read October 30, 2026 (42207438, 38280033, 35056889, 31214759, 31114762, 26058322, 18073150, 15245864, 9596706): none studies a drug interaction with a protegrin in people

ProtirelinNone found

No interaction study was found in a PubMed search on 2026-09-30 (201 hits read).

The search("Protirelin"[tiab] OR "thyrotropin-releasing hormone"[tiab] OR "Thypinone"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The query returned 201 hits (46 when restricted to humans), mostly physiology of thyrotropin-releasing hormone and studies of how illness or treatment changes the TRH test; none is an interaction study of protirelin as a drug. The closest, in depressed patients (PMID 14751427), found only a non-significant tendency for TSH responses to rise after antidepressant treatment.

PSMA I&SNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("PSMA I&S"[tiab] OR "PSMA-I&S"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PSMA-1007None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("PSMA-1007"[tiab] OR "18F-PSMA-1007"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
PT-141In the checker

FDA label, section 7, and PubMed

  • oral naltrexone: may significantly lower naltrexone exposure; avoid oral naltrexone products used for alcohol or opioid addictionCosette Pharmaceuticals. VYLEESI (bremelanotide) injection, US prescribing information, section 7. DailyMed set f1d0c1b5, version 1, effective November 13, 2025, read October 27, 2026.
  • oral medications: may slow gastric emptying; avoid with oral drugs that depend on threshold concentrations (e.g., antibiotics), and consider stopping bremelanotide if a quick-acting oral drug (e.g., indomethacin for pain) is delayedCosette Pharmaceuticals. VYLEESI (bremelanotide) injection, US prescribing information, section 7. DailyMed set f1d0c1b5, version 1, effective November 13, 2025, read October 27, 2026.
  • sildenafil (19 men with erectile dysfunction, intranasal PT-141): low doses together gave a greater erectile response than sildenafil alone, with no new or more frequent adverse eventsDiamond, L. E. et al. (2005). Co-administration of low doses of intranasal PT-141, a melanocortin receptor agonist, and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology, 65(4), 755-759. PubMed

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

The sildenafil study used an intranasal form, not the approved injection. The other two hits are reviews. Pairs with other peptides are rated in the Interaction Checker.

QRFP (26RFa)None found

No interaction study was found in a PubMed search on 2026-11-06 (2 hits read).

The search("qrfp"[tiab] OR "26rfa"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hit(s) read October 30, 2026 (36251705, 30772446): none studies a drug interaction with QRFP in people

RamoplaninNone found

No interaction study was found in a PubMed search on 2026-10-28 (4 hits read).

The search("Ramoplanin"[tiab] OR "A 16686"[tiab] OR "MDL 62198"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hits: laboratory antimicrobial combination and susceptibility studies and a 2002 review of treatment options for VRE; none is a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-28 (15 hits read).

The search("Recombinant Human Endostatin"[tiab] OR "Endostar"[tiab] OR "rh-endostatin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

15 hits: cell and animal studies of rh-endostatin combined with chemotherapy (cisplatin, oxaliplatin, doxorubicin, cyclophosphamide, gemcitabine, adriamycin), PD-1 blockade, dexamethasone, tetrandrine and other agents, reporting added anti-tumour or anti-angiogenic effects, and one study of administration sequence with cisplatin in mice; none is a pharmacokinetic or safety interaction study in people.

Regular human insulinFrom the label

FDA label, section 7 (Table 1)

  • antidiabetic agents, ACE inhibitors, angiotensin II receptor blockers, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analogues (e.g., octreotide), sulfonamide antibiotics: may increase the risk of hypoglycaemia; dose adjustment and more frequent glucose monitoring may be requiredEli Lilly. HUMULIN R (insulin human injection), US prescribing information, section 7, Table 1. DailyMed version effective June 16, 2026, read September 30, 2026.
  • atypical antipsychotics, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens, protease inhibitors, somatropin, sympathomimetics, thyroid hormones: may decrease the glucose-lowering effectEli Lilly. HUMULIN R (insulin human injection), US prescribing information, section 7, Table 1. DailyMed version effective June 16, 2026, read September 30, 2026.
  • alcohol, beta-blockers, clonidine, lithium salts; pentamidine: may increase or decrease the glucose-lowering effect; pentamidine may cause hypoglycaemia sometimes followed by hyperglycaemiaEli Lilly. HUMULIN R (insulin human injection), US prescribing information, section 7, Table 1. DailyMed version effective June 16, 2026, read September 30, 2026.
  • beta-blockers, clonidine, guanethidine, reserpine: may blunt signs and symptoms of hypoglycaemiaEli Lilly. HUMULIN R (insulin human injection), US prescribing information, section 7, Table 1. DailyMed version effective June 16, 2026, read September 30, 2026.
RelamorelinNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Relamorelin"[tiab] OR "RM-131"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Relaxin-3None found

No interaction study was found in a PubMed search on 2026-11-03 (1 hit read).

The search("relaxin-3"[tiab] OR "relaxin 3"[tiab] OR "RLN3"[tiab] OR "INSL7"[tiab] OR "Insulin-like peptide 7"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit is a laboratory study that shortened human relaxin-3 into receptor-selective analogues; it tested no second drug and gave nothing to people, so no human interaction study exists.

RelugolixFrom the label

FDA label, section 7

  • oral P-glycoprotein inhibitors: raise relugolix exposure; avoid, or take Orgovyx first and separate the doses by at least 6 hours, monitoring for adverse reactionsOrgovyx (relugolix) tablets, US prescribing information, section 7. DailyMed version 13, effective October 8, 2026, read October 27, 2026.
  • combined P-gp and strong CYP3A inducers: lower relugolix exposure and may reduce its effect; avoid, or raise the dose to 240 mg once dailyOrgovyx (relugolix) tablets, US prescribing information, section 7. DailyMed version 13, effective October 8, 2026, read October 27, 2026.
RetatrutideIn the checker

No interaction study was found in a PubMed search on 2026-10-27 (2 hits read).

The search("Retatrutide"[tiab] OR "LY3437943"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Not studied: the two hits are a rat study combining retatrutide with cagrilintide and a review. Investigational, so it has no label. The Interaction Checker's conflicts with semaglutide and tirzepatide rest on those drugs' labels, which advise against combining them with any other GLP-1 receptor agonist.

RetinalaminNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Retinalamin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
RezafunginStudied

PubMed

  • CYP probe substrates, transporter substrates, immunosuppressants and cancer therapies: two phase 1 crossover studies in healthy subjects found no clinically meaningful drug-drug interactionsFlanagan, S. et al. (2023). Absence of Clinically Meaningful Drug-Drug Interactions with Rezafungin: Outcome of Investigations. Microbiol Spectr, 11, e0133923. PubMed
RFRP-3 (GnIH)None found

No interaction study was found in a PubMed search on 2026-11-06 (3 hits read).

The search("rfrp-3"[tiab] OR "rfamide-related peptide 3"[tiab] OR "rfamide-related peptide-3"[tiab] OR "gnih"[tiab] OR "gonadotropin-inhibitory hormone"[tiab] OR "gonadotropin inhibitory hormone"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (32807874, 31290091, 28186349): none studies a drug interaction with RFRP-3 in people

RM2None found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("RM2"[tiab] OR "BAY 86-7548"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2023 study of a technetium-99m HYNIC-RM2 SPECT probe; not a drug interaction study.

RomidepsinFrom the label

FDA label, section 7

  • warfarin or coumarin derivatives: PT prolongation and INR elevation were seen in a patient on both; monitor PT and INR more oftenIstodax (romidepsin) for injection, US prescribing information, section 7. DailyMed set 03b39d40, version 22, effective January 31, 2023, read October 28, 2026.
  • strong CYP3A4 inhibitors: raise romidepsin exposure; monitor for toxicityIstodax (romidepsin) for injection, US prescribing information, section 7. DailyMed set 03b39d40, version 22, effective January 31, 2023, read October 28, 2026.
  • rifampin and strong CYP3A4 inducers: avoid the combinationIstodax (romidepsin) for injection, US prescribing information, section 7. DailyMed set 03b39d40, version 22, effective January 31, 2023, read October 28, 2026.
RomiplostimFrom the label

FDA label, section 7

  • other ITP therapies — corticosteroids, danazol, azathioprine, intravenous immunoglobulin and anti-D immunoglobulin: the label states Nplate may be used with themNplate (romiplostim) for injection, US prescribing information, section 7. DailyMed version 162, effective June 23, 2026, read September 30, 2026.
RomurtideNone found

No interaction study was found in a PubMed search on 2026-11-04 (10 hits read).

The search("romurtide"[tiab] OR "muroctasin"[tiab] OR "MDP-Lys(L18)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

10 hit(s) read November 4, 2026 (20083500, 7499064, 8084203, 1590684, 1473363, 2093210, 3142490, 3102442, 3847290, 6341226): all are animal or cell studies of combinations (antibiotics, interferon-gamma, endotoxin, cyclosporin A, which worsened its arthritis in rats); none studies a drug interaction in people

RotigaptideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("rotigaptide"[tiab] OR "zp-123"[tiab] OR "gap-486"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • itraconazole (CYP3A4/5 and P-gp inhibitor): rovatirelin Cmax rose 3.05-fold and AUC 2.82-fold; metabolite TAMP fellKobayashi, K. et al. (2020). Pharmacokinetic Drug Interactions of an Orally Available TRH Analog (Rovatirelin) With a CYP3A4/5 and P-Glycoprotein Inhibitor (Itraconazole). J Clin Pharmacol, 60, 1314-1323. PubMed
RubiscolinNone found

No interaction study was found in a PubMed search on 2026-11-07 (0 hits read).

The search("rubiscolin"[tiab] OR "rubiscolin-6"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
RusalatideNone found

No interaction study was found in a PubMed search on 2026-10-30 (1 hit read).

The search("rusalatide"[tiab] OR "TP508"[tiab] OR "TP-508"[tiab] OR "Chrysalin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (23594718): none studies a drug interaction with this drug in people

RusfertideFrom the label

FDA label: the Mimrylo prescribing information carries no drug interactions section

  • no drug: the label carries no drug interactions section and no boxed warningMimrylo (rusfertide) for injection, US prescribing information. DailyMed version 2, effective August 28, 2026, read September 30, 2026.
RuxotemitideNone found

No interaction study was found in a PubMed search on 2026-10-30 (3 hits read).

The search("ruxotemitide"[tiab] OR "LTX-315"[tiab] OR "LTX315"[tiab] OR "Oncopore"[tiab] OR "VP-315"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

3 hit(s) read October 30, 2026 (42843983, 34174350, 33446447): laboratory and animal studies testing it against bacteria or with other cancer treatments; none measures a drug interaction in people

Salusin-alphaNone found

No interaction study was found in a PubMed search on 2026-11-03 (0 hits read).

The search("salusin-alpha"[tiab] OR "salusin alpha"[tiab] OR "salusin-α"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No hits; salusin-alpha has not been given to people, only measured in blood and urine.

Salusin-betaNone found

No interaction study was found in a PubMed search on 2026-11-03 (0 hits read).

The search("salusin-beta"[tiab] OR "salusin beta"[tiab] OR "salusin-β"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No hits; salusin-beta has not been given to people, only measured in blood and urine.

SAR-bisPSMANone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("SAR-bisPSMA"[tiab] OR "64Cu-SAR-bisPSMA"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SARTATENone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("SARTATE"[tiab] OR "MeCOSar-octreotate"[tiab] OR "ucasareotide dasaroxetan"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Satoreotide Tetraxetan"[tiab] OR "DOTA-JR11"[tiab] OR "DOTA-JR-11"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Satoreotide Trizoxetan"[tiab] OR "NODAGA-JR11"[tiab] OR "OPS202"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SecretinFrom the label

FDA label, section 7

  • anticholinergic drugs: may cause a hyporesponse to stimulation testing; stop them at least 5 half-lives beforehandChiRhoStim (human secretin) for injection, US prescribing information, section 7. DailyMed version 20251008, effective October 8, 2025, read September 30, 2026.
  • H2-receptor antagonists and proton pump inhibitors: may cause a hyperresponse of gastrin, falsely suggesting gastrinoma; stop H2 blockers at least 2 days before, and check each PPI's own labelChiRhoStim (human secretin) for injection, US prescribing information, section 7. DailyMed version 20251008, effective October 8, 2025, read September 30, 2026.

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("secretoneurin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SeglitideNone found

No interaction study was found in a PubMed search on 2026-11-05 (0 hits read).

The search("seglitide"[tiab] OR "MK-678"[tiab] OR "MK 678"[tiab] OR "L-363586"[tiab] OR "L-363,586"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SelankNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Selank"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SelepressinNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Selepressin"[tiab] OR "FE 202158"[tiab] OR "FE-202158"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SemaglutideIn the checker

FDA labels (section 7 and Limitations of Use) and PubMed

  • other semaglutide-containing products or any other GLP-1 receptor agonist: concomitant use is not recommended (Wegovy's Limitations of Use)Novo Nordisk. WEGOVY (semaglutide) injection and tablets, US prescribing information, section 7 and Limitations of Use (section 1). DailyMed set ee06186f, version 19, effective June 18, 2026, read October 27, 2026.
  • insulin or an insulin secretagogue (e.g., a sulfonylurea): higher risk of hypoglycaemia, including severe; consider lowering their dose when starting semaglutideNovo Nordisk. WEGOVY (semaglutide) injection and tablets, US prescribing information, section 7 and Limitations of Use (section 1). DailyMed set ee06186f, version 19, effective June 18, 2026, read October 27, 2026.
  • oral medications: delayed gastric emptying may change their absorption; monitor, and consider more clinical or laboratory monitoring for drugs with a narrow therapeutic indexNovo Nordisk. WEGOVY (semaglutide) injection and tablets, US prescribing information, section 7 and Limitations of Use (section 1). DailyMed set ee06186f, version 19, effective June 18, 2026, read October 27, 2026.
  • levothyroxine: exposure rose 33% (90% CI 1.25 to 1.42) with semaglutide tablets in a drug interaction studyNovo Nordisk. RYBELSUS and OZEMPIC (oral semaglutide) tablets, US prescribing information, section 7. DailyMed set 27f15fac, version 14, effective January 30, 2026, read October 27, 2026.
  • levothyroxine (healthy volunteers, oral semaglutide 14 mg): total thyroxine exposure rose 33% while peak concentration was unchanged; the authors advise monitoring thyroid parametersHauge, C. et al. (2021). Effect of oral semaglutide on the pharmacokinetics of thyroxine after dosing of levothyroxine and the influence of co-administered tablets on the pharmacokinetics of oral semaglutide in healthy subjects: an open-label, one-sequence crossover, single-center, multiple-dose, two-part trial. Expert Opinion on Drug Metabolism & Toxicology, 17(9), 1139-1148. PubMed
  • metformin, warfarin, atorvastatin, digoxin (injected semaglutide 1 mg, healthy volunteers): no clinically relevant change in their pharmacokinetics; warfarin's INR response unchangedHausner, H. et al. (2017). Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects. Clinical Pharmacokinetics, 56(11), 1391-1401. PubMed
  • lisinopril, warfarin, digoxin, metformin (oral semaglutide, healthy volunteers): no apparent effect on lisinopril, warfarin or digoxin; metformin exposure rose 32%, judged not clinically relevantBækdal, T. A. et al. (2019). Effect of Oral Semaglutide on the Pharmacokinetics of Lisinopril, Warfarin, Digoxin, and Metformin in Healthy Subjects. Clinical Pharmacokinetics, 58(9), 1193-1203. PubMed
  • omeprazole (oral semaglutide, healthy volunteers): semaglutide exposure slightly and not significantly higher; not considered clinically relevantBækdal, T. A. et al. (2018). A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide. Expert Opinion on Drug Metabolism & Toxicology, 14(8), 869-877. PubMed
  • ethinylestradiol and levonorgestrel; furosemide; rosuvastatin (oral semaglutide, healthy volunteers): contraceptive exposure unchanged; furosemide exposure rose 28% and rosuvastatin 41%, which the authors did not expect to be clinically relevantJordy, A. B. et al. (2021). Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects. Clinical Pharmacokinetics, 60(9), 1171-1185. PubMed

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

The five PubMed studies are healthy-volunteer pharmacokinetic studies by the manufacturer's clinical pharmacologists (Novo Nordisk), found by narrowing the recorded query to clinical trials in healthy subjects (6 hits; the sixth concerns another drug). Pairs with other peptides are rated in the Interaction Checker.

SemaxStudied

PubMed

  • haloperidol: its effects in rats were studied against dopamine-receptor blockade with haloperidol; animal work, not a human interaction studySebentsova EA, et al. "Effects of semax against the background of dopaminergic receptor blockade with haloperidol." Bull Exp Biol Med, 2006;141(2):170-4. PMID: 16984088. PubMed
  • D-amphetamine: in rats it enhanced amphetamine-induced dopamine release in the striatum; animal work, not a human interaction studyEremin KO, et al. "[Semax potentiates effects of D-amphetamine on the level of extracellular dopamine in the Sprague-Dawley rat striatum and on the locomotor activity of C57BL/6 mice]." Eksp Klin Farmakol, 2004;67(2):8-11. PMID: 15188751. PubMed
SerelaxinNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("serelaxin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are animal studies of serelaxin combined with stem-cell exosomes or perindopril; no human drug-interaction study.

SermorelinIn the checker

PubMed

  • hexarelin (a growth hormone-releasing peptide): given together in six healthy men, growth hormone release was greater than the sum of each alone (synergy), and the synergy was lost on a repeat doseMassoud, A. F. et al. (1996). The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity. Clinical Endocrinology, 44(5), 555-562. PubMed
  • somatostatin infusion: reduced the growth hormone response to GHRH(1-29), alone or with hexarelin, in 12 healthy menMassoud, A. F. et al. (1997). Interaction of the growth hormone releasing peptide hexarelin with somatostatin. Clinical Endocrinology, 47(5), 537-547. PubMed
  • pyridostigmine: enhanced the growth hormone response to GHRH(1-29) in obese people with and without type 2 diabetes and in lean controls, but not in lean people with type 2 diabetesGiustina, A. et al. (1994). Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II diabetic patients. Metabolism, 43(7), 893-898. PubMed
  • long-term glucocorticoid treatment: blunted the growth hormone response to GHRH(1-29); the response to hexarelin was preservedGiustina, A. et al. (1995). Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess. Journal of Endocrinology, 146(2), 227-232. PubMed
  • acipimox: potentiated the growth hormone response to GHRH(1-29) in obese and normal-weight subjectsLee, E. J. et al. (1995). Acipimox potentiates growth hormone (GH) response to GH-releasing hormone with or without pyridostigmine by lowering serum free fatty acid in normal and obese subjects. Journal of Clinical Endocrinology and Metabolism, 80(8), 2495-2498. PubMed

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

These are single-dose growth hormone stimulation studies of GHRH(1-29)NH2, the sermorelin molecule; none measured a clinical outcome. The query's other hits are cell, animal and receptor-antagonist studies. Sermorelin has no current US label: DailyMed lists no maker's SPL (searched October 27, 2026). Pairs with other peptides are rated in the Interaction Checker.

SerpininNone found

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("serpinin"[tiab] OR "serpinins"[tiab] OR "pglu-serpinin"[tiab] OR "pyroglutaminated serpinin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SetmelanotideNone found

No interaction study was found in a PubMed search on 2026-10-06 (1 hit read).

The search("Setmelanotide"[tiab] OR "Imcivree"[tiab] OR "RM-493"[tiab] OR "BIM-22493"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a mouse study; no human interaction study.

SHLP2None found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("SHLP2"[tiab] OR "Small humanin-like peptide 2"[tiab] OR "MT-RNR2-derived SHLP2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SHLP6None found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("SHLP6"[tiab] OR "Small humanin-like peptide 6"[tiab] OR "MT-RNR2-derived SHLP6"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SialorphinNone found

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("sialorphin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (32759368): none studies a drug interaction with sialorphin in people

SiTATENone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("SiTATE"[tiab] OR "SiFAlin-TATE"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SnakinNone found

No interaction study was found in a PubMed search on 2026-11-08 (0 hits read).

The search("snakin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SolnatideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("solnatide"[tiab] OR "AP301"[tiab] OR "TIP peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SomapacitanFrom the label

FDA label, section 7

  • glucocorticoid replacement, especially cortisone acetate and prednisone: growth hormone inhibits 11β-HSD-1 and can lower serum cortisol; maintenance or stress doses may need raisingSogroya (somapacitan-beco) injection, US prescribing information, section 7. DailyMed version 8, effective February 25, 2026, read September 30, 2026.
  • drugs metabolised by cytochrome P450 enzymes: growth hormone increases CYP450-mediated clearance; monitor carefullySogroya (somapacitan-beco) injection, US prescribing information, section 7. DailyMed version 8, effective February 25, 2026, read September 30, 2026.
  • oral oestrogen: may reduce the IGF-1 response; higher doses may be neededSogroya (somapacitan-beco) injection, US prescribing information, section 7. DailyMed version 8, effective February 25, 2026, read September 30, 2026.
  • insulin and other glucose-lowering drugs: may reduce insulin sensitivity, particularly at higher doses; diabetes treatment may need adjustingSogroya (somapacitan-beco) injection, US prescribing information, section 7. DailyMed version 8, effective February 25, 2026, read September 30, 2026.

PubMed (human clinical-trial screen)

  • insulin: somatostatin infusion augmented insulin-mediated glucose disposal in healthy older subjectsSomatostatin enhances insulin-mediated glucose disposal in elderly subjects (1988). PubMed
  • hexarelin: hexarelin kept GH-releasing activity during high-dose somatostatin, and somatostatin withdrawal enhanced its responseInteraction of the growth hormone releasing peptide hexarelin with somatostatin (1997). PubMed
SomatremNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("somatrem"[tiab] OR "Protropin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SomatrogonFrom the label

FDA label, section 7

  • glucocorticoid replacement, especially cortisone acetate and prednisone: growth hormone inhibits 11β-HSD-1 and can lower serum cortisol; maintenance or stress doses may need raisingNgenla (somatrogon-ghla) injection, US prescribing information, section 7. DailyMed version 14, effective August 14, 2026, read September 30, 2026.
  • drugs metabolised by cytochrome P450 enzymes: growth hormone increases CYP450-mediated clearance; monitor carefullyNgenla (somatrogon-ghla) injection, US prescribing information, section 7. DailyMed version 14, effective August 14, 2026, read September 30, 2026.
  • oral oestrogen: may reduce the IGF-1 response; higher doses may be neededNgenla (somatrogon-ghla) injection, US prescribing information, section 7. DailyMed version 14, effective August 14, 2026, read September 30, 2026.
  • insulin and other glucose-lowering drugs: may reduce insulin sensitivity, particularly at higher doses; diabetes treatment may need adjustingNgenla (somatrogon-ghla) injection, US prescribing information, section 7. DailyMed version 14, effective August 14, 2026, read September 30, 2026.
  • supraphysiologic glucocorticoid treatment: may blunt the growth-promoting effect in children; adjust replacement dosing carefullyNgenla (somatrogon-ghla) injection, US prescribing information, section 7. DailyMed version 14, effective August 14, 2026, read September 30, 2026.
Somatropin (HGH)From the label

FDA label, section 7

  • glucocorticoid replacement: somatropin inhibits 11β-HSD1 and can unmask adrenal insufficiency or raise replacement needs, especially with cortisone acetate and prednisoneGENOTROPIN (somatropin), US prescribing information, section 7. DailyMed version 37, effective August 4, 2026, read October 5, 2026.
  • pharmacologic glucocorticoid therapy: may blunt growth-promoting effects in children; adjust dosing carefullyGENOTROPIN (somatropin), US prescribing information, section 7. DailyMed version 37, effective August 4, 2026, read October 5, 2026.
  • CYP450-metabolised drugs (e.g., corticosteroids, sex steroids, anticonvulsants, cyclosporine): their clearance may change; monitorGENOTROPIN (somatropin), US prescribing information, section 7. DailyMed version 37, effective August 4, 2026, read October 5, 2026.
  • oral oestrogen: women may need larger somatropin dosesGENOTROPIN (somatropin), US prescribing information, section 7. DailyMed version 37, effective August 4, 2026, read October 5, 2026.
  • insulin and oral or injectable hypoglycaemic agents: doses may need adjustmentGENOTROPIN (somatropin), US prescribing information, section 7. DailyMed version 37, effective August 4, 2026, read October 5, 2026.
SometriboveNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Sometribove"[tiab] OR "sometribove zinc"[tiab] OR "Posilac"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 1996 study of calves' responses to repeated endotoxin challenge during recombinant bovine somatotropin treatment; not a drug interaction study, and none in people.

SonefpeglutideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("sonefpeglutide"[tiab] OR "HM15912"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SotaterceptNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("sotatercept"[tiab] OR "Winrevair"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
SovateltideNone found

No interaction study was found in a PubMed search on 2026-10-03 (13 hits read).

The search("Sovateltide"[tiab] OR "IRL-1620"[tiab] OR "IRL 1620"[tiab] OR "PMZ-1620"[tiab] OR "SPI-1620"[tiab] OR "Tycamzzi"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

None of the 13 hits is a human interaction study. They are animal and tissue pharmacology of the endothelin-B receptor; the nearest is 15969946, in which IRL 1620 did not change paclitaxel plasma pharmacokinetics in tumour-bearing rats.

SpexinNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("spexin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The one hit is a rat study of spexin with progesterone; no human drug-interaction study.

SpinorphinNone found

No interaction study was found in a PubMed search on 2026-11-07 (1 hit read).

The search("spinorphin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (11829145): none studies a drug interaction with spinorphin in people

No interaction study was found in a PubMed search on 2026-09-30 (2 hits read).

The search("Elamipretide"[tiab] OR "SS-31"[tiab] OR "Bendavia"[tiab] OR "MTP-131"[tiab] OR "Forzinity"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits, both animal or cell studies of elamipretide combined with another agent, not interaction studies in people.

PubMed (human clinical-trial screen)

  • GHRH (growth hormone-releasing hormone): in 7 healthy men, a substance P infusion raised the GH peak after GHRH from 7 to 12 times baselineIntravenously infused substance P enhances basal and growth hormone (GH) releasing hormone-stimulated GH secretion in normal men (1992). PubMed

Substance P was given as a research infusion. Aliases naming its receptor (NK1) were excluded. Other human-trial hits are of NK1-blocking drugs such as aprepitant.

SurotomycinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Surotomycin"[tiab] OR "CB-183,315"[tiab] OR "CB-315"[tiab] OR "MK-4261"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • NPY2R agonists (BI 1820237): combined with a long-acting NPY2R agonist, it produced synergistic weight loss in animal models; a combination-efficacy finding from animals, not a safety interactionAugustin R, et al. "Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide." Mol Metab, 2025;99:102205. PMID: 40619099. PubMed
Syn-AkeNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Syn-Ake"[tiab] OR "Dipeptide Diaminobutyroyl Benzylamide Diacetate"[tiab] OR "β-Ala-Pro-Dab-NHBn·2AcOH"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • midazolam and other CYP3A4 substrates: in 17 men, one dose raised midazolam exposure (AUC) by 64% and seven days of dosing by 93%, consistent with tabimorelin inhibiting CYP3A4; drugs cleared by that enzyme would be expected to accumulateZdravkovic M, et al. "A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate." Eur J Clin Pharmacol, 2003;58(10):683-8. PMID: 12610745. PubMed
TachyplesinNone found

No interaction study was found in a PubMed search on 2026-11-07 (10 hits read).

The search("tachyplesin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

10 hit(s) read October 30, 2026 (39609311, 32003561, 29922995, 28355248, 19591887, 18068869, 17331619, 16586536, 12440153, 11724544): none studies a drug interaction with a tachyplesin in people

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Taldefgrobep alfa"[tiab] OR "BMS-986089"[tiab] OR "BHV-2000"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TaltirelinNone found

No interaction study was found in a PubMed search on 2026-10-05 (2 hits read).

The search("Taltirelin"[tiab] OR "Ceredist"[tiab] OR "TA-0910"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are rat studies; no human interaction study.

PubMed

  • lisinopril, warfarin, simvastatin, digoxin and an ethinylestradiol-levonorgestrel contraceptive: five clinical pharmacology studies in healthy volunteers measured how its slowing of gastric emptying changed these oral drugs' absorption; the effect on simvastatin was the most pronouncedBogman K, et al. "Assessment of Drug-Drug Interactions between Taspoglutide, a Glucagon-Like Peptide-1 Agonist, and Drugs Commonly Used in Type 2 Diabetes Mellitus: Results of Five Phase I Trials." Clin Pharmacokinet, 2019;58(9):1205-1214. PMID: 30968335. PubMed

Development of taspoglutide stopped; no label exists.

TB-500In the checker

No interaction study was found in a PubMed search on 2026-10-27 (0 hits read).

The search("TB-500"[tiab] OR "TB500"[tiab] OR "Ac-LKKTETQ"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR coadministration[tiab] OR co-administration[tiab])

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Not studied: no published interaction study. Pairs with other peptides are rated in the Interaction Checker.

No interaction study was found in a PubMed search on 2026-11-06 (0 hits read).

The search("tcap-1"[tiab] OR "teneurin c-terminal associated peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TecemotideNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Tecemotide"[tiab] OR "L-BLP25"[tiab] OR "BLP25 liposome vaccine"[tiab] OR "Stimuvax"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Technetium Tc 99m Apcitide"[tiab] OR "apcitide"[tiab] OR "AcuTect"[tiab] OR "P280"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: the abstract book of a 2016 intensive-care symposium, matched on a code name; unrelated.

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Technetium Tc 99m Etarfolatide"[tiab] OR "etarfolatide"[tiab] OR "Folcepri"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2025 rat study in which sodium para-aminohippurate reduced the kidney uptake of various radiopharmaceuticals; an animal study, not a drug interaction study in people.

PubMed

  • p-aminohippurate (PAH) and probenecid (organic anion transporter inhibitors): slower blood clearance and lower kidney uptake of MAG3 in healthy volunteers, so renal plasma flow estimated from the scan was underestimatedTakahara N, et al. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney. Nucl Med Biol, 2013. PubMed

1 hit(s) read October 30, 2026 (23618840); the US label (DailyMed set 0571c18b, version 9) has no drug interactions section.

TeduglutideFrom the label

FDA label, section 7

  • oral medicines generally: teduglutide may increase their absorption; monitor drugs needing titration or with a narrow therapeutic index, which may need a dose reductionGattex (teduglutide) for injection, US prescribing information, section 7. DailyMed version 20, effective September 5, 2025, read September 30, 2026.
  • benzodiazepines: altered mental status was seen in adults taking both in the clinical studiesGattex (teduglutide) for injection, US prescribing information, section 7. DailyMed version 20, effective September 5, 2025, read September 30, 2026.

PubMed

  • warfarin: PT-INR rose a median 80.9% after teicoplanin was added, against 30.6% with vancomycin, in a retrospective study of 49 patients; monitor INRNakano, T. et al. (2017). Effects of Teicoplanin on the PT-INR Controlled by Warfarin in Infection Patients. Yakugaku Zasshi, 137, 909-916. PubMed
  • tacrolimus: both are nephrotoxic; with drug monitoring of each, a 2-fold creatinine rise occurred in 2 of 67 stem cell transplant patients, reversiblyMori, T. et al. (2014). Nephrotoxicity of concomitant use of tacrolimus and teicoplanin in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis, 16, 329-332. PubMed

135 hits screened by title; most are in vitro antibiotic synergy studies. The two human interaction studies below were read in full abstract.

TeixobactinNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Teixobactin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: laboratory antibacterial synergy studies with polymyxin B and with cefepime; neither is a drug interaction study in people.

TelavancinFrom the label

FDA label, section 7

  • coagulation tests (PT, INR, aPTT, ACT): telavancin binds the phospholipid reagents and falsely raises results shortly after infusionCumberland/Theravance. VIBATIV (telavancin) US prescribing information, section 7. DailyMed version of December 19, 2025, read October 3, 2026.
  • urine protein tests: interferes with dipstick and dye-method urine protein assays; microalbumin assays are unaffectedCumberland/Theravance. VIBATIV (telavancin) US prescribing information, section 7. DailyMed version of December 19, 2025, read October 3, 2026.
TemporinNone found

No interaction study was found in a PubMed search on 2026-11-07 (9 hits read).

The search("temporin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

9 hit(s) read October 30, 2026 (41724849, 40886776, 39609311, 33321906, 28355248, 16269345, 15649993, 15273140, 15193922): none studies a drug interaction with a temporin in people

TeprotideNone found

No interaction study was found in a PubMed search on 2026-10-28 (13 hits read).

The search("teprotide"[tiab] OR "SQ 20881"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The 13 hits are animal and tissue studies using teprotide as an ACE-blocking tool, analogue syntheses and a review; none is a human drug-interaction study.

TeriparatideFrom the label

FDA label, section 7

  • digoxin: transient rises in calcium may predispose to digitalis toxicity; watch for its signsFORTEO (teriparatide), US prescribing information, section 7. DailyMed version 44, effective August 3, 2026, read October 5, 2026.

PubMed

  • octreotide: studied as a combination in portal hypertension, where the two vasoactive drugs were given together; the evidence is a rat haemodynamic study, not a human interaction trialChan CC, et al. "Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats." Scand J Gastroenterol. 1997;32(11):1159-63. PMID: 9354212. PubMed

The Terlivaz label has no drug interactions section; its boxed warning concerns serious or fatal respiratory failure. The 11 query hits are mostly animal physiology and case reports, and the one carried here is explicitly an animal study.

TertomotideNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Tertomotide"[tiab] OR "GV1001"[tiab] OR "GV-1001"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: a 2023 retrospective breast-cancer series and a 2020 laboratory hepatitis B study; neither is a drug interaction study.

TesamorelinIn the checker

FDA label, section 7

  • drugs metabolised by CYP450 liver enzymes (e.g., corticosteroids, sex steroids, anticonvulsants, cyclosporine): growth hormone may alter their clearance; monitor. Tesamorelin did not significantly change simvastatin (a CYP3A substrate) pharmacokinetics in healthy subjectsTheratechnologies. EGRIFTA WR (tesamorelin) for injection, US prescribing information, section 7 (the EGRIFTA SV label, DailyMed set 3d783378, version 9, carries the same section). DailyMed set 839334d3, version 2, effective July 29, 2026, read October 27, 2026.
  • glucocorticoid replacement for hypoadrenalism: may need higher maintenance or stress doses after tesamorelin is started; cortisone acetate and prednisone may be affected mostTheratechnologies. EGRIFTA WR (tesamorelin) for injection, US prescribing information, section 7 (the EGRIFTA SV label, DailyMed set 3d783378, version 9, carries the same section). DailyMed set 839334d3, version 2, effective July 29, 2026, read October 27, 2026.

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

The two PubMed hits are a rat study and a review; no published human interaction study beyond the label's simvastatin study. Pairs with other peptides are rated in the Interaction Checker.

PubMed

  • itraconazole and other strong CYP3A4 inhibitors: 28 volunteers took a single 2 mg dose, 14 of them after itraconazole 400 mg then 200 mg daily, to measure how the CYP3A4 inhibitor changed exposure to tesofensine, which the study treats as a CYP3A4 substrate with a long half-lifeLehr T, et al. "Semi-mechanistic population pharmacokinetic drug-drug interaction modelling of a long half-life substrate and itraconazole." Clin Pharmacokinet, 2010;49(1):53-66. PMID: 20000889. PubMed

The other hits are pharmacokinetic modelling papers and a rat appetite study.

TestagenNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Testagen"[tiab] OR "Testis peptide bioregulator"[tiab] OR "KEDG tetrapeptide (Khavinson testis)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TetracosactideFrom the label

FDA label (Cortrosyn), section 7

  • glucocorticoids and spironolactone: may falsely raise plasma cortisol; stop on the day of testing (longer for long-acting glucocorticoids)Amphastar. CORTROSYN (cosyntropin) for injection, US prescribing information, section 7. DailyMed version effective January 30, 2025, read October 5, 2026.
  • oestrogen-containing drugs: may raise total plasma cortisol; stop 4 to 6 weeks before testingAmphastar. CORTROSYN (cosyntropin) for injection, US prescribing information, section 7. DailyMed version effective January 30, 2025, read October 5, 2026.
Tetrapeptide-1None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Tetrapeptide-1"[tiab] OR "Leu-Pro-Thr-Val"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Tetrapeptide-21None found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Tetrapeptide-21"[tiab] OR "GEKG"[tiab] OR "GEKG peptide"[tiab] OR "Gly-Glu-Lys-Gly"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2025 cell study of platelet-rich fibrin with bioactive peptides on dermal fibroblasts; not a drug interaction study in people.

Tetrapeptide-26None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Tetrapeptide-26"[tiab] OR "SPLQ-NH2"[tiab] OR "Ser-Pro-Leu-Gln-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Tetrapeptide-30None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Tetrapeptide-30"[tiab] OR "PKEK"[tiab] OR "Pro-Lys-Glu-Lys"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TeverelixNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("teverelix"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Both hits are sheep studies of GnRH antagonists with other hormones; no human drug-interaction study.

ThioninNone found

No interaction study was found in a PubMed search on 2026-11-08 (7 hits read).

The search("thionin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

7 hit(s) read October 30, 2026 (30840914, 27208129, 26819228, 16377744, 8571430, 7530927, 7940586): none studies a drug interaction with a thionin in people

ThiostreptonNone found

No interaction study was found in a PubMed search on 2026-10-28 (14 hits read).

The search("Thiostrepton"[tiab] OR "thiostreptone"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

14 hits, all cell or animal studies of thiostrepton combined with anticancer drugs (cisplatin, paclitaxel, carboplatin, bortezomib, arsenic trioxide) or antibiotics; none is a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Thrombomodulin Alfa"[tiab] OR "Recomodulin"[tiab] OR "ART-123"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 2020 Japanese registry analysis of sepsis survival with thrombomodulin alfa (ART-123) and polymyxin B-immobilised haemoperfusion, an outcome comparison rather than a drug interaction study.

ThymalinNone found

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Thymalin"[tiab] OR "Timalin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit is a mouse toxicology study of thymus and spleen morphology after combined exposure to a carcinogen, not a drug interaction.

ThymoctonanNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Thymoctonan"[tiab] OR "THF-gamma 2"[tiab] OR "Thymic humoral factor gamma 2"[tiab] OR "THF-γ2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 1996 mouse study adding THF-gamma 2 to anticancer chemotherapy in Lewis lung carcinoma; not a drug interaction study in people.

ThymodepressinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Thymodepressin"[tiab] OR "Orilotimod"[tiab] OR "APO805"[tiab] OR "gamma-D-Glu-D-Trp"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ThymogenNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Thymogen"[tiab] OR "Timogen"[tiab] OR "Glu-Trp dipeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ThymomodulinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Thymomodulin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

PubMed

  • interferon alfa-2a and interleukin-2: given in sequence with both to 17 patients with metastatic renal cell cancer; no objective responses, toxicity driven mainly by interleukin-2, and the authors advised against the combinationDi Lauro L, et al. "Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer." Tumori, 1995;81(1):42-4. PMID: 7754540. PubMed

Most of the nine hits are false matches on the abbreviation TP (triptolide, testosterone propionate, theophylline).

Thymosin α1In the checker

PubMed

  • interferon alfa-2b (34 people with chronic hepatitis C): the combination gave a higher end-of-treatment biochemical and virological response than interferon aloneMoscarella, S. et al. (1998). Interferon and thymosin combination therapy in naive patients with chronic hepatitis C: preliminary results. Liver, 18(5), 366-369. PubMed
  • zidovudine and interferon alfa (HIV): in vitro the combination did not interfere with zidovudine's antiviral activity; the three-drug combination was well tolerated over 12 monthsGaraci, E. et al. (1994). Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. International Journal of Clinical & Laboratory Research, 24(1), 23-28. PubMed

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

Both are combination-therapy trials, not pharmacokinetic interaction studies. The other ten hits are cell or animal studies, a retrospective survival analysis and studies of other thymic peptides. 'TA1' was left out of the query as an ambiguous abbreviation. Pairs with other peptides are rated in the Interaction Checker.

Thymosin β4None found

No interaction study was found in a PubMed search on 2026-10-06 (7 hits read).

The search("Thymosin beta-4"[tiab] OR "thymosin beta 4"[tiab] OR "thymosin beta4"[tiab] OR "Thymosin β4"[tiab] OR "RGN-259"[tiab] OR "TMSB4X"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are laboratory and animal studies (one of thymosin beta-4 with ciprofloxacin in animal keratitis); no human interaction study. The query adds the spelled-out 'thymosin beta-4' forms, which the entry's aliases lack.

ThymostimulinNone found

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("Thymostimulin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit: a 1997 laboratory study of thymostimulin added to blood cells from breast-cancer patients after or during chemotherapy; not a drug interaction study in people.

ThymulinNone found

No interaction study was found in a PubMed search on 2026-10-05 (11 hits read).

The search("Thymulin"[tiab] OR "Facteur Thymique Sérique"[tiab] OR "Serum Thymic Factor"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are rodent, cell and rosette-assay studies; no human interaction study.

No interaction study was found in a PubMed search on 2026-10-28 (1 hit read).

The search("thyrotropin alfa"[tiab] OR "Thyrogen"[tiab] OR "recombinant human thyrotropin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are radioiodine and imaging studies, not drug-interaction studies; the Thyrogen label has no drug-interaction section.

TifuvirtideNone found

No interaction study was found in a PubMed search on 2026-11-04 (1 hit read).

The search("tifuvirtide"[tiab] OR "T-1249"[tiab] OR "T1249"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The single hit is a cell study combining the first and next generations of HIV fusion inhibitors, which found strong synergy against enfuvirtide-sensitive and resistant strains (PMID 19493996, "Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strains."). It is a membrane-fusion assay, not a human interaction study. Its human studies gave it as monotherapy or inside an unchanged failing regimen and published no interaction data, and no pharmacokinetic study of it exists, so no human interaction study was found.

TiplimotideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Tiplimotide"[tiab] OR "NBI-5788"[tiab] OR "NBI5788"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TirzepatideIn the checker

FDA labels (section 7 and Limitations of Use) and PubMed

  • other tirzepatide-containing products or any GLP-1 receptor agonist: coadministration is not recommended (Zepbound's Limitations of Use)Eli Lilly and Company. ZEPBOUND (tirzepatide) injection, US prescribing information, section 7 and Limitations of Use (section 1). DailyMed set 487cd7e7, version 40, effective August 28, 2026, read October 27, 2026.
  • insulin or an insulin secretagogue (e.g., a sulfonylurea): higher risk of hypoglycaemia; consider lowering their dose when starting tirzepatideEli Lilly and Company. MOUNJARO (tirzepatide) injection, US prescribing information, section 7. DailyMed set d2d7da5d, version 40, effective August 27, 2026, read October 27, 2026.
  • oral medications, especially those with a narrow therapeutic index (e.g., warfarin) or that depend on threshold concentrations: delayed gastric emptying may change their absorption; monitor these patientsEli Lilly and Company. MOUNJARO (tirzepatide) injection, US prescribing information, section 7. DailyMed set d2d7da5d, version 40, effective August 27, 2026, read October 27, 2026.
  • oral hormonal contraceptives: switch to a non-oral method or add a barrier method for 4 weeks after starting and for 4 weeks after each dose increase; non-oral hormonal contraceptives should not be affectedEli Lilly and Company. ZEPBOUND (tirzepatide) injection, US prescribing information, section 7 and Limitations of Use (section 1). DailyMed set 487cd7e7, version 40, effective August 28, 2026, read October 27, 2026.
  • lithium (case report): lithium toxicity (level 1.7 mEq/L) after a switch from semaglutide to tirzepatide; the authors rate the interaction probableBurson, J. R. & Leung, J. G. (2026). Lithium toxicity following a change from semaglutide to tirzepatide for weight loss management. The Mental Health Clinician, 16(1), 34-38. PubMed
  • sustained-release oral morphine (case report): life-threatening opioid toxicity six weeks after tirzepatide was started, with acute kidney injuryMataraarachchi, N. E. et al. (2026). Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine. Cureus, 18(8), e115380. PubMed
  • heart-failure medicines (angiotensin receptor-neprilysin inhibitors, beta blockers, mineralocorticoid receptor antagonists, SGLT2 inhibitors; case series): three patients developed symptomatic hypotension after starting tirzepatide and their regimens were reducedKido, K. et al. (2023). Call to action for drug interactions between tirzepatide and heart failure guideline-directed medical therapy. Journal of the American Pharmacists Association, 64(1), 169-173. PubMed

Pairs for this compound are rated in the Interaction Checker, with the source behind each rating.

The three PubMed sources are case reports or a case series: they can raise an interaction but cannot establish one. The other hits are reviews, animal studies, a hypothesis paper and further case reports (hydrochlorothiazide with high calcium; SGLT2 inhibitors with ketoacidosis). The oral-contraceptive advice rests on the label's own pharmacokinetic data. Pairs with other peptides are rated in the Interaction Checker.

TLQP-21None found

No interaction study was found in a PubMed search on 2026-11-06 (1 hit read).

The search("tlqp-21"[tiab] OR "tlqp21"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (18173805): none studies a drug interaction with TLQP-21 in people

TozuleristideNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Tozuleristide"[tiab] OR "BLZ-100"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TraferminNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Trafermin"[tiab] OR "Fiblast"[tiab] OR "Regroth"[tiab] OR "recombinant human FGF-2"[tiab] OR "rhFGF-2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TrevogrumabNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Trevogrumab"[tiab] OR "REGN1033"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Trifluoroacetyl Tripeptide-2"[tiab] OR "TFA-VYV"[tiab] OR "TFA-Val-Tyr-Val"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Tripeptide-10 Citrulline"[tiab] OR "T10-C"[tiab] OR "Decorinyl (trade name)"[tiab] OR "Lys-Asp-Ile-Cit-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Tripeptide-29None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Tripeptide-29"[tiab] OR "Gly-Pro-Hyp"[tiab] OR "Glycyl-prolyl-hydroxyproline"[tiab] OR "collagen tripeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Tripeptide-32None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Tripeptide-32"[tiab] OR "Chronolux"[tiab] OR "STP-NH2"[tiab] OR "Ser-Thr-Pro-NH2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TriptorelinFrom the label

FDA label, section 7 (no drug-drug interaction studies were conducted)

  • hyperprolactinaemic drugs: should not be used together, since hyperprolactinaemia reduces pituitary GnRH receptorsTRELSTAR (triptorelin), US prescribing information, section 7. DailyMed version 20, effective June 30, 2026, read October 5, 2026.
TrivehexinNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Trivehexin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TrofinetideFrom the label

FDA label, section 7

  • sensitive oral CYP3A and/or P-gp substrates: trofinetide can raise their levels; closely monitor for adverse reactions when a small increase could be seriousAcadia. DAYBUE (trofinetide) US prescribing information, section 7. DailyMed version of September 4, 2026, read October 3, 2026.
TrofolastatNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Trofolastat"[tiab] OR "MIP-1404"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
TuftsinNone found

No interaction study was found in a PubMed search on 2026-10-28 (18 hits read).

The search("Tuftsin"[tiab] OR "Thr-Lys-Pro-Arg"[tiab] OR "TKPR"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

18 hits, all animal or cell studies (tuftsin with liposomal amphotericin B or nystatin, diethylcarbamazine, neurotensin and others); none is a drug interaction study in people.

TyrothricinNone found

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Tyrothricin"[tiab] OR "tyrocidine-gramicidin complex"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: a 2016 chitosan film formulation and a 1979 mouse study against herpes simplex virus; neither is a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Ubiquicidin 29-41"[tiab] OR "UBI 29-41"[tiab] OR "Ubiquicidin(29-41)"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
UBT251None found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("UBT251"[tiab] OR "UBT-251"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
UlaritideNone found

No interaction study was found in a PubMed search on 2026-09-30 (6 hits read).

The search("Ularitide"[tiab] OR "Urodilatin"[tiab] OR "INN-00835"[tiab] OR "URO-7"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The six hits are animal and in vitro studies of vascular and airway responses; no interaction study in people.

UlimorelinNone found

No interaction study was found in a PubMed search on 2026-10-03 (0 hits read).

The search("Ulimorelin"[tiab] OR "TZP-101"[tiab] OR "TZP101"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
UrocortinNone found

No interaction study was found in a PubMed search on 2026-10-30 (32 hits read).

The search("Urocortin"[tiab] OR "urocortin 1"[tiab] OR "urocortin-1"[tiab] OR "urocortin I"[tiab] OR "Ucn1"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

All hits are animal, cell or primate pharmacology (CRF-receptor studies, mdx-mouse co-treatment, urocortin 2 experiments); none is a human drug-drug interaction study of urocortin.

Urocortin 2None found

No interaction study was found in a PubMed search on 2026-10-28 (8 hits read).

The search("urocortin 2"[tiab] OR "urocortin-2"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are animal and cell studies of urocortin 2 with other agents; none is a human drug-interaction study.

Urocortin 3None found

No interaction study was found in a PubMed search on 2026-11-06 (1 hit read).

The search("urocortin 3"[tiab] OR "urocortin-3"[tiab] OR "UCN3"[tiab] OR "stresscopin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (20060787): none studies a drug interaction with urocortin 3 in people

PubMed

  • clomiphene: co-treatment raised ovulation rates (72.4% against 34.2%) and lowered the FSH dose needed in clomiphene-resistant PCOSClomiphene citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial (2013). PubMed
  • metformin: pre-treatment and co-administration increased mono-ovulatory cycles in insulin-resistant PCOSA randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination (2005). PubMed
UroguanylinNone found

No interaction study was found in a PubMed search on 2026-10-28 (5 hits read).

The search("uroguanylin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits are animal studies (obese mice, isolated rat kidney, rat hepatocytes) and a review of the uroguanylin pain pathway; none studies a drug interaction with uroguanylin given to people.

Urotensin IINone found

No interaction study was found in a PubMed search on 2026-10-28 (13 hits read).

The search("urotensin II"[tiab] OR "urotensin-II"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Hits are animal and cell studies of urotensin II with other vasoactive agents or receptor antagonists; none is a human drug-interaction study.

No interaction study was found in a PubMed search on 2026-11-03 (0 hits read).

The search("urotensin II-related peptide"[tiab] OR "urotensin-related peptide"[tiab] OR "URP"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No hits. URP has never been given to a person, so no interaction with a drug has been studied.

UtreglutideNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("utreglutide"[tiab] OR "GL0034"[tiab] OR "GL-0034"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
VancomycinFrom the label

FDA label, section 7 (which states that no interaction studies were done)

  • any drug: the label records that no drug interaction studies have been conducted for the oral capsulesVancocin (vancomycin hydrochloride) capsules, US prescribing information, section 7. DailyMed version 12, effective December 22, 2025, read September 30, 2026.

Oral vancomycin acts in the gut and is minimally absorbed; the intravenous product is a separate label with its own warnings.

VapreotideNone found

No interaction study was found in a PubMed search on 2026-10-03 (6 hits read).

The search("Vapreotide"[tiab] OR "RC-160"[tiab] OR "BMY 41606"[tiab] OR "Sanvar"[tiab] OR "Octastatin"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

None of the 6 hits is a human interaction study: they are a cell study of vapreotide at the NK1 receptor, a mouse inflammation model, and rodent cancer studies combining somatostatin and LHRH analogues.

VasopressinFrom the label

FDA label, section 7

  • catecholamines: additive effect on blood pressure and other haemodynamic parameters; monitor and adjust the vasopressin dosePar Health. VASOSTRICT (vasopressin) injection, US prescribing information, section 7. DailyMed version of May 20, 2026, read September 30, 2026.
  • indomethacin: may prolong vasopressin's effect on cardiac index and systemic vascular resistancePar Health. VASOSTRICT (vasopressin) injection, US prescribing information, section 7. DailyMed version of May 20, 2026, read September 30, 2026.
  • ganglionic blocking agents: may increase the pressor responsePar Health. VASOSTRICT (vasopressin) injection, US prescribing information, section 7. DailyMed version of May 20, 2026, read September 30, 2026.
  • drugs that cause SIADH: may increase the pressor responsePar Health. VASOSTRICT (vasopressin) injection, US prescribing information, section 7. DailyMed version of May 20, 2026, read September 30, 2026.
  • drugs that cause diabetes insipidus: may decrease the pressor responsePar Health. VASOSTRICT (vasopressin) injection, US prescribing information, section 7. DailyMed version of May 20, 2026, read September 30, 2026.

No interaction study was found in a PubMed search on 2026-11-06 (2 hits read).

The search("vasostatin-1"[tiab] OR "vasostatin-2"[tiab] OR "vasostatin-i"[tiab] OR "vasostatin-ii"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hit(s) read October 30, 2026 (21799030, 16445995): none studies a drug interaction with chromogranin-A vasostatin in people

VeldoreotideNone found

No interaction study was found in a PubMed search on 2026-11-05 (0 hits read).

The search("veldoreotide"[tiab] OR "DG3173"[tiab] OR "DG-3173"[tiab] OR "somatoprim"[tiab] OR "PTR-3173"[tiab] OR "COR-005"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
VentfortNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Ventfort"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Vessel dilatorNone found

No interaction study was found in a PubMed search on 2026-10-30 (2 hits read).

The search("Vessel dilator"[tiab] OR "proANP 31-67"[tiab] OR "proANP(31-67)"[tiab] OR "proANF 31-67"[tiab] OR "pro-atrial natriuretic peptide 31-67"[tiab] OR "atrial natriuretic peptide prohormone 31-67"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The two hits are a human co-infusion of two atrial-natriuretic-peptide prohormone fragments (vessel dilator given with kaliuretic hormone) and a conscious-monkey study; neither is a human drug-drug interaction study with a medicine.

VesugenNone found

No interaction study was found in a PubMed search on 2026-10-05 (0 hits read).

The search("Vesugen"[tiab] OR "KED tripeptide"[tiab] OR "Lys-Glu-Asp"[tiab] OR "Vascular tripeptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
VilonNone found

No interaction study was found in a PubMed search on 2026-10-03 (2 hits read).

The search("Vilon"[tiab] OR "Lys-Glu"[tiab] OR "KE peptide"[tiab] OR "Lysylglutamic acid"[tiab] OR "AB-0 peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

Neither hit is a human interaction study: 14743610 is a mouse study in which giving vilon at the same time as cyclophosphamide shortened survival (cited on the entry), and 10931531 matched only because a kinase-inhibitor peptide's sequence contains Lys-Glu.

VIPNone found

No interaction study was found in a PubMed search on 2026-09-30 (91 hits read).

The search("aviptadil"[tiab] OR "vasoactive intestinal peptide"[ti]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits are laboratory studies of VIP's physiology alongside other mediators (histamine, carbachol, retinoic acid); none is a drug interaction study of aviptadil in people.

PubMed (the Pluvicto label carries no drug-interactions section)

  • various drugs, reviewed across 83 studies of therapeutic radiopharmaceuticals: interactions reported, most absent from product information and most at low evidence levels (88% CEBM level 3 or 4); the abstract does not list Pluvicto-specific pairsSystematic review of drug interactions involving therapeutic radiopharmaceuticals, including lutetium-177 vipivotide tetraxetan (2026). PubMed

Of six hits, the others are a safety comparison, preclinical combination studies and a dosimetry study, not interaction studies.

VirginiamycinNone found

No interaction study was found in a PubMed search on 2026-10-28 (15 hits read).

The search("Virginiamycin"[tiab] OR "Stafac"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

15 hits: studies of the synergy between virginiamycin's own two components (streptogramins A and B) on the bacterial ribosome, a 1994 broiler study of growth promoters' effect on monensin toxicity, turkey growth, absorption with polyethylene glycol and a 1972 report of allergic contact dermatitis; none is a drug interaction study in people.

VisolutenNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Visoluten"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
VK2735None found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("VK2735"[tiab] OR "VK-2735"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
VMT-α-NETNone found

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("VMT-α-NET"[tiab] OR "VMT-alpha-NET"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
VoclosporinFrom the label

FDA label, section 7

  • strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin): contraindicated: raise voclosporin exposureAurinia. LUPKYNIS (voclosporin) US prescribing information, section 7. DailyMed version of August 25, 2026, read October 3, 2026.
  • moderate CYP3A4 inhibitors (verapamil, fluconazole, diltiazem): reduce the voclosporin dose as the label specifiesAurinia. LUPKYNIS (voclosporin) US prescribing information, section 7. DailyMed version of August 25, 2026, read October 3, 2026.
  • grapefruit: avoid food or drink containing grapefruitAurinia. LUPKYNIS (voclosporin) US prescribing information, section 7. DailyMed version of August 25, 2026, read October 3, 2026.
  • strong and moderate CYP3A4 inducers: avoid: lower voclosporin exposure and may reduce efficacyAurinia. LUPKYNIS (voclosporin) US prescribing information, section 7. DailyMed version of August 25, 2026, read October 3, 2026.
  • narrow-therapeutic-window P-gp substrates: voclosporin inhibits P-gp; reduce the substrate's dose if neededAurinia. LUPKYNIS (voclosporin) US prescribing information, section 7. DailyMed version of August 25, 2026, read October 3, 2026.
  • OATP1B1/1B3 substrates (e.g. simvastatin): voclosporin inhibits these transporters and can raise substrate exposureAurinia. LUPKYNIS (voclosporin) US prescribing information, section 7. DailyMed version of August 25, 2026, read October 3, 2026.
VosoritideNone found

No interaction study was found in a PubMed search on 2026-09-30 (1 hit read).

The search("Vosoritide"[tiab] OR "Voxzogo"[tiab] OR "BMN 111"[tiab] OR "BMN-111"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit, a laboratory study combining a phosphatase inhibitor with BMN-111 to enhance bone growth in a model; not an interaction study in people.

WE-14None found

No interaction study was found in a PubMed search on 2026-11-06 (1 hit read).

The search("we-14"[tiab] OR "we14"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

1 hit(s) read October 30, 2026 (9098742): none studies a drug interaction with WE-14 in people

XeninNone found

No interaction study was found in a PubMed search on 2026-10-28 (4 hits read).

The search("xenin"[tiab] OR "xenin-25"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

The hits are animal or isolated-pancreas studies, including xenin analogues co-administered with other peptides in mice and xenin-25 potentiating GIP; none is a human drug-interaction study.

No interaction study was found in a PubMed search on 2026-10-28 (2 hits read).

The search("Zadavotide Guraxetan"[tiab] OR "PSMA I&T"[tiab] OR "PSMA-I&T"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

2 hits: a 2025 rat study of para-aminohippurate reducing kidney uptake of radiopharmaceuticals and a 2016 review of PSMA I&T; neither is a drug interaction study in people.

No interaction study was found in a PubMed search on 2026-10-28 (0 hits read).

The search("Zelenectide Pevedotin"[tiab] OR "BT8009"[tiab] OR "BT-8009"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
Zelpultide alfaNone found

No interaction study was found in a PubMed search on 2026-11-04 (0 hits read).

The search("zelpultide alfa"[tiab] OR "zelpultide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])
ZiconotideFrom the label

FDA label, section 7 (no formal pharmacokinetic interaction studies were performed)

  • intrathecal opiates: the combination has not been studied in placebo-controlled trials and the label does not recommend itPrialt (ziconotide acetate) injection, US prescribing information, section 7. DailyMed version 4, effective September 15, 2026, read September 30, 2026.
  • CNS depressants — antiepileptics, neuroleptics, sedatives: may raise the incidence of dizziness, confusion and depressed consciousnessPrialt (ziconotide acetate) injection, US prescribing information, section 7. DailyMed version 4, effective September 15, 2026, read September 30, 2026.
  • diuretics: named with the above as raising the risk of depressed levels of consciousnessPrialt (ziconotide acetate) injection, US prescribing information, section 7. DailyMed version 4, effective September 15, 2026, read September 30, 2026.
ZilucoplanNone found

No interaction study was found in a PubMed search on 2026-09-30 (0 hits read).

The search("Zilucoplan"[tiab] OR "Zilbrysq"[tiab] OR "RA101495"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

0 hits. The label carries no interactions section; its boxed warning is about serious meningococcal infections, a risk of complement inhibition rather than an interaction.

No interaction study was found in a PubMed search on 2026-10-03 (5 hits read).

The search("Zoptarelin Doxorubicin"[tiab] OR "AEZS-108"[tiab] OR "AEZS 108"[tiab] OR "AN-152"[tiab] OR "Zoptarelin doxorubicin acetate"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

No measured human interaction study. The closest, 29204687, is a PBPK model built on phase I and II data with in vitro OATP1B3 and OCT2 inhibition; it predicted no significant change in simvastatin or metformin levels. The other four hits are cell and stability studies.

No interaction study was found in a PubMed search on 2026-11-07 (4 hits read).

The search("αct1"[tiab] OR "alphact1"[tiab] OR "act1"[tiab] OR "granexin"[tiab] OR "connexin43 mimetic peptide"[tiab]) AND ("drug interactions"[MeSH Terms] OR "drug interaction"[tiab] OR "drug-drug interaction"[tiab] OR "pharmacokinetic interaction"[tiab] OR "coadministration"[tiab] OR "co-administration"[tiab])

4 hit(s) read October 30, 2026 (34328666, 26542214, 12760852, 11451677): none studies a drug interaction with αCT1 in people

How to read it

From the label means the drug's US prescribing information was read, and its drug interactions section is summarised with the label's version and date. A label with no interactions section is recorded as such, which is not the same as a drug being safe to combine with anything.

Studied means a published study gave the compound together with another drug and reported the result. Many of these are animal or laboratory studies, and each record says so where it applies.

None found means a PubMed search for interaction studies, shown under each entry, returned nothing about the compound itself. It is a statement about the literature, not a guarantee that no interaction exists. Of the 296 entries approved nowhere (research-only), 269 are in this group.

In the checker means the compound's common pairings are rated in the Interaction Checker, which shows the source for each rating. Its row here also carries the compound's own record: the label, the published studies, or the recorded search that found none.

This page describes evidence; it is not medical advice. Anyone combining a peptide with a prescribed drug should ask the prescriber or a pharmacist.